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Iron deficiency and depression occur predominantly in women, in both 
developed and developing countries. Our aim was to improve understanding of the 
association between iron deficiency and depressive mood. We explored the role of 
fatigue in the relationship between iron deficiency and depressive mood, the effect of 
confounding factors, and whether stress was a modifier of the association of iron 
deficiency and depressive mood. Two cross-sectional data sets were used to 
implement our research objectives. One was the 1982-1984 Hispanic Health and 
Nutrition Examination Survey (HHANES). The other was an observational study with 
Spanish-speaking Mexican factory workers that was conducted in 2001. In the 
HHANES, iron status was represented by the continuous variable body iron stores. 
Severe depressive mood and a fatigue index were assessed with a modified Center of 
Epidemiologic Studies Depression Scale. Stress was operationalized by variables 
representing social and biological stressors. In the Mexican study, the variables were 
hemoglobin, the Beck Depression Inventory, the Fatigue Severity Scale, and cortisol 
response over two work days. In both studies, only women who were premenopausal 
and not pregnant were included. 
Results were consistent between the two studies. With improving iron status, 
the risk of severe depressive mood decreased significantly. Fatigue had no or a minor 
impact on the effect of iron status. No confounders were identified for the main effect 
model. Stress was a significant, synergistic modifier of the association between iron 
 status and severe depressive mood. Women exposed to both stress and iron deficiency 
were at significantly higher risk of severe depressive mood compared to women who 
experienced none or one of the risk factors. In the Mexican sample, socioeconomic 
status was a negative confounder of this interaction. This research indicates that 
studies that explore the biological association between iron deficiency and depressive 
mood should focus on women who experience high stress levels. In a population with 
limited access to medical services, improving iron status in women of reproductive 
age might be a good alternative to drug therapy in order to alleviate severe depressive 
mood. 
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Chapter 1: INTRODUCTION 
Public Health Relevance 
In adults, iron deficiency (ID) and depression are disorders found 
predominantly in women of reproductive age [1-10]. Both represent a substantial 
public health burden worldwide; prevalence of iron deficiency anemia (IDA) in 
reproductive age women is 48% [1]. Likewise, prevalence of lifetime major depressive 
disorder (MDD) in women is between 1.8 and 23.1% [2]; rates of dysthymia range 
from 5.4 to 12.2% [2]. In the developing world, IDA was the 3rd leading cause of 
increased Disability-Adjusted-Life-Years (DALYs) in women aged 15 to 45 (4.1% of 
all causes of DALYs) [3]. MDD worldwide was the leading cause of DALYs, with 
13.7% of total DALYs in women, whereas in developed countries it accounted for 
19.8%. 
In the US, 5% of reproductive age women suffer from IDA; iron deficiency 
without anemia (IDNA) occurs in 11% [4]. Hispanic American women of 
reproductive age experience a wide range of ID prevalence: 4% of Mexican 
Americans have IDA [4], while between 6.5 and 20% of Hispanic American women 
experience IDNA [4, 5]. In Mexico, the prevalence of anemia (this definition includes 
all types of anemia, not only IDA) was 20.8% in non-pregnant women 12–49 years of 
age in 1999 [6]; however, this level dropped to 16% in 2006 [7]. Low transferrin 
saturation1 (a measure of IDNA) was observed in 40.5% of Mexican women in 1999 
[9].  
Prevalence of lifetime MDD of women in the US has been estimated to be 
between 6 and 21.3% [10-12]; MDD within the previous 12 months was 12.9% [10]. 
Prevalence of lifetime MDD in Hispanic Americans was 12.3% [13]. Important to 
note is that lack of acculturation appears to have a protective effect in Hispanic 
                                                 
1 Transferrin saturation quantifies the amount of transport iron in blood plasma. A value below 16% is 
considered an indicator of ID [8]. 
2 
Americans; thus, recent immigrants have lower rates of depression than those who 
were born in the US or are more acculturated [13-19]. For women in Mexico, the 
lifetime prevalence of MDD is 15.9% [20]. MDD in the previous 12 months occurred 
in 5.8 to 7.6% of the Mexican women [20, 21], and MDD within 6 months in 5.7% 
[20]. Note that only the study of Bello et al. [21] was nationally representative, while 
the other two studies represent urban centers [20]. 
ID in the Brain: Effect on Neurotransmitters and Depression  
Serum ID has been demonstrated to translate directly into brain ID [22-24]. 
Moreover, iron is a cofactor in the synthesis of serotonin, dopamine, and 
norepinephrine [25-27]. It stands to reason that ID should result in lower 
concentrations of these three neurotransmitters in the brain. The actual association 
between ID and the neurotransmitters serotonin and norepinephrine, though, is 
inconsistent. One study with ID animals showed the expected decrease in serotonin 
concentrations [28]; another found no change [29]. Activity of tryptophane 
hydroxylase, the iron-dependent enzyme that is part of the pathway that converts 
tryptophane to serotonin, appears to be unchanged [28, 30]. An increase [30] or 
decrease [30] in serotonin metabolites with ID was observed. The neurotransmitter 
norepinephrine has rarely been studied. It appears to remain unchanged [30] or is 
higher [31, 32] in ID rats. Better information is available on dopamine: ID appears to 
decrease the density of dopamine receptor D2 [33, 34]; dopamine transporters are 
downregulated as well, resulting in a slower reuptake of dopamine in the presynaptic 
cell [35, 36]. In conjunction, dopamine levels have been found to be higher in ID rats 
[29, 32]; dopamine metabolites are lower [29]. Last, monoamine oxidase, which 
breaks down all three neurotransmitters, has been shown to decrease in ID animals 
[28, 30]. 
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In humans, observational studies generally confirm that ID is associated with 
depression [37-40], albeit one study found no relationship [41]. A total of 5 
supplementation trials (4 with placebo controls, and 1 with a high-iron-diet control) 
were undertaken to explore the same association. Four of the 5 trials found no 
association [42-45]; all of these trials were undertaken with female participants from 
developed countries (USA, Australia, and Switzerland). Only one study with poor, 
postpartum South African women reported an effect of the supplementation compared 
to placebo [46].  
ID, Fatigue, and Depression 
ID has been associated with a decreased ability to perform physical labor [47-
51], and with perceived fatigue [39, 43-45, 52]. In addition, fatigue is associated with 
depression, to the extent that it is a diagnostic criterion for all mood disorders related 
to depression [53]. Thus, correlations between fatigue and depression are generally 
between r=0.3 and 0.6 [54-59]. The associations between ID, fatigue, and depression 
have not been explored, even though all three have been assessed together in a number 
of studies [38, 39, 41, 43, 45]. This is of importance, since the lack of evaluation of the 
effect of fatigue on the relationship between ID and depression might result in 
misclassification. For example, participants who experience higher fatigue (but not 
depression) due to ID would nevertheless be rated as more depressed in a depression 
assessment instrument; this would be a consequence of their increased scores in the 
fatigue section. Thus, ID individuals would be at a statistically higher risk of 
depression, even though they are in fact not more depressed, just more fatigued. This 
potential for misclassification was recognized by Pollitt [60].  
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ID, Confounders, and Depression 
ID and depression in women share several underlying causes. These include 
low socioeconomic status (SES) [4, 12, 18-21, 61-86]; age [4, 10, 18, 20, 21, 74, 82, 
86, 87]; ethnic group [4, 12, 71, 83, 84, 88, 89]; perceived lack of control over one’s 
environment or health [17, 63, 78, 90]; social isolation [81, 91]; disrupted marital 
status including divorce, widowhood, and separation [18, 20, 65, 68, 74, 92, 93]; and 
postpartum status or higher parity [4, 83-86, 94]. However, the majority of articles 
investigating the association between ID and depression in humans do not indicate 
control of confounders [37, 40, 41, 43, 45, 46], thus increasing the likelihood of 
spurious relationships.  
ID, Stressor Exposure, and Depression: Interaction and Biological Mechanisms 
It is intriguing that the 1 of 5 iron supplementation trials that showed 
significant effects of supplementation on depressive mood took place in a developing 
country with postpartum women [46]. In contrast, the remaining 4 trials all had 
negative results [42-45]; participants were women in developed countries who were 
not in the postpartum stage of their life. It stands to reason that these different results 
might be due to the interaction of stressor exposure (poverty and postpartum status) 
and ID. If both exposures act independently on neurotransmitter availability to 
postsynaptic neurons, then a synergistic increase of the risk of depression appears 
possible. 
Stressor exposure is a well-established risk factor of depression. Chronic 
exposure to stressors overuses the stress system of the hypothalamo-pituitary-adrenal 
(HPA) axis [95]. The HPA axis is ultimately a system that evolved in order to respond 
to short-term (acute) stress [95, 96]. The overuse of this response system is called 
allostatic overload [95, 97]. A large number of stressors have been detected in 
previous research: low SES [64, 98], job strain [99-101], number of hours worked 
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[102], sleep deprivation [103], low social support at work [104] or in one’s personal 
life [102], home strain (number of children) [102, 105], daily perceived stressors 
[106], and negative affect [106]. Buffers of stressors are good coping ability, high self-
efficacy, and good social support [107-110]. In the literature, identified stressors that 
are associated with an increased risk for depression include low SES [64-66], food 
insecurity [111], not being married [65, 93], low social support [91], lack of control at 
home or at work [90], job strain [100] or longer-term unemployment [65]. Low mood 
has also been reported as a result of a trial inducing sleep deprivation [112]. 
In recent years, the biological mechanisms that associate stressor exposure or 
perceived stress and depression are better understood. The interlacing of three 
complex systems – stress, immunity, and neurotransmitters – appears to explain the 
association. 
Stressor exposure initiates the discharge of corticotrophine releasing hormone 
(CRH) from the hypothalamus [96]. CRH is taken up by the pituitary gland, which in 
turn produces adrenocorticotropin (ACTH). ACTH initiates the release of cortisol 
from the adrenal gland. Cortisol increases glucose availability, effectively providing 
energy for a potentially life-saving “fight and flight” response [113]. Downregulation 
of cortisol output occurs via a negative feedback loop with two types of cortisol 
receptors in the brain. The mineralocorticoid receptors prevent a disturbance of the 
cortisol homeostatis [114]. The glucocorticoid receptors, which have a low affinity for 
cortisol, downregulate cortisol output back to normal levels after a stress response 
[114]. Binding of larger amounts of cortisol on the glucocorticoid receptors, therefore, 
decreases the output of the HPA cascade [115]. 
The key hormones of the HPA axis, which are involved in feedback loops with 
the immune system and the brain, are CRH and cortisol [96].  
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Two phenomena have been observed in stressed individuals: hypercortisolism 
and hypocortisolism. Hypercortisolism is usually considered a sign of acute stress [96, 
113], and it is associated with depression [115, 116]. The causal mechanism is 
probably an impairment of the negative feedback-loop of cortisol to HPA cascade 
[115]; specifically, glucocorticoid receptors might not be as sensitive to cortisol as in 
healthy individuals [117, 118].  
Hypocortisolism is thought to be a consequence of chronic stress [119] or 
previous traumatic experience [113, 115, 120, 121]. It is characterized by cortisol 
levels that are lower than normal and/or a blunted stress response [120-122]. 
Hypocortisolism might be caused by one or several of the following mechanisms: a) 
adrenal exhaustion (either primary or after prolonged periods of high cortisol output), 
b) downregulation of CRF after a period of hypersecretion, c) CRF hypersecretion and 
pituitary CRF receptor downregulation, d) increased sensitivity of glucocorticoid 
receptors, or e) morphological changes in tissues involved in the HPA axis [115, 120, 
121]. Hypocortisolism is associated with depression, but also with a large number of 
other disorders such as chronic pain, arthritis, asthma, posttraumatic stress disorder, 
obesity, or fatigue (chronic fatigue syndrome), to name a few [96, 113, 115, 119, 120, 
122, 123].  
All types of stressors (acute or chronic) are associated with activation of the 
immune system and the release of proinflammatory cytokines such as tumor necrosis 
factor, interleukin-1, and interleukin-6 [115]. When negative feedback of cortisol is 
inhibited such as occurs in MDD, acute phase proteins and plasma and central nervous 
system proinflammatory cytokines are upregulated [115].  
Originally, depression was considered solely a consequence of low 
concentrations of neurotransmitters in the synaptic cleft [124]. Therefore, signal 
transmission from one nerve cell to the next was impaired. Evidently serotonin, 
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norepinephrine, and dopamine were the primarily involved neurotransmitters [114, 
122, 124-129]. In addition, evidence attributes depression to insufficient sensitivity of 
dopamine receptors (called D2-like receptors) [126, 127].  
Recently, depression is seen as a consequence of an inflammatory immune 
response [115, 130-134], which in turn can be activated by stress [115]. The 
accumulated evidence is substantial.  
In the psychoneuroendocrinological literature the phenomenon is described as 
“cytokine-induced sickness behavior” [132, 135, 136]. Elevated cytokine levels induce 
symptoms such as loss of appetite, sleepiness, withdrawal, fear, and fatigue [130, 133, 
135, 136], probably as a consequence of the modulation of the neurotransmitters 
serotonin, norepinephrine, and dopamine in brain areas that are associated with 
emotional regulation and psychomotor function and reward [137]. It is striking how 
much sickness behavior mirrors the symptoms of depression. Thus it is thought that 
depression and sickness behavior may be due to the same or to a similar mechanism, 
inflammation in the brain [132, 135-137]. 
It has been shown that high levels of proinflammatory cytokine in plasma 
correspond to high cytokine levels in the brain [115, 130, 136]. Therapies involving 
the administration of the cytokine interferon-α frequently induce severe depression as 
a side effect [132, 133, 137].2 Animals that exhibit cytokine-induced sickness-
behavior recovered when treated with cytokine antagonists or anti-inflammatory 
cytokines [137]. In humans, cytokines (interleukin-6) appear to be upregulated in 
melancholic MDD compared to minor depression or non-depressed subjects [96]. 
Antidepressant treatment appears to reverse this dysfunction: patients who exhibit 
depression as a side effect of cytokine treatment can go into remission [132, 137]. In 
fact, antidepressant treatment reestablishes the normal inhibitory control of cortisol on 
                                                 
2 Interferon-α activates other proinflammatory cytokines such as interleukin-6, interleukin-1, and tumor 
necrosis factor [138]. 
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immune cells [115]. It has also been found to decrease proinflammatory cytokines and 
to increase anti-inflammatory cytokines [137, 139].  
The two states of abnormal cortisol levels, hypo- and hypercortisolism, have 
both been linked to increased circulating cytokine concentration.  
The association between high cortisol concentrations and/or stressor exposure, 
high proinflammatory cytokine levels, and depression is well established. Apparently, 
moderate stressor exposure results in a subsequent upregulation of proinflammatory 
cytokines [115, 120, 137, 140]. High circulating cortisol concentrations are received 
by cortisol receptors on lymphocytes and normally downregulate their 
proinflammatory cytokine output [96]. Thus, glucocorticoids act as anti-inflammatory 
agents [96, 115, 120, 121]. Similarly, while acute stressor exposure initially shows no 
reactivity of the immune system, a subsequent upregulation of immune response can 
be observed [120, 130, 137]. In general, healthy subjects without MDD show immune 
suppression when exposed to high cortisol levels, while subjects with MDD show 
reduced responsiveness to this cortisol challenge [115]. This is thought to be due to 
decreased sensitivity of lymphocytes to cortisol stimulus [141]. Evolutionary theory 
has been employed to expand on this evidence: individuals with a ready-to-act 
immune system are at an advantage compared to their less responsive peers since they 
have a better chance of survival (and subsequent reproduction) when faced with 
physical threat and potential injury [115, 122].  
Depression has also been associated with hypocortisolism and/or reduced 
responsitivity to stressors [122, 142, 143]. A second hypothesis of the association 
between stress and depression has therefore been developed. Since high circulating 
cortisol levels act as immune system supressants, inhibiting the secretion of 
proinflammatory cytokine [96, 115, 120, 121], low cortisol levels might be responsible 
for a disinhibition of the immune system and for excessive release of cytokines [119, 
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140], thereby increasing the risk for depression [115, 120, 121]. Studies have shown 
that participants exposed to chronic stress and/or with downregulated cortisol show an 
upregulated immune system [119, 120, 140]. It is thought that downregulation of 
cortisol during chronic stress might have a protective effect, since a chronically 
suppressed immune system does not allow for optimal defense against antigens during 
acute physical trauma [115, 121, 122]. 
MDD has been brought into context with both hyper- and hypocortisolism. 
Melancholic MDD, which defines a state of hyperarousal in depressive disorder [53, 
144], seems to be associated with upregulation of CRH and cortisol [96, 113, 122]. 
Twenty to 30 percent of all patients with MDD suffer from melancholic MDD [122].  
Hypocortisolism, characterized by low levels of CRH, low or normal levels of 
cortisol, or reduced responsiveness of cortisol during acute stress, appears to cause 
atypical depression3 and seasonal affective disorder [96, 113, 122, 144]; atypical 
depression is defined by increased fatigue and weight gain. It should be noted that the 
term atypical depression may be misleading since it indeed is a common diagnosis in 
MDD: 15 to 30% of MDD cases experience atypical depression [122].  
Both subtypes of depression are associated with depressive mood and lack of 
pleasure in life [122].  
Studies not differentiating between melancholic and atypical depression 
usually find a glucocorticoid hypersecretion [115]. 
Hyper- and hypocortisolism are both associated with changes in 
neurotransmitter levels. Hypercortisolemia and melancholic MDD occur together with 
upregulated norepinephrine [122], albeit studies are not entirely consistent. It has also 
been shown that exposure to acute stress increases the amount of norepinephrine in the 
brain [145]. However, patients who have symptoms concordant with hypocortisolism 
                                                 
3 Atypical depression is characterized by hypersomnia, hyperphagia, lethargy, fatigue, and apathy [122]. 
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show also an upregulation of the neurotransmitter norepinephrine [121]. It has been 
suggested that norepinephrine is centrally stimulated by cortisol or CRH [122]; in light 
of the previously mentioned evidence it seems most likely that the upregulation is due 
to CRH or cytokines. In terms of serotonin, high cortisol levels appear to increase the 
expression of its transporter gene, thus decreasing available serotonin at the synaptic 
cleft, and increasing the likelihood of depression [146, 147]. Last, low community 
SES and low personal SES – both chronic stressors – have been shown to decrease 
serotonergic responsitivity [66]. Dopamine has been investigated in context with 
cortisol as well: hypercortisolemia is associated with suppression of the mesolimbic 
dopaminergic system. Lack of dopamine might be the cause for the anhedonia of 
depression [113].  
Cytokine exposure and neurotransmitter availability are associated as well: the 
availability of serotonin appears to decrease during cytokine exposure as a result of 
degradation of tryptophane [125, 133, 137]; thus, tryptophane cannot be synthesized 
into serotonin. It appears as well that serotonin transporters are activated by 
proinflammatory cytokines, thus reducing serotonin even further [125]. Other studies, 
though, have found an increase in serotonin and norepinephrine upon release of 
proinflammatory cytokines [130, 132]. 
Finally, a note of caution is in order concerning the stated biological 
mechanisms. The interactions between the stress, immune, and neurotransmitter 
systems are complex. Numerous positive and negative feedback mechanisms exist. 
Thus, directionality is at times in question. For instance, proinflammatory cytokine 
exposure decreases the number and affinity of glucocorticoid receptors [120], thus 
creating a feedback from cytokine concentrations to the negative cortisol feedback 
loop. Other studies have found that cytokines stimulate the HPA axis [132, 133, 137]. 
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Catecholaminergic fibers project into the hypothalamus, thus probably affecting CRH 
release [122]. 
In summary, ID and stress both affect neurotransmitter availability. As a 
consequence, they could synergistically increase the risk of depression.  
The theoretical framework of this dissertation is presented in Figure 1.1. While 
ID and depression are associated, we find two pathways. One is the association 
between ID, decreased neurotransmitter concentrations in the brain, and increased risk 
of depression. The second pathway is the association between ID, fatigue, and 
depression. This would imply a misclassification of fatigued persons as depressed. 
Confounders might account partially or fully for the relationship between ID and 
depression. Last, stress might modify the association between ID and depression, 
resulting in a higher risk of depression in participants exposed to both ID and stress. 
 
Figure 1.1: Relationship between iron deficiency and depression. 
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The hypotheses in this dissertation will explore the plausibility of the 
association between ID and depressive mood. They are the following: 
1) ID increases the risk of depressive mood. 
2) The association between ID and risk of depressive mood remains significant 
despite the statistical control for fatigue, thus indicating an effect of brain ID 
on depressive mood. Nevertheless, fatigue might account for some of the 
association of ID and risk of depressive mood, which would indicate a second 
pathway via the mediator fatigue. 
3) The association between ID and risk of depressive mood is significant despite 
the statistical control of confounders. Confounder control might affect the 
strength of the association between ID and risk of depressive mood.  
4) Inclusion of stressor exposure or stress as a modifier of the association 
between ID and risk of depressive mood will show a higher risk of depressive 
mood for individuals with ID and stress, compared to all the other possible 
combinations (ID and no stress exposure, no ID and no stress exposure, and no 
ID and stress exposure). 
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Chapter 2: IRON DEFICIENCY AND DEPRESSIVE MOOD IN HISPANIC 
AMERICAN WOMEN4 
Abstract 
Background: Both iron deficiency and depression are most likely to occur in 
premenopausal women. Although an association between iron deficiency and 
depression has been shown in a number of studies, the role of fatigue, confounding, 
factors and stressor exposure either was not or was only infrequently considered.  
Objectives: To explore a) the mediating effect of fatigue in the relationship 
between iron deficiency and depression, b) the role of confounders, and c) the 
synergistic effect of stressor exposure. 
Methods: Data from 1375 Hispanic American women of Cuban, Puerto Rican, 
and Mexican descent were retrieved from the Hispanic Health and Nutrition 
Examination Survey (HHANES), 1982–1984. The women were between 20 and 55 
years of age and had not reached menopause. Exclusion criteria were menopause, 
pregnancy, abuse of cocaine or inhalants, macrocytic anemia, and ferritin levels > 200 
μg/L. Previous week’s depressive mood was assessed with the 20-statement Center of 
Epidemiological Studies – Depression scale (CESD-20). A continuous body iron store 
variable was calculated that included the iron status indicators hemoglobin, ferritin, 
protoporphyrin, and transferrin saturation. Adding the scores of three fatigue-related 
questions of the CESD-20 created a previous-week’s fatigue index. Consequently, a 
shortened version of the CESD-20 was introduced since the CESD-17 excluded the 
statements that composed the fatigue scale. Binary logistic regression analysis with the 
dichotomized CESD-17 contrasted cases with a score above the 90th percentile against 
cases with a score below the 90th percentile. Body iron stores and previous-week’s 
fatigue were the independent variables of principal interest, while other confounders 
                                                 
4 Maike Rahn, Jere D. Hass, Division of Nutritional Sciences, Cornell University, Ithaca, NY, 14853. 
14 
were considered. Interactions between iron stores and potential stressors assessed the 
synergistic effect of stressor exposure on the relationship between iron stores and 
depressive mood. All models were adjusted for complex survey sampling methods.  
Results: Of the sample, 6% were iron deficient anemic (hemoglobin < 120 g/L 
and two additional iron status indicators beyond cutoff5), and 12% were iron deficient 
without anemia (hemoglobin ≥ 120g/L, but two additional indicators beyond cutoff5). 
Body iron stores had a mean of 295 mg and ranged from –1140 mg to 1117 mg. A 
total of 18% were assessed as depressed with a CESD-20 score greater than 16 points; 
while 7.9% were above the 90th percentile of the CESD-17. Fifty percent reported 
some previous-week’s fatigue, and 3% reported high previous-week’s fatigue. The 
logistic regression model revealed that iron stores showed a significant negative 
relationship (odds ratio 0.89, confidence interval 0.82 to 0.97) with depressive mood 
after controlling for previous-week’s fatigue, socioeconomic status (SES), and ethnic 
group. Modifiers of the relationship between iron deficiency and depressive mood 
were the stressors post-pregnant and postpartum status, low SES, and low control over 
one’s health. Women with lower iron stores and higher stressor exposure were at 
greater risk of experiencing depressive mood. 
Conclusions: Iron deficiency and risk of depressive mood had an inverse 
association despite the inclusion of previous-week’s fatigue and potential confounders. 
Every 100 mg decrease of iron stores increased the odds ratio of severe depressive 
mood by 11%. The relationship was modified by post-pregnant status, socioeconomic 
status, and perceived control over one’s health. Exposure to both a stressor and low 
iron stores increased the risk of severe depressive mood significantly, while exposure 
to only one or no risk factor did not. 
                                                 
5 MCV<80 fL, ferritin <12 µg/L, transferrin saturation < 16%, protoporphyrin > 70 µg/dL 
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Introduction 
Iron deficiency (ID) and depression both occur commonly in young and 
middle-aged women. In the US, five percent of women between 20 and 49 years of 
age suffer from IDA [4], while iron deficiency without anemia (IDNA) occurs in 11 
percent. The prevalence of major depression over 12 months for women in the US was 
shown to be 12.9 percent [10].  
The relationship between ID and depression has been described frequently in 
the research literature. Observational studies generally find an association between the 
two disorders [37-40]. An exception were Hunt and Penland [41], who were not able 
to find a connection. Recently, four randomized placebo-controlled iron 
supplementation trials with non-clinical populations with mixed results have been 
added to the literature. One study included 143 female US college students with iron 
status ranging from IDA to iron sufficient. The authors were not able to establish a 
significant improvement of depression scores with iron supplementation [42, 148]. 
The second study included 52 IDNA or iron-sufficient women, and did likewise not 
find an improvement in depression scores [43]. The third trial, with 366 IDNA 
women, was also not able to establish an association between iron supplementation 
and depression [44]. The authors had excluded all women with psychiatric disorders. 
The fourth study took place with 95 women in a community near Cape Town in South 
Africa: depression scores were alleviated in IDA women after an iron supplementation 
from 6 weeks to 9 months postpartum [46]. A fifth supplementation trial with 44 
IDNA Australian women did not use a placebo group but instead used a high iron diet 
as the control condition [45]. While the iron supplemented group showed a significant 
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improvement in ferritin levels, no differences in mental health scores could be found 
between the two groups at the end of the trial.  
It is generally thought that ID results in an alteration of neurotransmitter 
concentrations in the brain, thus causing depression. Indeed, iron is a cofactor in the 
synthesis of serotonin, dopamine, and norepinephrine [25-27]. Consequently, lower 
brain iron concentration should result in lower concentrations of at least one of the 
three neurotransmitters. However, the results for serotonin and norepinephrine are not 
consistent [28-32]. The neurotransmitter dopamine gives the best indication of iron-
deficiency-induced altered nerve-signal transmission due to lower D2 dopamine 
receptor density and transport downregulation [29, 32-36]. In addition, the activity of 
monoamine oxidase, which is involved in the breakdown of all three 
neurotransmitters, seems to be reduced [28, 30]. Alteration of concentrations of 
serotonin, dopamine, and/or norepinephrine in the brain are primarily implicated as 
causes of depression [124, 149]. 
Challenging the results of the relationship between ID and depression in 
human studies, though, are a number of limitations that – to our knowledge – have 
rarely or never been addressed in the published literature. First, no study has included 
fatigue when considering the relationship between ID and depression. A number of 
studies measured all three variables [38, 39, 41, 43, 45] but did not analyze the 
interrelationships. This is of importance since fatigue is both a result of ID [39, 43-45, 
52] and a diagnostic criterion for several types of depression [53]. Hence, fatigue and 
depression are associated [54-59]. Failure to account for fatigue might result in 
misclassification of solely fatigued cases as depressed, because depression scale scores 
are likely to be higher in fatigued than in non-fatigued subjects. Pollitt [60] mentioned 
this possibility in a discussion of ID and behavior change in children. 
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Second, the majority of studies investigating the association between ID and 
depression are observational in nature, but few employed sufficient confounder 
control. Thus, the observed relationship might be caused by an unknown, underlying 
factor [60, 150]. In reality, a number of common risk factors have been identified for 
depressive mood, and lower intake of iron absorption enhancers or ID in women, such 
as lower socioeconomic status (SES) [4, 12, 18-21, 61-86], age [4, 10, 18, 20, 21, 74, 
82, 86, 87] , social isolation [81, 91], disrupted marital status or being unmarried [18, 
20, 65, 68, 74, 92, 93], perceived lack of control over one’s environment or health [17, 
63, 78, 90], ethnic group [4, 12, 71, 83, 84, 88, 89], and postpartum status or parity [4, 
74, 82-86, 94, 151, 152]. In addition, food insufficiency by itself has been identified as 
a risk factor of depressive symptoms [111]. 
It is of additional interest whether specific subpopulations might be at higher 
risk for depression: individuals experiencing stressors such as low SES might have a 
greater likelihood of depression when ID than subgroups who are exposed only to one 
or none of the risk factors. Exposure to chronic stress appears to reduce serotonin 
availability [121, 122, 145] and to increase norepinephrine concentrations [6, 7, 9, 
130, 132] in the brain via an upregulation of the non-specific plasma immune response 
and proinflammatory cytokines [115, 119, 120, 130, 136, 140]. Consequently, 
individuals exposed to chronic stress are at higher risk of atypical major depressive 
disorder (MDD) [96, 113, 122].  
Our observational study conducted in Mexico in 2001 indicates that an inverse 
association between hemoglobin and risk of severe depressive mood is indeed 
maintained when controlling for fatigue and SES covariates (Chapter 3). In addition, 
area under the cortisol curve over time of day was a modifier of this association. 
Women who were below the median of the area under the cortisol curve showed a 
significantly increasing risk of severe depressive mood with decreasing hemoglobin 
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values, while women equal to or above the median did not show a significant 
association (Chapter 4). 
In summary, three primary research questions will be explored: 1) Does fatigue 
account partially or fully for the relationship between ID and depression? 2) Is the 
relationship between ID and depression partially or fully due to confounding? and 3) 
Does exposure to stressors result in an amplification of the relationship between iron 
status and depressive mood? 
Methods 
Sample selection 
The relationship between ID and depression in women was explored with the 
Hispanic Health and Nutrition Examination Survey (HHANES), a public-use data set 
provided by the National Center of Health Statistics 
(http://www.cdc.gov/nchs/nhanes.htm). Target populations of the 1982 to 1984 survey 
were Puerto Ricans in the New York City (NYC) region, Cubans in Miami, and 
Mexicans in the Southwest of the United States. The sampling procedures of the 
HHANES were complex [153]: primary sampling units (PSUs) were identified when 
1980 census data indicated a county with a sizeable percentage of Hispanic 
population. A total of 210 PSUs were included in the sampling procedure. Criteria for 
stratification of the PSUs differed by region: in the NYC region it was the number of 
Puerto Ricans, in Miami no stratification was utilized, and in the Southwest the 
number of Hispanics, degree of urbanization, and median income were used. Selection 
of a particular household required that at least one household member claimed to be of 
Mexican, Puerto Rican, or Cuban origin. Last, the probability of selection of 
participants was based on age. Children and older adults were oversampled, with 
different weights assigned depending on ethnic group. Interviews were conducted in 
either Spanish or English.  
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Inclusion criteria for the present data set required that respondents had, at a 
minimum, completed the assessment of their iron status and depressive mood (Figure 
2.1). The adult data set of the HHANES, from which most of the variables for our 
analysis were derived, contained women age 20 and older. Exclusion criteria were the 
use of inhalants or cocaine, a current pregnancy, and menopause. Since the HHANES 
data contained no information on acute phase response indicators, ferritin values of all 
women with ferritin levels greater than 200 μg/L were recoded to missing, which 
effectively prevented their inclusion in the calculation of the body iron stores indicator 
(see below). Ferritin values greater than 200 μg/L in reproductive age women are 
considered to be artificially high as the result of an acute infection [154]. Use of 
antidepressants would have been an important exclusion criterion, but this information 
is not available in the public use data set, even though it was collected in the original 
HHANES. 
Variables 
A continuous body iron store variable was created based on an algorithm 
developed by Cook et al. [155]. The iron stores (mg) variable allowed for the inclusion 
of the iron status indicators hemoglobin, ferritin, transferrin saturation, and erythrocyte 
protoporphyrin, yielding a continuous score for all levels of iron status from 
sufficiency to depletion. Depending on the level of hemoglobin and ferritin, a total of 
3 different formulas were used to calculate iron stores. A value of iron stores of less 
than –300 mg indicated IDA (hemoglobin < 12 g/l, and ferritin < 12 µg/L), while a 
value between –300 mg and 0 mg indicated IDNA (hemoglobin ≥ 12 g/l and ferritin < 
12 µg/L). A value equal to or above 0 mg implied iron sufficiency. A 100 mg increase 
in iron stores corresponded to an 6.6 g/L increase of hemoglobin in IDA participants.  
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Figure 2.1: Derivation of sample size. 
 
OUT
N=2960 
N=1560 
N=57 
Substance abuse (cocaine, illegal  
inhalants)
N=1375 
N=230 
No ferritin values for iron store 
calculation (n=26 lost because ferritin > 
200 µg/L) 
N=49 
Anemia due to other causes than iron 
deficiency (hemoglobin<120 g/L  and 
ferritin > 12 µg/L) 
N=2 
No transferrin saturation for iron store 
calculation 
IN 
N=9643 
HHANES adult data set 
Teenagers, women and men, aged 12  years 
of age and older 
N=4292 
Women age 18 and older 
N=2903 
N=1967 
Teenagers between 12 and 18 years 
of age 
N=3384 
Men 
N=1219 
Postmenopausal 
N=113 pregnant 
N=185 
No information on relevant 
covariates: SES, ethnic group, 
potential stressors 
N=1056 
No CESD (missing for < 20 yrs)  
N=770 
No hemoglobin 
N=686 
no sampling procedures information N=1841 
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Depression in this population was assessed with the Center of Epidemiological 
Studies – Depression scale (CESD) [156]. The 20 statements of the CESD assess 
symptoms of depression over the week previous to the date of interview. The general 
domains of the scale address depressed affect, positive affect, somatic and retarded 
activity, and interpersonal issues. Answers are coded from 0 for “rarely or some of the 
time (less than 1 day)” to 3 for “most of the time (5–7 days).” The final additive score 
of a respondent can range between 0 and 60. A second questionnaire, the Diagnostic 
Interview Schedule (DIS), was used in the HHANES to assess lifetime major 
depression, minor depression, and dysthymia. The coding of the DIS questionnaire 
allowed only for differentiation between respondents with past major depressive 
episode(s) and with current major depressive episodes. 
Two fatigue variables were created for the current analysis. Previous-week’s 
fatigue was constructed out of fatigue-related statements of the CESD (Appendix E, 
CESD). Statements relating to fatigue were “I could not get going,” “My sleep was 
restless,” and “I felt that everything I did was an effort.” All three statements showed 
sufficiently high factor loadings only in the somatic and retarded activity factor [156, 
157], but not in the other factors. The scores of the three questions were added to 
create the previous-week’s fatigue index. The second fatigue variable, lifetime fatigue, 
utilized questions from the DIS: “Has there ever been a period lasting two weeks or 
more when you felt tired out all the time?”, “Have you ever had a period of two weeks 
or longer when you were sleeping too much?”, and “Has there ever been a period of 
two weeks or more when you talked or moved more slowly than is normal for you?” 
An affirmative answer was coded as 1, a negative answer as 0. The sum of the scores 
constituted the lifetime fatigue index. 
The HHANES provides a number of potential confounders of the relationship 
between ID and depression (Table 2.1). Ethnicity of the participants was coded as 
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Puerto Rican if the respondent claimed full or partial Boricuan or Puerto Rican 
descent; as Cuban if she stated full or partial Cuban or Cuban American descent; and 
as Mexican if she claimed full or partial Mexican, Mexican American, or Chicano 
descent. A number of respondents who did not rate themselves according to any of the 
three ethnic groups were summarized into a fourth category, Undetermined (Hispano, 
Latin American, American, Spanish, Spanish American, Central or South American, 
Anglo-American, or Other).  
A number of nutrients have been associated with depression and/or anemia. 
Vitamin B12 and folate deficiency appear to be correlated with mood changes [158-
163] and to cause macrocytic anemia [8, 154]. The calculation of iron stores 
automatically excludes cases with macrocytic anemia, since hemoglobin levels below 
the cutoff of 12 g/dl have to be accompanied by ferritin levels below normal; whereas 
macrocytic anemia is characterized by a hemoglobin level less than 12 g/dl and a 
ferritin level greater than or equal to 12 µg/L. To further examine the impact of 
nutrient deficiencies, a variable indicating folate deficiency was created for values of 
red blood cell folate below 140 nmol/L [8]. Treatment with zinc appears to alleviate 
symptoms of depression [164-166]. Therefore, a variable signifying inadequate zinc 
intake was calculated based on Food Frequency Records provided in the HHANES 
questionnaire. Inadequate zinc intake was defined as an intake of less than 6.8 mg per 
day, which is the estimated average requirementfor women between 18 and 50 years 
of age [167]. It has been suggested that increased consumption of omega-3 fatty acids 
(specifically docohexaenoic acid) suppresses the production of proinflammatory 
cytokines, which in turn could reduce the risk of depression [168]. Nutrient intake data 
for the HHANES have been generated only for polyunsaturated fatty acid in general, 
which is not specific enough for our purposes since the category includes omega-6 and 
omega-3 fatty acids.  
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Table 2.1: Independent variables considered in logistic regression analysis. 
Independent 
variable 
Explanation 
Iron stores Continuous score of iron status (mg/100) 
Previous-week’s 
fatigue 
Additive score of 3 fatigue-related statements of the CESD 
Lifetime fatigue Additive score of 3 fatigue-related statements of the DIS 
Ethnic group Mexican, Puerto Rican, Cuban, Undetermined 
Acculturation Language of interview (English/Spanish) 
Area of residence in central city, not in central city, or not in standard 
statistical metropolitan area 
Marital status married with spouse living in the household, married with 
spouse not living in the household, separated, divorced, 
widowed, and never married 
Health insurance 
status 
health insurance (yes/no), or reason why no health 
insurance 
Poverty index ratio < 130%, between 130% and 300%, and > 300% 
smaller than 130% (yes/no) 
Space available  number of rooms in household minus number of household 
members 
Kitchen Complete kitchen available (yes/no) 
Education of 
respondent 
Number of completed years; no high school, high school, 
college, graduate 
Occupation of 
respondent 
Private employee, federal government, state government, 
local government, self employed in incorporated business 
or practice, self-employed in unincorporated business, 
practice or farm 
Education of head of 
household 
Number of completed years; no high school, high school, 
college, graduate 
Occupation of head 
of household 
Private employee, federal government, state government, 
local government, self employed in incorporated business 
or practice, self-employed in unincorporated business, 
practice or farm 
Food stamps, now  Family is presently receiving food stamps (yes/no) 
Food stamps, 
previous month 
Family received food stamps last months (yes/no) 
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Table 2.1 (Continued) 
Independent 
variable 
Explanation 
Food stamps, not 
sufficient 
Food stamp value was not sufficient to cover costs, and 
additional money had to be spend for food; food stamps 
received, monetary value was sufficient; no food stamps 
received 
Past major episodes 
of depression 
Past episode ended between 0 to 2 weeks, 2 weeks to 1 
month, 1 month to 6 month, 6 months to 1 year, or more 
than one year; generally coded as: past major depression 
(yes/no) 
Red blood cell folate 
status 
< 140 nmol/L, ≥ 140 nmol/L 
24-hour zinc intakes below the EAR of 6.8 mg/day for women between 18 and 
50 years of age, ≥ 6.8 mg/day 
Sleep deprivation Hours slept over last 24 hours; less than 6 (yes/no) 
Post-pregnancy Within 12 months post-pregnancy (yes/no) 
Postpartum Within 12 months postpartum, includes post-pregnant 
women who never had anything but life births, or who are 
currently breastfeeding; excludes all cases that are post-
pregnant but not postpartum (yes/no) 
Control over health Control over one’s future health; a great deal, or some, very 
little or none 
 
The questions determining whether a woman has been pregnant during the last 
12 months were “Have you been pregnant during the last 12 months?” and “How 
many months ago did that pregnancy end?” (with answer categories “less than 4 
months ago,” “4–7 months ago,” “7–10 months ago,” and “10–12 months ago”). The 
HHANES questionnaire did not determine whether a live birth had taken place within 
the 12 months prior to the interview. Hence, it did not differentiate between women 
who were postpartum (defined as delivering a live infant), and those who were post-
pregnancy (which includes life birth, miscarriage, stillbirth, and abortion). In order to 
create a subsample with postpartum women, only those women were added who 
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reported a pregnancy over the 12 months prior to interview and a) whose number of 
live births was equal to the number of pregnancies or b) who reported that they were 
currently breastfeeding. 
The analysis of the modifying effect of stressors on the relationship between 
ID and depression tested for interactions between potential stressors and iron stores. 
Stressors that are known to increase the risk for depression are available in the 
HHANES. Food insufficiency (food stamps not sufficient for food purchases), 
crowding (number of rooms available per household member), disrupted marital status 
(divorced, widowed, separated), postpartum status, lack of sleep, and lack of control 
over one’s future health were considered stressors. In the HHANES survey, Puerto 
Ricans have consistently been shown to have higher rates of depression even after 
controlling for potential explanatory variables [67]. Therefore, the ethnic category of 
Puerto Rican was considered to code for an unknown stressor, and was tested as such 
in interactions. While SES is not necessarily to be equated with stressors, low SES is 
one of the fundamental causes of negative health outcomes [169]. Therefore, a higher 
exposure to stressors (which are more proximal to the health outcome) is associated 
with lower SES. Thus, measures of low SES (poverty index ratio, years of education, 
health insurance, availability of a full kitchen, and food stamp recipient) were also 
investigated as modifiers.  
Statistics 
Since the independent variable previous-week’s fatigue was created from three 
CESD statements, the depression score of the CESD was summed from the 17 
remaining statements that had not been used for the fatigue variable (named here 
depressive mood or CESD-17). In this fashion, a spurious correlation between the 
same statements in outcome and predictor variable was avoided. The established 
cutoff for the CESD-20 of a score of 16 and greater has been developed by Radloff 
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[156] with a white and African American  study population. The necessity of a higher 
cutoff for the CESD-20 in groups other than the original study population has been 
suggested [170-175]; with cutoffs ranging from 17 to 23, depending on ethnic and 
income group. Hence, two dichotomous variables of the CESD-20 for a cutoff score 
greater than 16 and greater than 23 were created. In order to transfer the cutoffs of the 
CESD-20 to the CESD-17, the approximate percentile equivalents in this data set were 
assessed. The 80th percentile of the CESD-20 score distribution equaled a score of 16, 
the 90th percentile a score of 25. Thus, cases in the upper 80th and the upper 90th 
percentile of the CESD-17 were defined as suffering from moderate and severe 
depressive mood, respectively. Internal consistency of all newly created scales or 
indices was assessed with Chronbach’s alphas. 
Descriptive statistics such as means and frequencies were calculated with 
survey statistics provided by SAS Statistical Software, version 9.1 [176]. In the same 
fashion, significance testing with Chi-square or Fisher’s-Exact test was performed 
with the surveyfrequency procedure provided by SAS. Associations between a 
categorical and a continuous variable were tested by using proc surveyregression or 
proc surveylogistc. 
Since the right-tailed distribution of the scores of the CESD-17 violated 
assumptions for residual distribution of simple linear regression, the outcome was 
dichotomized and logistic regression was performed. Logistic regression analysis was 
conducted with SAS Statistical Software [176]. The outcome variable was CESD-17, 
with a cutoff above the 90th percentile. The determining variables of main interest 
were previous-week’s fatigue and iron stores. The iron stores variable (mg) was 
divided by 100 in order to allow for a more meaningful interpretation of the magnitude 
of the effect. In addition, a dichotomized version of the variable with a cutoff of –200 
mg was used; this cutoff was suggested by Cook [155] after analyzing the distribution 
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of iron stores of women of reproductive age in the National Health and Nutrition  
Examination Survey III (NHANES III). Other variables of interest are listed in Table 
2.1.  
All logistic regression models were adjusted for the complex design of the 
survey, specifically weighing, stratification, and clustering PSUs in the SAS Statistical 
Software survey analysis module. The expansion weights provided in the HHANES 
were transformed to relative weights = n/N × weight [177]. This allowed for 
comparison between weighted and unweighted models since it preserved the original 
sample size. Design effects were calculated as the square root of the ratio of the 
standard errors adjusted for all survey sampling techniques (weighing, stratification, 
and clustering) to the standard errors adjusted for simple random sampling without 
survey sampling adjustment [177]. 
Final logistic regression models were determined on the basis of theoretical 
assumptions, model significance, and variable significance. Model diagnostics were 
performed with deviance residuals, assessing the overall fit of the model, looking for 
outliers, and outlying relative weights. In addition, the associations of relative weight 
with key variables were investigated. Covariates considered in the logistic regression 
models were confirmed with factor analysis (see Appendix A, section 1.2.1, Factor 
analysis). Interactions were considered to be significant, with an alpha below 0.2. 
Results 
Descriptive statistics 
A total of 1375 participants matched the inclusion criteria; 314 women had 
iron stores below 0 mg (Table 2.2). The weighted mean body iron stores of the whole 
sample was 295 mg, while unadjusted mean iron stores was 305 mg. The minimum 
iron stores value was –1140 mg, and the maximum value was 1117 mg.  
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Table 2.2: Participant characteristics. Weighted and unweighted means and unadjusted standard deviations (SD). Statistical testing 
with Chi-square or t- test. Significance based on comparison with iron sufficient group. 
Variable Iron stores < –200 mg Iron stores –200 to 0 mg Iron stores > 0 mg 
 Weighted 
mean 
Unweighted 
mean 
Unadjusted 
SD 
Weighted 
mean 
Unweighted 
mean 
Unadjusted 
SD 
Weighted 
mean 
Unweighted 
mean 
Unadjusted 
SD 
N (unweighted) 137 177 1061 
N (weighted) 136 193 1046 
Age (years) 33.3 35.1* 9.3 31.8 32.9 8.9 30.9 32.5 8.5 
Iron Stores (mg) –403.6* –400.5* 160.8 –96.7* –93.1* 53.3 458.6 462.3 277.4 
Hemoglobin g/L 115.1* 115.3* 12.7 132.4* 133.2* 7.4 136.5 136.4 8.5 
Ferritin μg/L 3.3* 3.4* 2.6 6.7* 7.0* 3.0 48.2 48.6 36.6 
Protoporphyrin 
μg/dL 
128.4* 121.9* 140.0 57.2* 56.9* 15.2 49.7 50.2 15.5 
Transferrin 
Saturation % 
10.7* 11.1* 5.4 20.8* 20.9* 7.6 27.3 27.1 10.5 
*p<0.05 between ID and iron sufficient group 
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Table 2.3 presents frequencies of relevant variables by iron status. Seventy-
seven women were iron deficient anemic (IDA) with hemoglobin levels below 120 
g/L and two other indicators of iron deficiency beyond cutoff.6 A total of 170 women 
matched the criteria of iron deficiency without anemia (IDNA), which was defined as 
hemoglobin levels above or equal to 120 g/L, but with two additional iron status 
indicators beyond cutoff.6 Hemoglobin levels ranged from 64 g/l to 167 g/L; the 
minimum ferritin was 1 μg/L, and the maximum was 196 μg/L.  
The overall number of cases with a weighted poverty index ratio below 130% 
was 161 (40.8%). In terms of ethnic group, the majority of the sample was of Mexican 
descent (69%), followed by 12.1% Puerto Rican, and 4.8% Cuban; a total of 13.6% 
had declared Hispanic ethnicity but undetermined geographic origin. 
In terms of the variables assessing depressive mood, a total of 272 women 
(18%) were above the cutoff of 16 points of the CESD-20 recommended by Radloff 
[156]. However, it has been argued that disadvantaged populations and/or ethnicities 
other than the original study population might require cutoffs higher than 16, in order 
to assess depression accurately [11, 170-175]. At the highest recommended cutoff of 
23 [11, 174], 145 women (9.3%) showed depressive symptomatology. Two hundred 
and sixty-seven women (17.4%) were above the 80th percentile of the CESD-17. A 
total of 131 women (7.9%) were in the upper 90th percentile of the CESD-17. Scores 
of the CESD-20 ranged from 0 to 60, scores of the CESD-17 ranged from 0 to 51. A 
total of 40 women (2.4%) were identified by the DIS as suffering from a current major 
depressive episode. Of these, 29 were above the cutoff of 16 of the CESD-20, 27 were 
above the cutoff of 23 of the CESD-20, and 26 were above the 90th percentile of the 
CESD-17. A total of 63 women had suffered from at least one episode of major 
depression in the past.  
                                                 
6 Mean corpuscular volume (MCV) < 80 fL, ferritin <12 µg/L, transferrin saturation < 16%, 
protoporphyrin > 70 µg/dL 
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The index of previous-week’s fatigue ranged from 0 to 9 points, with an 
overall weighted mean score of 1.5. The lifetime fatigue index (DIS) ranged from 0 to 
2. 
Table 2.3: Participant characteristics. Frequencies in percent. Adjusted for 
stratification, clustering, and probability of selection. Statistical testing with Chi-
square or Fisher’s-Exact test. Significance based on comparison with iron sufficient 
group. 
Variable Iron stores  
< –200 mg 
Iron stores 
–200 to 0 mg 
Iron stores > 0 
mg 
N (unweighted) 137 177 1061 
N (weighted) 136 193 1046 
% Ethnic group    
Puerto Rican 8.0a 9.7a 82.3 
Cuban 8.5a 10.9a 80.7 
Mexican 11.2ab 15.8a 73.1 
Undetermined 5.5ab 10.3a 84.1 
% IDA 56a 0 0 
% Ferritin < 12 
μg/L 
100a 8.7a 4.4 
% Poverty index 
ratio < 130 
12.6a 13.2a 74.1 
% Poverty index 
ratio > 130–300 
8.6ab 14.1a 77.3 
% Poverty index 
ratio > 300 
6.9ab 15.6a 77.4 
% Living with 
spouse 
64.8 67.9 64.1 
% Less rooms 
than people in 
household 
38.7a 27.1 23.0 
a p<0.05 between ID and iron sufficient group 
b p<0.05 between ID groups 
c Red blood cell folate only assessed in women 18 to 44 years of age 
 31 
Table 2.3 (continued) 
Variable Iron stores 
< –200 mg 
Iron stores 
–200 to 0 mg 
Iron stores > 0 
mg 
% High lifetime 
fatigue 
1.3 0.9 1.6 
% High previous-
week’s fatigue 
1.2 4.1 2.8 
% CESD-20 > 16 14.9 18.5 16.2 
% CESD-20 > 23 8.7 10.7 8.5 
% CESD-17 90th 
percentile 
8.7 8 7.7 
% Zinc (24-hour) 
intake < 6.8 
mg/day 
0 0 0.2 
n RBC folatec 
(unweighted) 
109 131 839 
N RBC folate 
(weighted) 
111 146 866 
% RBC folate < 
140 nmol/L 
3.9 5.9 4.4 
Internal consistency 
The CESD-20 had a standardized Cronbach’s alpha of 0.91. The newly created 
CESD-17 scale showed good internal consistency, with a standardized Cronbach’s 
alpha of 0.89. The index of previous-week’s fatigue had a standardized Chronbach’s 
alpha of 0.65, while the lifetime fatigue index had a poor internal consistency, with a 
standardized Chronbach’s alpha of 0.50. It was therefore decided to use previous-
week’s fatigue in the following analysis. 
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Logistic regression analysis 
The logistic regression analysis with CESD-17 (90th percentile cutoff) as the 
outcome variable showed a significant inverse correlation: a 100 mg increase in iron 
stores resulted in an 11% decrease in odds of depressive mood after controlling for all 
covariates (Table 2.4, Model 4). All models presented in Table 2.4 were significantly 
different with p<0.001 (Chi-square test). No relationship between iron stores and 
CESD-17 with the 80th percentile cutoff could be established (not shown). Iron status 
as a categorical variable, instead of the continuous variable iron stores, was tested as 
well; neither IDA (hemoglobin < 120 g/L and ferritin < 12μg/L) nor IDNA (ferritin < 
12μg/L) was statistically significant (not shown). 
Role of fatigue  
In models without previous-week’s fatigue, the iron stores variable showed a 
marginally significant or significant inverse relationship with depressive mood (Table 
2.4, Models 1 and 3). The inclusion of previous-week’s fatigue strengthened the effect 
of iron stores slightly (Table 2.4, Models 2 and 4). Previous-week’s fatigue was 
strongly correlated with the outcome: a unit increase in the score of previous-week’s 
fatigue increased the odds of depressive mood by 2.14. 
Confounders and covariates 
The inclusion of covariates that might be potential confounders made no 
difference in the odds ratios of iron stores (Appendix Table A.1). The three variables 
that were finally added as covariates were ethnic group, living with spouse, and space 
in the household (Table 2.4). In addition to model building, factor analysis was used to 
confirm confounding (Appendix Table A.1). The three covariates reflected three 
identifiable factors coding for ethnic status, SES based on marital status, and SES 
based on personal achievements. The inclusion of ethnic group, living with spouse, 
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and space in the household increased the explanatory power of the model 
substantially: from an area under the receiver operator curve of 0.7 to 0.9 (Table 2.4, 
Models 2 and 4). The poverty index ratio was not significant in models adjusted for 
relative weight. 
Interactions 
Interactions were included in the final model to explore the modifying effect of 
stressor exposure on the relationship between iron stores and depressive mood. They 
were judged to be significant at a p-value less than 0.2. While not all interactions 
showed a difference of alpha less than 0.05 between the group with the highest risk 
and the reference, the general pattern that emerged was the same: it was found that ID 
increased the likelihood of depressive mood (CESD-17>90th percentile) when 
exposure to stressors was present as well. 
Women who were between 0 and 12 months post-pregnancy with iron stores 
below –200 mg had an almost 5 times greater odds ratio of depressive mood than 
women who were not post-pregnant and had iron stores greater or equal to –200 mg 
(Figure 2.2). This relationship was replicated in an interaction between the variables 
postpartum status and iron stores as well: postpartum women with iron stores smaller 
than –200 mg had an odds ratio of 4.8 compared to women who were not postpartum 
and had iron stores greater or equal to –200 mg (p=0.02; not shown). The odds of 
depressive mood for women with a poverty index ratio below 130% and iron stores 
below –200 mg was almost 3 times greater than for women with a poverty index ratio 
greater or equal to 130% and iron stores greater or equal to –200 mg (Figure 2.3). The 
finding with poverty index ratio was replicated with other indicators of SES 
(Appendix Figure A.1, Appendix Figure A.2, Appendix Figure A.3). Finally, expected 
moderate to low control over one’s future health was identified as a risk factor for 
severe depressive mood in ID women (Figure 2.4): women who were exposed 
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experienced a 1.6 greater odds ratio of depressive mood when ID than women with 
high expected control and iron stores greater than –200 mg.  
Discussion 
In summary, risk of depressive mood was significantly decreased with 
increasing iron status in the premenopausal Hispanic American women of this sample. 
A 100 mg increase in iron stores resulted in an 11% decrease in the odds of depressive 
mood measured by the CESD-17 (Table 2.4, Model 4). This relationship was 
significant while controlling for previous-week’s fatigue, SES, and ethnic group. 
Previous-week’s fatigue did not act as a mediator as hypothesized. Likewise, SES and 
ethnic group did not confound the relationship between iron stores and depressive 
mood. However, their inclusion reduced the confidence interval of the coefficient of 
iron stores, making iron stores significant. Thus, either previous-week’s fatigue, or 
SES and ethnic group, or both, are necessary in the model. Stressor exposure modified 
the relationship between ID and depressive mood, thus increasing the probability of 
depressive mood in ID women. 
Limitations and plausibility 
Causality 
As a result of the observational study design of the HHANES, a causal 
relationship between ID and depressive mood could not be established. Associations 
might have been due to a common underlying factor that had not been controlled in 
the statistical analysis. In addition, directionality cannot be assessed with the current 
study design since all measures were taken concurrently. Likewise, the identified 
modifying relationships between iron stores and stressors could not establish which 
variable is the modifier and which the modified. It is important to keep in mind, 
though, that the purpose of the present analysis was not to establish a causal link 
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between ID and depressive mood. Instead, the HHANES data set presented a time- 
and cost-effective way to conduct a plausibility analysis while addressing challenges 
to previously published research.  
Past depression 
The correlation between iron stores and depressive mood might be a result of 
previous impairments in psychological functioning. Severe depression in the past 
increases the likelihood of a recurrence of depression [178]. Past depression might 
also result in dietary habits that predispose a person to ID, although to our knowledge 
no study has explored this relationship. Including past major depression7 in the full 
model (Table 2.4, Model 4) did not change the odds ratio (OR) of iron stores 
(OR=0.89) or previous-week’s fatigue (OR=2.1), which indicates that past major 
depression is not a confounder. Unexpectedly, the variable past major depression 
showed a lower probability of current depressive mood in the full model with an OR 
of 0.14 (confidence interval [CI] 0.05, 0.41) compared to cases with no history of 
major depression. This result is counter to established relationships [93], and calls into 
question the validity of the past major depression variable. Further investigation of the 
variable revealed that the effect is due to one group of 17 cases who reported that their 
last bout of major depression ended sometime between 1 and 6 months prior to the 
survey (OR=0.098, CI 0.04,0.26). Two of these cases ranked in the upper 90th 
percentile of CESD-17. Scrutiny of potential explanatory variables revealed no pattern 
in terms of health insurance, ethnicity, residence, marital status, reproductive status, or 
measures of SES (not shown). A number of possible explanations for this finding can 
be suggested. This group might contain a larger number of users of antidepressant 
medication whose likelihood of depression is lower than expected based on their 
history. Unfortunately, no information on medication usage is available in this data 
                                                 
7 For definition see Appendix E, 1. Diagnostic Interview Schedule, Depression Module. 
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set. Another explanation might be that this group constitutes persons who are most 
recently in partial or full remission, full remission of a major depressive episode being 
defined as being symptom-free for at least 2 months [179]. They therefore have a 
lower likelihood than cases in longer time intervals of remission to currently 
experience depressive mood. Finally, it should be cautioned that the recall of the 
timing of previous depressive episodes in the DIS has been reported to be inaccurate 
[180].  
Validity of the subsample of the HHANES 
The final sample used for analysis represents only a subset of the full 
HHANES sample. While cases were excluded on the basis of distinct criteria that 
might have affected the investigated relationship, or because of missing variables, a 
bias could have been introduced that reduced the validity of the final conclusions for a 
general female Hispanic sample. A comparison was undertaken between the final 
sample of 1375 cases and the 1528 women who were excluded based on missing 
information on depression, sampling procedures, or hemoglobin values (Figure 2.1, 
n=2903). No significant differences between the two groups were found in terms of 
depression scores, ethnic group composition, or poverty index ratio (Appendix Table 
A.3). The subsample of 1375 women was significantly younger than the excluded 
group (33 years of age versus 35 years).  
Validity of Hispanic sample 
The external validity of the present analysis is by nature limited, since the 
population sampled in the HHANES were US Hispanics in the early 1980s. Risk 
factors of depression might differ today or in other ethnic groups.  
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Table 2.4: Logistic regression model with CESD-17 as dependent variable (event defined as being in the upper 90th percentile of 
the distribution), n=1375. Odds ratios (OR), lower and upper limit of confidence intervals (CI) of odds ratio, and design effects 
(DEF). The models are adjusted for stratification, clustering (PSUs), and relative weights. Ref PR = reference Puerto Rican, c = 
area under the ROC curve. 
Variable  Model 1 Model 2 Model 3 Model 4 
  OR CI DEF OR CI DEF OR CI DEF OR CI DEF 
Intercept  0.10 0.09, 0.12 0.73 0.01 0.009, 0.015 0.31 0.38 0.29, 0.50 0.51 0.38 0.02, 0.7 0.67 
Iron 
stores 
(mg)/100 
 0.95 0.90,1.006 1.33 0.89 0.82, 0.97 1.24 0.94 0.89,0.99 1.37 0.89 0.82,0.97 1.38 
Previous-
week’s 
fatigue 
    2.15 1.95,2.36 0.80    2.14 1.95,2.35 0.72 
Living 
space  
       0.84 0.77, 0.92 1.24 0.82 0.73,0.92 1.07 
Spouse in 
house 
(Ref not) 
       0.45 0.37, 0.56 0.19 0.52 0.33,0.81 0.54 
Ethnic 
group (ref 
PR) 
Cuban 
Mexican 
Undeter. 
      0.43 
0.35 
0.40 
0.21, 0.87 
0.25, 0.47 
0.20, 0.78 
1.05 
0.47 
0.84 
0.87 
0.40 
0.31 
0.35, 2.17 
0.22, 0.74 
0.12, 0.82 
0.96 
0.79 
0.88 
–2LL  753 436 705 412 
c  0.514 0.923 0.708 .936 
 38 
 
 
 
 
 
 
 
 
Figure 2.2: Odds ratios of depressive mood with iron stores < –200 or > –200 mg, 
grouped by post-pregnant status. Logistic regression model with CESD-17 as 
dependent variable (event defined as being in the upper 90th percentile of the 
distribution). Covariates were previous-week’s fatigue, space available, living with 
spouse, and ethnic group. The model excluded cases that were post-pregnant but not 
postpartum. The model is adjusted for stratification, clustering (PSUs), and relative 
weights. Group size in rectangles above bars. P-value of difference from reference 
group (ref), and differences with significance below 0.05 shown by different letters. 
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Figure 2.3: Odds ratios of depressive mood with iron stores < –200 or > –200 
mg/100, grouped by poverty index ratio < 130%, or > 130%. Logistic regression 
model with CESD-17 as dependent variable (event defined as being in the upper 90th 
percentile of the distribution). Covariates were previous-week’s fatigue, and ethnic 
group. The model is adjusted for stratification, clustering (PSUs), and relative weights. 
Group size in above bars. P-value of difference from reference group (ref), and 
differences with significance below 0.05 shown by different letters. 
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Figure 2.4: Odds ratio of depressive mood with iron stores < –200 or > –200 mg, 
grouped by expect high control over one’s future health or other. Logistic regression 
model with CESD-17 as dependent variable (event defined as being in the upper 90th 
percentile of the distribution), n=1298. Covariates were previous-week’s fatigue, 
space available, and ethnic group. The model is adjusted for stratification, clustering 
(PSUs), and relative weights. Group size in bars. P-value of difference from reference 
group (ref), and differences with significance below 0.05 shown by different letters. 
Validity of the CESD-20 
General  
The CESD-20 was created specifically to assess the level of depressive 
symptomatology in a population, not to be used as a clinical screening tool [156]. 
Cross-validations of the CESD-20 with more extensive mental health screening 
instruments assessing a range of depressive disorders have found sensitivities between 
40 and 95%, specificities between 61 and 95%, and positive predictive values (PPV) 
between 6 and 48% [170, 173, 175, 181, 182]. Consequently, the CESD-20 at times 
does not perform well as a clinical assessment tool of depression. Comparison to the 
DIS has also suggested that CESD-20 assesses anxiety as well [181, 182]. It has 
therefore been suggested to use the CESD-20 as a tool for assessing emotional distress 
[172, 183]. It should be kept in mind, though, that anxiety disorder is also a common 
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comorbidity of depressive mood [53], which might account for the higher rates of 
anxiety in cases identified as depressed by the CESD. 
Hispanic culture 
The CESD-20 was developed with an English-speaking sample of White and 
African American respondents [156]. A large number of articles have investigated the 
cultural definition of depression in the Hispanic culture. Specific cultural terms for 
mood disorders are not addressed in the CESD-20 translations. For example, in 
Mexican culture, the term “nervios” (loosely translated as “nerves”) includes somatic 
disorders (such as gastrointestinal problems, vomiting, lump in throat, and headaches), 
as well as dysthymia, major depression, and anxiety [184]. In Puerto Rican culture the 
term “ataques de nervios” can include a number of behavioral and somatic symptoms, 
all indicative of depression or other mental health issues [185]. No information was 
found on special expressions for depression in Cuban culture. 
Somatization of dysthymia or major depression is more frequent in Hispanic 
populations; this is especially true in conjunction with being above 40 years of age and 
having a low level of acculturation [157, 186, 187]. Low levels of acculturation have 
been shown to be a protective factor against depression in Mexican Americans and 
Puerto Ricans. In the HHANES it was found that Mexican Americans and Puerto 
Ricans have lower risk of depression when less acculturated [18, 19]. 
In summary, the CESD-20 might not be as accurate as more extensive 
depression assessment instruments. Moreover, in Hispanics, depression appears to be 
experienced differently than in White comparison groups. More physical symptoms 
are associated with depressive mood, and culturally specific language terms are 
employed that at times describe a variety of emotional disorders. None of this is 
accounted for in the CESD-20. In addition, the CESD-20 appears to also identify cases 
with high anxiety. In the present analysis, misclassification of cases by the CESD-17 
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should result in a weakening of the association between ID and depressive 
symptomatology since a high rate of false negatives and false positives occurs. 
Nevertheless, we were able to demonstrate a relationship between ID and depressive 
mood, which indicates the strength of the relationship in this data set.  
Scale construction of CESD-17 and previous-week’s fatigue 
The variables of previous-week’s fatigue and depressive mood were both 
created from the CESD-20. Thus, neither variable is an established measure, which 
calls into question their validity. However, the internal validity of the two constructed 
scales was good, and the inverse association between iron status and depressive mood 
despite the control for fatigue has been confirmed in our study in Mexican women 
(Chapters 3 and 4). It is important to recognize that the current analysis solved the 
important problem of correlating a fatigue scale with a depression scale, while both 
instruments contain questions assessing fatigue. Thus, the relationship might have 
been considered spurious, if not for the removal of the fatigue statements from the 
CESD-20. Finally, it should be mentioned that no useful alternative measures of 
fatigue or depression were available in the HHANES data set. Lifetime fatigue from 
the DIS had poor internal consistency, and the depression measure of the DIS could 
only be coded concurrently for major depression.  
Antidepressant use 
A significant limitation of this data set is that that no information on 
antidepressant medication use was available. Although use of antidepressant 
medication had been collected during the HHANES survey, the data are in poor 
condition, and have therefore not been made available to the public (E.A. Frongillo, 
personal communication; also consult the NCHS website 
http://www.cdc.gov/nchs/nhanes.htm) [188]. Since antidepressant use could not be 
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controlled for statistically, women with low iron stores might show low levels of 
depression solely as a result of the alleviating effects of antidepressant medication. On 
the other hand, it might be safe to assume that the number of women who are using 
antidepressants in this sample is small. The data were collected in the early 1980s, 
when antidepressant use was not yet widespread. In addition, the sample population 
includes a significant percentage of the poor and/or immigrants, who might not have 
access to medical services or, consequently, to antidepressants. It should also be noted 
that women who use antidepressants should experience less depression, therefore 
weakening a potential relationship between iron stores and depressive mood. 
Nevertheless, we were able to demonstrate an effect. 
Substance abuse 
Users of illegal substances were excluded from the sample, as long as they 
reported having used drugs within the last month (n=57, see compare Figure 2.1), 
since they represent a subpopulation that might have reduced the external validity of 
the results to the general population. The HHANES questionnaire assessed abuse of 
illegal inhalants and cocaine, but no information on heroin use was collected. 
Additional data on current prescription drug and alcohol use were gathered. 
Prescription drug use was self-rated; participants answering questions about the use of 
“pills just to enjoy the feeling they give” or for “nonmedical reasons” within the past 
month. Alcohol use was self-reported as well, with answers ranging from “abstainer” 
to “heavy drinker” (“Do you now consider yourself a…?”). Data on 1349 cases were 
available for prescription drug use, and for the full data set on alcohol use. In the 
current sample, only 1 participant indicated abuse of prescription drugs, 85 rated 
themselves as medium to heavy drinkers, and 6 as heavy drinkers. The inclusion of 
alcohol abuse as a possible confounder in the final model (Table 2.4, Model 4) showed 
that the variable was not significant (not shown).  
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It is important to keep in mind that all substance abuse was self-reported. 
Consequently, prevalence of substance abuse might have been underestimated, and not 
all substance abusers might have been excluded or controlled for. Substance abuse can 
be associated with low consumption of enhancers of iron absorption (such as vitamin-
C-containing fruits and vegetables) [189, 190], although two studies found no 
difference in iron status between drug abusers and non-abusers [191, 192]. Substance 
abuse is also associated with depression [53, 193-197]. In summary, unmeasured 
substance abuse might still have contributed as a positive confounder to the significant 
relationship between iron stores and depressive mood. 
Premenstrual syndrome (PMS) and perimenopause 
While postmenopausal women were excluded from the current sample, no 
information was available on perimenopause and premenstrual status. Perimenopause 
is associated with a higher risk of depression [198-200]. In addition, perimenopausal 
women might have a lower prevalence of ID than the younger age groups, because of 
decreased menstrual blood loss. This is supported by studies assessing iron status in 
menopausal or late middle-age women [155, 201-203]. Thus perimenopausal status 
fulfills the criteria of a confounder of our analysis, albeit a negative one. Even without 
adjusting for perimenopausal status, the relationship between iron stores and 
depressive mood in this analysis is significant. Older chronological age was used as an 
indicator for the role of perimenopause in the relationship between iron status and 
depressive mood; it was not significant. PMS and premenstrual dysphoric disorder 
(PMDD) have been shown to be associated with depressive mood [179, 198, 204-206]. 
No information on either disorder or on the exact menstruation cycle was gathered in 
the HHANES. However, iron status is not affected by menstruation cycle [207]. 
Therefore, a systematic strengthening of the association between iron stores and 
depressive mood in premenopausal women is unlikely.  
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Other nutrients that may cause depression 
A number of nutrients have been associated with depression and/or anemia, 
including zinc, folate, vitamin B12, and ω-3 polyunsaturated fatty acids (specifically 
docosahexanenoic acid) [158-163, 168]. For Hispanics, only levels of ω-3 
polyunsaturated fatty acids in breast milk, not in the diet, have been reported [208]. In 
the analysis, all nutrients except ω-3 polyunsaturated fatty acids were accounted for; 
no information for ω-3 polyunsaturated fatty acids was provided in the data set [209]. 
In summary, if cases with low iron stores were also deficient in ω-3 
polyunsaturated fatty acids, the nutrient might have acted as a positive confounder. 
However, it is also important to keep in mind that the evidence of the depression-
lowering properties of ω-3 polyunsaturated fatty acids is inconsistent and controversial 
[210-212].  
Post-pregnancy variable 
While the HHANES contains an extensive section on reproductive history, it 
was not documented whether the last pregnancy ended in a live birth, abortion, 
miscarriage, or stillbirth. Thus the variable that connotes post-pregnancy (n=167) 
probably contains a mix of cases. Therefore, a more stringent postpartum variable was 
constructed. Criteria for inclusion were that the woman reported that 12 months or less 
passed since her last pregnancy, and that she is either breastfeeding now, or only had 
live births. It is possible, although highly unlikely, that a woman was currently 
breastfeeding a child from a previous pregnancy even though her most recent 
pregnancy did not end in a live birth. More probable is that a number of valid cases of 
postpartum women with recent live births were screened out of the postpartum 
variable; thus the true number of postpartum women might have been higher than 74 
cases. Despite the small number of cases, the interaction between iron stores and 
postpartum status was significant (p-value of 0.02); postpartum women with ID had an 
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odds ratio of depressive mood that was 4.8 times greater than the reference group 
(women who were not post-pregnant and had iron stores >– 200 mg; p-value of 
comparison 0.07). Thus, the calculated odds ratio of depressive mood of the 
postpartum group with ID was almost the same as the one of the post-pregnant group 
(4.9 for post-pregnancy, Figure 2.2). On the other hand, a miscarriage or a stillbirth 
might present a risk factor for depression in itself [213], and – once iron stores are low 
– a contributing factor to the higher odds ratio.  
Internal validity 
Body iron stores was derived from hemoglobin, ferritin, protoporphyrin, and 
transferrin saturation. Point estimate and distribution of iron stores is accordingly 
mirrored by all four of the iron status measures (Table 2.2).  
Validity of depressive mood (CESD-17) was assessed by comparison with 
other variables available in the data set. The cutoff of the 90th percentile of the CESD-
17 (a score ≥ 21) was set to correspond with the 90th percentile of the CESD-20 (score 
≥ 26). In order to validate the cutoff of the CESD-17, the second depression scale used 
in the HHANES survey, the DIS, was employed. The DIS is used to assess lifetime 
depression, but it can be coded to reflect current major depression by combining the 
diagnosis of major depression with a question inquiring about the end of the last 
episode of low mood (see Appendix E, Diagnostic Interview Schedule, Depression 
Module). In the current sample, the concordance between current major depression 
(DIS) and depressive symptomatology (CESD-17) was as follows (Appendix Table 
A.4): sensitivity = 80%, specificity = 92.6%, and PPV = 24%. The equivalent results 
for survey-adjusted frequencies (not shown) would be a sensitivity of 79.3%, a 
specificity of 93.9%, and a PPV of 24.4%. Other studies have cross-validated the 
CESD with the diagnosis of major depression of the DIS. For Caucasians they show a 
sensitivity between 45 and 95%, a specificity of 64 to 95%, and a PPV of 15 to 28.4% 
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[170, 173, 181, 182]. Comparison of the CESD with the diagnosis of major depression 
of the Schedule for Affective Disorders and Schizophrenia (SADS) yielded a 
sensitivity of 60 to 63%, a specificity of 83.4 to 93.9%, and a PPV of 6.7 to 33% [173, 
175]. When the CESD was compared with the SADS while focusing on any 
depressive illness, the sensitivity was 40.8 to 59.4%, the specificity was 85.9 to 
94.9%, and the PPV was 24.7 to 47.6% [173, 175]. A comparison of the CESD with 
the DIS diagnosis of major depression in US Hispanics yielded the following: in 
English-speaking participants, sensitivity of 81.2% and specificity of 60.8%; in 
Spanish-speaking participants, sensitivity of 84.2% and specificity of 64.5% [182].  
One hundred and twenty-eight cases are above the cutoff of 23 points in the 
CESD-20. However, of these, only 108 women are above the 90th percentile of the 
CESD-17 (Appendix Table A.4). Cases that were at or below the 90th percentile but 
above 23 points in the CESD-20 were nevertheless reclassified as not severely 
depressed. The majority of these cases (91%) had between 23 and 25 points (mean 
24). When comparing the cases above the 90th percentile of the CESD-20 and the 
CESD-17, 1016 cases were classified as not experiencing depressive mood, and 105 
cases were classified as depressed by both scales (Appendix Table A.5). Only 3 cases 
were below or equal to the 90th percentile of the CESD-20 and above the 90th 
percentile of the CESD-17. Conversely, 6 cases were above the 90th percentile of the 
CESD-20 and below or equal to the 90th percentile of the CESD-17. Thus, differential 
classification of the different scales was minimal. 
In summary, in the present sample the CESD performed well when compared 
to the DIS diagnosis of major depression, especially when compared to results of other 
studies. Sensitivity and specificity were high; and although the PPV appears low, it 
depends on prevalence and lies within the range of what has been previously observed 
in the literature. It should be noted that the CESD has been created with the intention 
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of capturing cases in the general population that are suffering from depressive 
symptomatology [156]. Thus, it was developed as a screening tool, and a range of 
types of depression might be identified as cases. It is therefore safe to assume that the 
women considered depressed according to the CESD-17 probably suffer from less 
severe forms of depression as well, such as dysthymia or minor depression (compare 
Appendix D). It is important to keep in mind as well that the CESD-20 appears to 
assess only not depressive mood, but also anxiety.  
Fatigue in the previous week had only a minor effect on the relationship 
between iron stores and depressive mood (Table 2.4). In fact, its inclusion in the 
model appeared not to be necessary when covariates concerning ethnic group and SES 
were also present. Previous-week’s fatigue showed good internal consistency, with a 
Chronbach’s alpha of 0.65. It correlated significantly (r=0.23, p<0.0001, weighted 
correlation) with the lifetime fatigue measure constructed from the DIS (Appendix E, 
Lifetime Fatigue Score, DIS). Likewise, of the 18 cases with high lifetime fatigue (a 
DIS fatigue score of 3), 22% rated high in previous-week’s fatigue as well (score 
greater than 5); while only 7% of the cases with low to moderate DIS lifetime fatigue 
rated high in previous-week’s fatigue (Chi-square p=0.005; not shown). Previous-
week’s fatigue was also correlated with the CESD-17 with a coefficient of 0.69 
(p<0.0001, weighted correlation). A correlation of this magnitude is to be expected 
based on the published literature [54-57]. When evaluating frequency distributions, 
only 3% of the respondents without depressive mood (90th percentile of the CESD-
17) complained about high previous-week’s fatigue – compared to 53% of the 
respondents with depressive mood (Chi-square p<0.001; not shown). This bivariate 
distribution between high fatigue and depressive mood has previously been observed 
[58, 59]. In order to further validate previous-week’s fatigue, its relationship with iron 
stores was explored. It was assumed that lower iron stores would be associated with 
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higher fatigue. However, the opposite was true: a 100 mg increase in iron stores was 
associated with a 6% increase in the odds of high previous-week’s fatigue (Appendix 
Table A.6). Since the previous-week’s fatigue variable behaved as expected overall, 
characteristics of this sample could well be implicated with the positive correlation. 
Therefore, the relationship between previous-week’s fatigue and iron stores was 
examined for confounding and influential subgroups. Depressive mood turned out to 
be an important negative confounder of the relationship between fatigue and iron 
stores. However, the inclusion of other potential confounders such as poverty index < 
130%, ethnic group, postpartum status, parity, age, body mass index (BMI), oral 
contraceptive use, or physical activity did not alter the positive relationship between 
the two variables of interest. It was found that only younger participants showed a 
positive relationship between the odds of high previous-week’s fatigue and iron stores 
(interaction, p=0.007; Appendix Figure A.5). No other variables available in the data 
set were considered helpful in elucidating the unexpected finding. One might 
speculate that the younger subgroup, because of youthful vigor, may not have 
experienced the debilitating effects of lower iron stores to the same degree as an older 
group. Therefore, the younger age group would not rate as high in the previous-week’s 
fatigue variable. 
In light of these findings, we examined the association of depressive mood and 
iron stores with the CESD-20 with a cutoff of 23, and without previous-week’s fatigue 
in the model; marital status, ethnic group, and crowding were covariates. We found 
that the results are comparable to our models presented in Table 2.4. With every 100 
mg increase in body iron stores, the odds ratio of depressive mood decreased 
significantly by 5% (Appendix Table A.8). 
In order to further validate our constructed depressive mood and fatigue 
variables, a comparison with data from our Mexican sample (Chapter 3) was 
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undertaken. The CESD-17 ranged from 0 to 48 points in the Mexican data set of 
n=100, with a mean of 17 points (not shown). The CESD-20 had a mean of 20 and 
ranged from 0 to 55 points. Previous-week’s fatigue had a mean of 2.8 and ranged 
from 0 to 9 points. The correlation coefficient between the CESD-17 and previous-
week’s fatigue was 0.63 (p<0.0001). The correlation coefficients of the Fatigue 
Severity Scale (FSS, description in Chapter 3) with the CESD-17 and previous-week’s 
fatigue were  0.47 and 0.46 (p<0.001), respectively. The CESD-20 was associated 
with the CESD-17 (r=0.99, p<0.001). Since the 90th percentile of the CESD-17 was 
much higher in the Mexican sample (31 points) than in the HHANES, no categorical 
comparisons between the two CESD-17 versions were undertaken. When comparing 
the CESD-17 with the Beck Depression Inventory (BDI, Chapter 3), the correlation 
coefficient was 0.59 (p<0.0001), which was comparable to the correlation between the 
BDI and the CESD-20 (r=0.63, P<0.0001; not shown). The BDI and previous-week’s 
fatigue were significantly (P<0.001) correlated as well (r=0.58), whereas the BDI and 
the FSS had a correlation coefficient of 0.50 (p<0.0001).  
We also replicated the logistic regression models that we employed in the 
HHANES analysis. Sensitivity/specificity analysis in the Mexican data set indicated 
that the CESD-20 cutoff of 21 performed best when compared to the severe depressive 
mood of the BDI: sensitivity was 78%, specificity 92% (not shown). With the cutoff 
of 21, 40% of the cases were labeled as severely depressed. When reanalyzing the 
association between the CESD-20 (with a cutoff of 21) and hemoglobin in the 
Mexican data set, severe depressive mood decreased significantly (p=0.004) by 4% 
with every g/L increase of hemoglobin (not shown). Covariates were a factor 
indicating SES and crowding, and MCV>94 fL (compare Chapter 3). When including 
the FSS as an additional covariate in this model, the effect of hemoglobin on severe 
depressive mood (CESD-20 with cutoff of 21 points) increased to a 5% rise with every 
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additional change in g/l of hemoglobin (p=0.004). Alternatively, when assessing the 
association between the CESD-17 with hemoglobin in the Mexican data set, the 90th 
percentile of the CESD-17 yielded only 10 cases. Thus, the cutoff for the CESD-17 of 
the HHANES was used as an outcome (score of 21). When assessing the effect of 
hemoglobin in this model, it had an OR of 0.98, but the p-value (p=0.18) indicated 
only a trend (not shown). This model controlled for previous-week’s fatigue, factor 
SES, and crowding, and MCV>94 fL (compare Chapter 3).  
We concluded that the results of the analysis of the associations between 
indicators of fatigue, depressive mood, and iron status with the Mexican data set 
implied that the CESD-17 and previous-week’s fatigue correlated in the expected 
direction with fatigue and depression instruments, and with iron status in our Mexican 
data set. 
Mechanisms 
ID in this study was associated with a higher likelihood of depressive mood. 
The explanation for this finding might be that ID affects concentrations of 
neurotransmitters in the synaptic cleft between nerve cells; alterations in serotonin, 
epinephrine, or dopamine levels are generally considered a cause of depression [124]. 
The relationship between ID and neurotransmitter levels in the brain has been 
explored in animal studies. Iron is a cofactor for the synthesis of all three 
aforementioned neurotransmitters [26]. Serotonin concentration, or serotonin synthesis 
or breakdown, appears to be affected by ID, although not all studies show consistent 
results: ID rats have exhibited reduced concentrations of serotonin in the brain [28]. 
The concentration of the serotonin metabolite 5-hydroxyindole-3-acetic acid was 
found to be lower (while serotonin concentrations were not changed) [29], or higher 
[31] with ID. The synthesis of serotonin by tryptophane hydroxylase was found to be 
unchanged [28], or increased [214] with ID. The neurotransmitter norepinephrine has 
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rarely been investigated; it appears to remain unchanged [30] or is higher [31, 32] in 
ID rats. More consistent information is available on dopamine. ID appears to decrease 
the density of dopamine receptor D2 [33, 34]. In addition, dopamine transporters are 
downregulated, resulting in a slower reuptake of dopamine in the presynaptic cell [35, 
36]. Consequently, dopamine levels have been found to be higher in ID rats [29, 32]; 
and dopamine metabolites to be lower [29]. The activity of monoamine oxidase, which 
is involved in the breakdown of serotonin, seems to be reduced during ID [28, 30]. 
In this analysis we have also shown that the effect of ID on depressive mood is 
modified by SES, post-pregnancy status, and perceived control over one’s health. The 
potential mechanism for this potentiating effect might be that lack of iron in the brain 
and exposure to social stressors both act on the neurotransmitter systems of the brain. 
Consequently, the probability of depressive mood is higher with exposure to both risk 
factors. This is, to our knowledge, the first analysis to explore this interaction. In the 
social epidemiological literature, the relationship between stressor exposure and risk 
of depression has been well documented. The suggested mechanism is that chronic 
stressor exposure creates an overuse of one of the stress systems (the hypothalamo-
pituitary-adrenal [HPA] axis) that is generally responsible for a short-term response to 
stressors; the overuse of this response system is called allostatic overload [95, 97]. 
Factors that increase stress have been identified, such as low SES [64, 98], sleep 
deprivation [103], job strain [99-101], low social support at work [104], low social 
support in private life [102], home strain (number of children) [102, 105], number of 
hours worked [102], daily perceived stressors [106], and negative affect [106]. Factors 
that might buffer the effect of stressors appear to be good coping ability, high self-
efficacy, and good social support [107-110]. In addition, factors that are associated 
with an increased risk for depression have been documented; they include low SES 
[64-66], low social support [91], not being married [65, 93], low control at home or at 
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work [90], job strain [100], or longer-term unemployment [65]. Low mood has been 
reported as a result of a trial inducing sleep deprivation [112]. 
Hypocortisolism has been associated with chronic stress [102, 119, 123, 215, 
216] and a higher risk of atypical major depressive disorder (MDD) [96, 113, 122]. 
The mediating mechanism might be an upregulation of the immune system due to 
chronically low cortisol levels [115, 130-134], which is reflected in high 
concentrations of plasma and brain proinflammatory cytokines, namely tumor necrosis 
factor, interleukin 1, and interleukin 6 [115, 119, 120, 125, 130, 133, 136, 137, 140]. 
Elevated cytokine concentrations in the brain reduce the availability of serotonin [121, 
122, 145], whereas norepinephrine concentrations appear to increase [6, 7, 9, 130, 
132]. 
External validity 
Prevalence of IDA in the present sample was 6% in 182, which is higher than 
the US average of 5% in 1988 [4]; IDNA in this sample was 12%, which is 1% higher 
than the more current US average. Thus a total of 18% of the present sample suffers 
from ID.  
The iron stores variable in the present analysis was calculated from a formula 
developed by Cook et al. with the NHANES III (1988–1994) [155]. The mean 
unadjusted iron store of 305 mg of the HHANES sample was comparable to the 
authors’ mean iron store of 309 mg for women 18 to 44 years of age; while women 45 
to 64 years of age had a much higher mean value with 608 mg. The variation in iron 
stores in the present analysis was, with an unadjusted standard deviation of 398 mg, 
similar to Cook et al.’s study, which reported standard deviations in the younger 
women of 346 mg and of 372 mg in the older. The wider variation of the HHANES 
sample was due to more extreme negative values. A newer formula by Cook et al. that 
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utilizes the ratio of serum transferrin receptors to serum ferritin [217] could not be 
used because serum transferrin receptors were not determined in the HHANES. 
The prevalence of depressive mood in the present sample was as follows: 
percent lifetime prevalence of major depression (definition in Appendix D, Major 
Depressive Disorder) as assessed by the DIS was 7.0%, prevalence of depressive 
symptomatology over the last week based on the cutoff of 16 of the CESD-20 was 
18.1%, prevalence of depressive symptomatology based on the CESD-20 cutoff of 23 
was 9.3%, and prevalence of depressive mood based on the 90th percentile of the 
CESD-17 was 7.9%. This compares to a lifetime prevalence of major depression for 
women in the US of between 6 and 21.3% [10-12]. Vega et al. [13] showed a 
prevalence of lifetime major depression of between 10 and 14% for Californian 
Mexican Americans. The rate of depressive symptomatology assessed by the CESD in 
women was found to be 33% in Hispanic Americans [218] and 37% in the general US 
population [170].  
The significant inverse association between iron stores and depressive mood 
that was found in the present analysis (Table 2.4) is confirmed by a large host of 
studies. The majority are cross-sectional [37-40]; only one is a randomized trial with 
placebo group [46]. In contrast, negative results were found by one cross-sectional 
study [41], three randomized placebo-controlled iron supplementation trials [43, 44, 
148, 219], and one supplementation trial that used a high iron diet as the control 
condition [45]. It is important to note that the randomized trial that had a significant 
relationship between iron supplementation and lowered depression scores took place 
with IDA postpartum women in South Africa [46], while the four trials with negative 
results all included partially or exclusively non-IDA participants; the participants were 
not postpartum, and came from developed countries (Switzerland, Australia, and 
USA) [42-45]. Our observational study with female Mexican factory workers 
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indicated that the inverse association between iron status and risk of severe depressive 
mood remains after controlling for fatigue and SES (Chapter 3). 
One can speculate that the difference between the South African trial and the 
four others might be due to the fact that a) the South African trial supplemented only 
IDA women, allowing for maximum effect size of iron supplementation on alleviation 
of depression scores; and b) iron supplementation had a stronger effect in women who 
were postpartum and from South Africa because it disrupted the synergistic effect of 
higher exposure to stressors and ID on depression. 
No study has been identified in the literature that explores the more complex 
relationship between ID, fatigue, and depression, even though a number of studies 
assessed all three [38, 39, 41, 43-45]. Moreover, to our knowledge, this is the first 
study exploring the modifying effect of stressors on the relationship between ID and 
depressive mood. The only references that might allude to our hypothesized 
interaction between stressors and ID could be the results of the recent randomized iron 
supplementation trials [43-46, 54-57, 148, 219]: South African women who are, in 
addition, postpartum, simply might have higher stress levels than the women in the 
other four trials and therefore show a greater remission of depression with iron 
supplementation.  
In the present study, previous-week’s fatigue had a positive correlation with 
depressive mood. A strong association between the two has also been shown in a 
number of other studies: correlation coefficients were between 0.35 and 0.62 [58]. 
Fuhrer et al. [59] found that fatigued participants had a higher depression score of 23.5 
compared to peers reporting no fatigue (score 17.6; p=0.0001); Hickie et al. [53] 
showed that 21% of their fatigued participants were also distressed, versus 7% of the 
non-fatigued subjects. This is logical, given that fatigue is one of the diagnostic 
criteria of depression [39, 43-45]. 
 56 
Fatigue and ID are related; in our analysis we found a positive correlation of 
previous-week’s fatigue and iron stores, which is contrary to the published literature 
[38, 41]. Two studies found no relationship between fatigue and iron status [220]. 
Since our variable, previous-week’s fatigue, appears to be a valid measure of fatigue, 
the remaining conclusion would be that confounding or a subgroup influenced the 
expected results. We were not able to identify such a confounding variable. However, 
previous-week’s fatigue in our analysis does not appear to have the originally 
hypothesized major influence on the relationship between ID and depressive mood.  
We are not aware of any published study that explores the effect of stress as a 
modifier of the association between iron status and depressive mood. The results of 
our Mexican study indicate that women with low salivary cortisol levels throughout 
the workday have an increasing risk of severe depressive mood with decreasing 
hemoglobin values, whereas this association is not significant in women with cortisol 
values equal to or above the median (Chapter 4). 
Clinical significance of association 
The magnitude of the effect of ID on depressive mood should determine 
whether iron supplementation is considered an important therapy for depression. The 
accepted current therapy for depression is administration of antidepressants such as 
selective serotonin reuptake inhibitors. To our knowledge, only one randomized 
controlled trial assessing the efficacy of antidepressant therapy has been published that 
can be compared with our type of data; this study used a different depression scale 
(Hamilton Rating Scale for Depression) to assess their results, and chose as one of 
their outcomes the probability of remission after therapy. Detke et al. [153] tested the 
antidepressants Duloxetine and Parocetine on a total of 367 patients with major 
depressive disorder. Depending on the dosage, Duloxetine reduced the probability of 
remission by 21 to 28% compared to a placebo, while Paroxetine reduced it by 17%. 
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From our cross-sectional analysis we can estimate the potential effect of improving 
body iron status. This simulation is based on a logistic regression model adjusted for 
survey methods that uses as the dependent variable non-depressive mood, which is 
defined as all cases equal to or below the 90th percentile of the CESD-17. The 
covariates of this model were previous-week’s fatigue, space available, spouse in 
house, and ethnic group, the same as in Model 4, Table 2.4. The odds ratio of the iron 
stores variable was 1.12 (CI 1.03, 1.22). In our study, a change from iron stores of –
600 mg (IDA equivalent to a hemoglobin value of 10 g/dL) to 0 mg (iron sufficient) 
would increase the probability of remission of depressive mood by 3.24%. For an 
IDNA woman with an iron store of –200 mg, the probability of remission when 
reaching iron sufficiency would increase by 1%. An iron-sufficient person with an iron 
store of 0 mg who changes to a positive iron store of 600 mg would have an increased 
probability of remission of depressive mood of 1.8%. When assessing the effect of 
improving from an iron store of –600 mg to iron sufficient (0 mg) in women with 
stressor exposure (a poverty index ratio of < 130%), the probability of remission 
increased 3.21%. Thus, the effect of an improvement of iron status is, at best, 
approximately one fifth of the effect of an antidepressant; iron supplementation when 
depressive mood and ID are present has therefore only a substantial effect in women 
who present with severe to moderate IDA. It should be noted that the definition of 
remission in Detke et al.’s study (score of ≤ 7 points on a depression scale after 8 
weeks of treatment) differs substantially from the present research, which impairs the 
comparison of outcomes. 
Conclusions 
In conclusion, a significant increase of risk of depressive mood was shown 
with decreasing iron stores in US Hispanic premenopausal women; this was true even 
after statistically controlling for fatigue and potential confounders. A synergistic 
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relationship between iron stores and a variety of stressors was found: depressive mood 
was highest in women with low iron stores and exposure to a stressor.  
Comparison to the published literature invites speculation about the reasons 
why the present analysis showed support for the main study hypotheses:  
o Using a continuous measure of ID (iron stores) versus categorical threshold 
variables (IDA or IDNA) might have increased the likelihood to detect the 
relationship. This sample might otherwise not have had a large enough 
portion of IDA or IDNA women to detect a difference in depressive mood. 
Second, it appears as though the relationship between ID and depressive 
mood in our sample might span the full spectrum of iron status; testing 
only IDA could have missed a large and significantly affected group.  
o The HHANES might have been a good sample for testing the hypothesized 
relationship since a large percentage of women are below 130% of the 
poverty index ratio. Having a higher stressor exposure might have made 
participants more susceptible to the effect of ID on depressive mood.  
o It should be noted that the effect of alleviation of ID on remission of 
depressive mood is at best one fifth of the effect of antidepressants. 
Based on the results of the present analysis, it is recommended that future 
research  
o include mid- and high-level depression as an outcome  
o analyze the relationship in IDA and severely IDNA women to maximize 
the effect of ID on depressive mood 
o use a continuous measure of iron status in addition to the traditional 
categorical cutoffs 
o target the analysis to young and early middle-aged women 
o focus on groups that are exposed to stressors 
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o assess interactions between stressors and iron status. 
Future exploration of this topic should continue by means of a randomized 
placebo-controlled iron supplementation trial in order to allow for more definitive 
answers about causal relationships. In addition to adhering to the aforementioned 
improvements, the plausibility would be increased if  
o the response of fatigue and depression scores to supplementation could be 
observed in two separate groups, one fatigued and not depressed, and one 
depressed. The accuracy of the diagnosis should be assured by conducting 
clinical interviews at baseline.  
o better measurements of fatigue and depressive mood were to be used 
o a measure of internal stress were to be included instead of measuring only 
external stressors. A possible biological marker of perceived stress is 
cortisol. 
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Chapter 3: IRON DEFICIENCY AND DEPRESSIVE MOOD IN FEMALE 
MEXICAN FACTORY WORKERS8 
Abstract 
Background: Iron deficiency and depression are both disorders found 
primarily in premenopausal women. Results of studies that explore the association 
between the two are inconsistent. 
Objectives: To investigate the magnitude of association of iron deficiency and 
depressive mood in poor female Mexicans. To assess the effect of a) fatigue as a 
mediator and of b) potential confounders. 
Methods: Iron status, fatigue, depressive mood, and socioeconomic and 
behavioral factors were assessed in 100 female Mexican garment-factory workers. 
Iron status was assessed with hemoglobin, ferritin, transferrin saturation, mean 
corpuscular volume, and protoporphyrin. Severity of depressive mood was defined 
with the Beck Depression Inventory cutoffs for severe (≥29) and moderate (20–28) 
depressive mood. Fatigue was assessed with the Fatigue Severity Scale. The 
magnitude of the association between depressive mood and iron deficiency was 
investigated with logistic regression analysis. Outcomes were the risk of moderate or 
severe depressive mood. Iron status indicators were used as either continuous or 
dichotomized variables, or as composites. Covariates were fatigue and potential 
confounders. Socioeconomic and lifestyle covariates were further summarized with 
factor analysis. 
Results: The participants were on average 27 years old, and 51% were above a 
BMI of 25 kg/m2. Ninety-two percent had a household income below the national 
Mexican poverty line for household income. Average hemoglobin value was 131 g/L 
                                                 
8 Authors: Maike Rahn1, Sonia L. Hernandez Cordero2, Fabricio Campirano2, Juan A. Rivera2, Salvador 
F. Villalpando2, Jere D. Haas1. 1 Division of Nutritional Sciences, Cornell University, Ithaca, NY, 
14853; 2 Research Center for Nutrition and Health, National Mexican Institute of Public Health 
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± 16; the 25th percentile was at 123 g/l. Anemia was therefore present in 24% of the 
sample, whereas 21% had iron depletion (hemoglobin < 123 g/L, and at least one other 
indicator of iron deficiency beyond cutoff). The percentage of moderate and severe 
depressive mood was 25 and 26, respectively. Mean fatigue score was 3.8, ranging 
from a score of 1 to 7. Only hemoglobin level was significantly related with risk of 
severe depressive mood. For every g/L increase in hemoglobin, the odds ratio of 
severe depressive mood decreased by 6%. Including fatigue and a factor score for 
socioeconomic status and crowding into the statistical model did not substantially 
change this association. Risk of moderate depressive mood was not associated with 
iron status. 
Conclusion: In female Mexican factory workers, lower hemoglobin levels are 
strongly associated with increased risk of severe depressive mood. 
Keywords: Mexican, hemoglobin, iron, depression, fatigue, confounder 
Introduction 
Iron deficiency (ID) and depression are both prominent public health problems 
in premenopausal women. Forty-eight percent of women in developing countries have 
iron deficiency anemia (IDA) [1]. Prevalence of major depressive disorder (MDD) in 
developing countries is between 2 and 23%. In Mexico, prevalence of anemia in 
women is between 16% (in 2006) and 21.5% (in 1999) [6, 7]; whereas 41% are ID [9]. 
Prevalence of lifetime MDD is 7.8 to 15.9% in Mexican women [13, 20], and 
prevalence within the previous year is 5.8 to 7.6% [20, 21].  
ID and depressive mood are positively associated in the majority of 
observational studies [37-40]. Iron supplementation trials have inconsistent results, 
with 4 trials in industrialized nations finding no association [42-45], while 1 trial with 
South African postpartum women shows a significant improvement in depression 
scores with iron supplementation compared to placebo [46]. This study is the only one 
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addressing the association in a developing nation. It appears that an efficacious 
supplementation with iron might be more probable in women living in poverty beyond 
the levels found in developed countries. 
The role of fatigue in this relationship has not been investigated in the 
published literature. However, fatigue is not only associated with iron status [39, 43-
45, 52], but is also a part of the clinical diagnosis of depression [53]. Indeed, it is 
significantly associated with depressive mood [54-59]. Thus, misclassification of ID 
and fatigued participants as depressed could occur when depressive mood is measured 
with depression assessment instruments that include fatigue as part of the assessment.  
An additional challenge to the validity of the findings is that the majority of the 
studies have not controlled for confounders [37, 40, 41, 43, 45, 46]. Several factors 
such as low socioeconomic status (SES) [4, 12, 18-21, 61-86], ethnic group [4, 12, 71, 
83, 84, 88, 89], marital status [18, 20, 65, 68, 74, 92, 93], social isolation [81, 91], and 
locus of control [17, 63, 78, 90] are associated with both risk of depression and ID. 
Therefore, without confounder control, the association could be spurious.  
Our work with the Hispanic Health and Nutrition Examination Survey 
(HHANES) explored these research questions as well. It shows that fatigue and other 
covariates affect the inverse association between iron status and risk of depressive 
mood only minimally or not at all (Chapter 2). 
In order to elucidate the nature of the relationship between iron status and 
depressive mood, this chapter investigates the following hypotheses:  
1) ID and risk of depressive mood have a significant inverse association in a 
sample of poor female Mexicans. 
2) The association between the ID and depressive mood will remain significant, 
despite the control for fatigue in the model. Fatigue might be a mediator of the 
relationship between ID and depressive mood.  
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3) ID and depressive mood will continue to be associated, even with the inclusion 
of confounders in the statistical model.  
Methods 
Location 
In the summer of 2001, an observational study with female garment-factory 
workers was undertaken in the Mexican state of Morelos. Morelos is located in the 
central mountainous region of Mexico, 50 miles south of Mexico City, at a mean 
elevation of 1548 m (4856 ft). The factories were located in a garment-factory 
complex (Ciudad de la Confeccíon) south of the city of Cuernavaca. The study 
assessed the effect of ID on two outcomes: emotional health and work productivity. 
This chapter will report on the emotional health study; the results of the productivity 
study can be found in Hernandez-Cordero et al. [221]. Logistic and technical support 
was provided by the National Institute of Public Health of Mexico (INSP).  
Screening and matching 
Managers of the Ciudad de la Confeccíon were asked in the summer of 2000 
whether they would be interested in participating in the study. A total of 4 managers of 
the 6 factories agreed. In those factories, all women were invited to participate in the 
first stage of the study in the summer of 2001. This screening stage measured a 
number of characteristics necessary for the selection of the sample. Hemoglobin status 
was initially assessed by HemoCue (HemoCue AB, Aengelholm, Sweden) from a 
sample of capillary blood. Calibration of the Hemocue with a reference cuvette 
provided by the manufacturer was performed daily before the start of measurements. 
A two-page questionnaire was administered to obtain information about the type of 
work, number and ages of children, age of the worker, and reproductive status. 
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Women who were pregnant, were younger than 18 years of age, or had a child 
younger than 1 year of age were not eligible for participation in the study.  
Since the initial prevalence of anemia of 11% during screening turned out to be 
much lower than the originally anticipated 20 to 23% [6], a block design for sampling 
was used. Women with anemia (defined as hemoglobin levels < 120 g/L) were given 
priority. Women without anemia (hemoglobin > 130 g/L) were matched to the anemic 
women. Matching criteria deemed influential on the measured outcomes were physical 
intensity of the work (productivity part), and family situation (emotional health study). 
Family situation grouped women into 1) younger than 40 years of age and having no 
children under 10 years, 2) younger than 40 years of age and having children under 10, 
and 3) older than 40 years. Clusters consisted of one anemic participant and two to 
three non-anemics who were randomly chosen from the pool of eligible non-anemic 
women. Women who did not fit any of the inclusion criteria were excluded from 
further participation. After 3 weeks in the sampling pool, non-anemic cases were 
dropped. All women who were excluded received information on their weight, height, 
body mass index (BMI), and hemoglobin status the next day. Women who had 
screening hemoglobin levels below 120 g/L were counseled to see a physician and 
referred to the free medical clinical on site. They also received a month’s supply of 
iron supplement capsules with instructions on how to take them. Women whose 
hemoglobin levels were less than 80 g/L or greater than 169 g/L were immediately 
counseled to see the physician on site. They were not included in the study. Once all 
interested women were identified and matched, the next factory was approached. 
Anemics who had no match in their factory were matched to non-anemics from a 
different factory. Thus, matched pairs might not have necessarily been nested within 
the same factory.  
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Data collection 
The second stage of the study included a venuous blood draw, which was 
collected into vacutainer tubes and refrigerated until arrival at the INSP, where all 
blood samples were analyzed. Hemoglobin [g/L] and mean corpuscular volume 
(MCV) [fL] were assessed in an automated system, Cell Dyn (Abott, Santa Clara, 
California, USA); protoporphyrin [μg/dL] concentrations were measured with a ZPP 
Hematofluorometer (AVIV Biomedical, Lakewood, New Jersey, USA). Sampling 
clusters with complete information were selected randomly into a subsample for a 
more extensive iron status evaluation (compare Appendix B, section 1.2.1, Methods 
for subsample: Sample selection). Subsequent analysis revealed that hemoglobin was 
the only iron status indicator in this sample affecting risk of depressive mood. 
Therefore, in order to maximize sample size, only hemoglobin, MCV, and 
protoporphyrin were used in the analysis. For methods of the more extensive iron 
status evaluation in the subsample, see Appendix B, section 1.2.1, Methods for 
subsample: Iron status.  
All iron status indicators were evaluated as continuous and categorical 
variables. Cutoffs were the following: hemoglobin < 123 g/L,9 protoporphyrin > 70 
μg/dL, and MCV < 80 fL. In addition, composite measures were developed. Iron 
depletion without anemia (IDeNA) was defined as hemoglobin ≥ 123 g/L, and MCV 
and/or protoporphyrin beyond cutoff. Iron depletion with anemia (IDeA) was 
hemoglobin < 123 g/L and MCV or protoporphyrin beyond cutoff. All other cases 
with hemoglobin > 123 g/L and no IDeNA were defined as iron sufficient.  
In addition, stage 2 included depression assessment with the Spanish version of 
the Beck Depression Inventory-II (BDI; The Psychological Corporation, Harcourt 
Brace & Company: San Antonio) [223] (Appendix E, Beck Depression Inventory). 
                                                 
9 As a result of the higher altitude of Cuernevaca, hemoglobin values are generally higher than at sea 
levels. Hence, the suggested cutoff for anemia is 123 g/L instead of the usual 120 g/L [222]. 
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The BDI is a clinical screening tool that assesses the presence and severity of 
depression in adults and adolescents [223, 224]. The instrument contains 21 statements 
with four answer choices ranging in scoring from 0 to 3. A total additive score ranges 
from 0 to 63 points. The BDI provides cutoffs for minimal (score of 0–13), mild (score 
of 14–19), moderate (score of 20–28), and severe (≥29) depression. Women who 
answered questions on the BDI about suicide in the affirmative were referred to the 
free medical service in the Ciudad de la Confeccíon. They also received travel fare to 
a social service center that addressed mental health needs at no cost to their clients. 
For validation purposes of the BDI, the Spanish version of the Center of 
Epidemiologic Studies Depression Scale (CESD) [225] was included as well 
(Appendix E, CESD). The CESD is a depression screening tool originally developed 
by Radloff et al. [156] for an English-speaking population. It consists of 20 items. It 
has been validated and used in Mexican populations [218, 225, 226]. Order of 
administration of the two depression scales was alternated for every new participant 
entering stage 2 of the study. 
Fatigue was assessed with the Fatigue Severity Scale (FSS) [227] (Appendix 
E, Fatigue Severity Scale). The FSS was chosen because it is a short fatigue-severity 
assessment tool and has shown good differentiation between fatigue in non-depressed 
and fatigue in depressed subjects [227]. It was originally developed from a 29-item 
fatigue assessment instrument [228]. Participants estimate their range of fatigue from 
1 to 7; a visual aid was provided that allowed participants to point to the level of 
fatigue they had experienced in the past 2 weeks. The final additive score of the 9-
statement scale is divided by 9. The FSS had not been translated into Spanish 
previously; therefore, translation was undertaken with the help of a professional 
translator. The scale was subsequently back-translated into English by a bilingual 
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speaker other than the translator. Discrepancies were resolved by discussion with 
native speakers. This method was recommended by Brislin et al. [229].  
Additional questionnaires included a health history; a short food-intake record; 
an SES evaluation that was originally used by the Mexican National Nutrition Survey 
of 1999 [230]; information on the living situation such as marital status, household 
composition, time spent with second jobs, or child care support (Appendix E, Mexico 
2001). Since only the SES evaluation was developed in Spanish at the INSP, all other 
questionnaires were translated with the aforementioned method [229]. 
All questionnaires were tested with volunteers in order to explore 
comprehension; they were then modified if necessary. Interviewers were trained for 
several days in the administration of the questionnaires; the training included mock 
interviews with the coordinators and volunteers from the INSP staff. All parts of the 
questionnaires were read to the respondent; thus it was ensured that semiliterate and 
illiterate women had a good understanding of the questions and the answer options.  
After completion of the interview, participants received information on their 
weight, height, BMI, and iron status. Upon completion of the study within a factory, 
an item considered useful by the factory workers was donated (e.g., a microwave or a 
first aid kit). The project had been approved by both the Human Research Review 
Boards at Cornell University and the INSP.  
Statistical analysis 
Statistical analysis was carried out with SAS 9.1 [176]. Two main outcome 
variables were created from the BDI: severe depressive mood (≥29 points), with all 
other categories (none to moderate; <29 points) as a reference; and moderate and 
severe depressive mood (≥20 points), with all others (none to mild; <20 points) as a 
reference. In addition, two outcome variables contrasted severe depressive mood (≥29 
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points) with none to mild (0–19 points), and moderate depressive mood (20–28 points) 
with none to mild (0–19 points). 
Because of the study design, modeling was done using several procedures. 
Adjustment for the higher level of factory was done with a mixed-model procedure for 
logistic regression (proc glimmix). Matching was adjusted for by inserting the 
matching criteria as control variables into the model. In addition, proc logistic was 
used to estimate factory effect as a modifier of the relationship between iron status and 
depressive mood. The magnitude of the effect of the factory variable and the matching 
criteria were assessed. Models were adjusted according to the statistical importance of 
the variables and their impact on the effect of iron status.  
Variables indicating iron status were the independent variables of main 
interest. All iron status indicators were tested as both continuous and categorical 
variables. Composite indicators were tested as well. Curvilinear relationships were 
assessed. Hypotheses 2 and 3 were tested by inserting fatigue and potential 
confounders into the established models with the iron status indicators. Covariates 
were initially entered individually; subsequently, all variables with a p<0.2 were tested 
in various combination, in order to explore their importance.  
Covariates of interest included physical characteristics, lifestyle and family 
situation, and SES. More specifically, they were a) physical characteristics: BMI; age; 
reproductive status; medications taken; oral contraceptive use; alcohol use; b) family 
situation: marital status; number of children under 5, 10, or 18 years of age; whether 
the father helps with child care; whether the woman lives with family, friends, and if 
yes, with whom; or alone, c) work: physical strenuousness of the work at the factory; 
whether the woman worked in a second job, and if yes, how many days of the week; 
d) SES: quality of the roof, walls, and floor; water source; sanitation; household 
income; number of possessions; crowding (number of rooms – number of persons 
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living in home); and whether the kitchen was separate or not, or no kitchen existed. 
For a more specific description of the variables, see Appendix E, Mexico 2001. 
Folate and vitamin B12 deficiencies have both been shown to be associated 
with depression [160-163, 231]. Likewise, folate and vitamin B12 deficiencies are 
associated with macrocytic anemia [8, 154]. Thus, cases with MCV>94 fL [154] were 
identified as macrocytic and potentially folate- or vitamin-B12-deficient. Cases with 
anemia (hemoglobin < 123 g/dL) and macrocytosis were considered to be folate-
deficient anemic or vitamin-B12-deficient anemic, and were excluded. Models 
assessing the effect of MCV>94 fL were treated as follows: cases with high MCVs 
were initially excluded from the statistical analysis; subsequently, MCV>94 fL was 
included as a control variable.  
Residual plots were investigated for outliers. In order to explore the relative 
importance of specific cases, observations were excluded and models rerun; odds 
ratios of the reduced data set were compared with those of the full data set. Exclusion 
was based on extreme values of depression scores or iron status indicators, as well as 
high residual values. Best models were chosen based on theoretical considerations, 
significance of the variables, significance of the models, and parsimoniousness.  
In addition, factor analysis (SAS 9.1, Promax procedure) was performed in 
order to assess interrelationships between social, economic, and demographic 
variables, and to summarize variables that expressed a similar domain in the 
preliminary regression analysis. Factors were set to be correlated (oblique rotation). 
Variables included were type of wastewater removal; quality of floor, walls, and roof; 
quartiles of number of possessions; water source; availability of separate kitchen for 
cooking; household income (<4377 pesos,10 ≥4377 pesos), quartiles of crowding 
(number of rooms – number of persons living in house); household composition 
                                                 
10 equivalent of US $157/month in summer of 2001; national household poverty line in 
Mexico in 2001 [232] 
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(living alone, with parents, with brothers or sisters, with a friend, or other); marital 
status (married or living with boyfriend, single, or divorced, separated, widowed, 
single mother); father helping with child care (no kids, yes, no); participant’s number 
of work days in a second job; children under 10 (yes, no; quartiles), under 5 (yes, no; 
quartiles), and under 18 (yes, no; quartiles). All variable levels were re-coded 
according to their risk of being a cause for depression based on the literature review. 
For instance, women reporting higher poverty, crowding, a second job, children under 
10, or a disrupted marital status would be considered at higher risk. Factor models 
were evaluated based on scree plots, underlying expectations, interpretability, and 
amount of variance explained. Resulting factor scores were tested as independent 
effects in the logistic regression model. 
Sample selection 
A total of 337 women were screened. The overall response rate to the 
invitation to the initial screening stage was 69%. The breakdown by factory was as 
follows: Unger 85%, Phantom 73%, CIM 65%, and Avi 32%. Of the screened 
individuals, 134 were invited to participate in the 2nd stage of the study. Of those, 4 
cases refused, 2 women could not be located, 4 reduced their hours of work to 6, and 
for 6 women no match could be found. A final total of 118 women was included based 
on inclusion criteria, blocking, and matching characteristics. Figure 3.1 shows the 
creation of the final sample size of 100 cases. For selection of the subsample with 
complete iron status data, refer to Appendix B, section 1.2.1, Methods. A comparison 
of characteristics between women participating in the screening stage only and the 
final study participants showed no significant differences (p<0.05) in terms of marital 
status, height, weight, and age (Appendix Table B.1). 
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Figure 3.1: Sample selection. 
- 3 missing depression scale 
- 2 missing fatigue 
- 4 missing hemoglobin, MCV, protoporphyrin 
118 
115 
113 
109 
104 
102 
- 1 age 17 yrs. 
- 1 antidepressant medication 
- 1 antianxiety medication 
- 2 in menopause 
- 2 missing marital status 
100 
- 2 macrocytic anemia 
Sample with hemoglobin, MCV and 
protoporphyrin 
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Results 
Sample description 
A prominent feature of this sample was the high percentage of depression 
(Table 3.1). Twenty-five percent suffered from moderate depressive mood, whereas 
26% had severe depressive mood. With the recommended cutoff of the CESD of 16 
points [156], 59% of the sample can be considered depressed. BDI scores ranged from 
0 to 61 points. Twenty-four percent were anemic, 21% had IDeA, and 15% suffered 
from IDeNA (Table 3.2). Hemoglobin ranged from 87 to 161 g/L. The percentage of 
participants who had MCVs greater than 94 fL was 23. This sample might, therefore, 
have a high percentage of folate or vitamin B12 deficiency that has not yet resulted in 
anemia. In addition, 51% of the participants were overweight or obese (Table 3.3). 
Only 5% of the sample used oral contraceptives; none of the women reported drinking 
more than 1.5 glass of alcohol on a daily basis (not shown). The proportions of women 
from different factories were as follows: Unger were 55% of the sample, Phantom 
24%, CIM 15%, and Avi 6% (not shown). For a description of the subsample with 
complete iron status indicators, consult Appendix B, section 1.2.2, Results for 
subsample. 
Socioeconomic covariates: Factor analysis 
Analysis of potential confounders showed that variables indicating crowding in 
the home were associated with severe depression. Since several of the categorical 
crowding indicators had small cell sizes, a factor analysis was performed, creating the 
continuous factor “crowding” (factor 2; Table 3.4). A higher quality of the roof and 
the walls in this factor was associated with having a kitchen exclusively for cooking 
(instead of no kitchen, or one for cooking and sleeping), more rooms for the number of 
people in the house, and no children under 10 years of age. Factor 2 showed that 
crowding is also a socioeconomic phenomenon, since it includes the quality of the 
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house. Other factors identified in the analysis were a wealth factor (factor 1) and a 
child care/work hours factor (factor 3). Factor 1 showed that better wastewater 
removal, better water source in the house, higher quality of house construction, being 
married, and a higher number of possessions were associated. Factor 3 indicated that 
women with children under 10 years of age were less likely to work in a second job. 
When women were working in a second job, and had children under 10, fathers were 
more likely to be involved in child care. It should be noted that only 13% of the 
women had a second job, and 26% had children under 10 years of age (not shown). 
Factors correlations were between |0.057| and |0.28| (not shown). Household income 
and family composition did not load high enough (loading |0.4|) in any of the factors 
to be included in the final analysis. 
Main effects model: Influence of fatigue and socioeconomic covariate 
Factory as a random factor in the glimmix procedure demonstrated a lack of 
effect on hemoglobin, even though factory accounted for some of the variation (Table 
3.5, Model 5). Moreover, all matching criteria included in the model were not 
significant and did not affect the coefficient of iron status (not shown). Thus, the most 
parsimonious model, a linear logistic regression without factory as a random factor, 
and without adjustment for matching criteria, was chosen as the appropriate model 
(Table 3.5, Model 4). Initial logistic regression models excluded all cases with 
macrocytosis (MCV>94 fL). Despite the smaller sample size, the effect of hemoglobin 
on severe depressive mood was significant (not shown). Also, a model having 
MCV>94 as a control variable worked just as well, while maintaining the full sample 
size. Hence it was the preferred model.  
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Table 3.1: Subject characteristics, mood; mean (SD), median, 25th and 75th 
percentile, or %; n=100. 
Variable Mean (SD)  Median 25th p. 75th p. % of whole 
sample 
BDI 22.1 (14.0) 20 13.5 29.5  
Fatigue 3.8 (1.5) 3.7 2.7 4.9  
CESD-20a 20.1 (10.6) 18.5 13.0 26.0  
% BDI moderate 
score 20–28 
    25% 
% BDI severe score 
≥ 29 
    26% 
% CESD-20 > 16     59% 
a The Spanish version of the Center of Epidemiologic Studies Scale (CESD) [156] was used as a 
validation tool in this study; a score above 16 is the recommended cutoff for depressive disorders. 
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Table 3.2: Subject characteristics, iron status; mean (SD), median, 25th and 75th 
percentile, or %; n=100; iron depletion is defined as hemoglobin < 12.3 g/dl, and 
mean corpuscular volume (MCV) or protoporphyrin beyond cutoff. 
Variable Mean (SD)  Median 25th p. 75th p. % of whole 
sample 
Hemoglobin g/L 131 (16) 134 123 141  
MCV fL/l 88.7 (8.5) 91.3 85.4 93.6  
Protoporphyrin μg/dL 79.0 (67.3) 55.0 36.5 94.7  
%Hemoglobin < 12.3 
g/dL 
    24% 
% MCV < 80 fL     15% 
% Protoporphyrin > 70 
μg/dL 
    37% 
% Iron depletion with 
anemia 
    21% 
% MCV or 
protoporphyrin beyond 
cutoff; but hemoglobin > 
12.3 g/dL 
    15% 
% MCV>94a     23% 
a indicator of macrocytosis, therefore potential folate and/or vitamin B12 deficiency 
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Table 3.3: Subject characteristics, general; mean (SD), median, 25th and 75th 
percentile, or %; n=100. 
Variable Mean (SD)  Median 25th p. 75th p. % of whole 
sample 
Age (yrs) 27.1 (7.8) 24.5 20 33  
BMI kg/m2 25.6 (4.2) 25.1 22.6 28.6  
Factor 2 (Table 2) 
(crowding, SES) 
0.0 (1.0) 0.2 –0.5 0.6  
% BMI>25 kg/m2     51% 
% BMI>30 kg/m2     14% 
% Household 
Income<4377 pesosa 
    92% 
% Dirt floor     10% 
% dirt floor, walls and 
roof plastic, asbestos or 
metal 
    4% 
a equivalent of US $157/month in summer of 2001; poverty line level 1 for households in 2000 [232] 
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Table 3.4: Factor structure for socioeconomic variables. Bold numbers reflect factor 
loadings > |4|. 
Variable Factor 1 
House/SES 
Factor 2 
Crowding, SES 
Factor 3 
Life stage 
Wastewater removal 0.61 –0.07 –.07 
Quality of floor 0.75 0.38 –0.02 
Number of possessions 
(quartiles) 
0.61 0.20 0.15 
Water source 0.61 0.34 –0.16 
Marital status 0.47 –0.1 –0.15 
Quality of walls 0.59 0.41 0.17 
Quality of roof 0.58 0.48 0.10 
Availability of kitchen 0.09 0.72 0.02 
Crowding (quartiles) 0.27 0.68 –0.02 
Father’s involvement 
in child care 
–0.01 0.01 0.82 
Mother works 2nd job –.07 –0.25 0.53 
Children under 10 –.01 –0.47 –0.70 
Variance explained 2.6 1.99 1.6 
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Table 3.5: Logistic regression models; outcome Beck Depression Inventory (BDI) 
severe depressive mood; OR (95% CI); n=100. 
Variables Fixed factor models; OR (95% Confidence Intervals) Mixed 
model 
  Model 1 Model 2 Model 3 Model 4 Model 5 
Intercept 0.21 (0.11, 
0.40)**** 
0.006 (0.00, 
0.05)**** 
0.20 (0.10, 
0.39)**** 
0.003 (0.00, 
0.03)**** 
0.002 (0.00, 
0.03)** 
Centered 
hemoglobin g/L 
0.95 (0.92, 
0.98)** 
0.94 (0.90, 
0.97)** 
0.95 (0.92, 
0.98)** 
0.94 (0.90, 
0.98)** 
0.95 (0.91, 
0.98)** 
Fatigue  2.26 
(1.50,3.42)**** 
 2.52 (1.61, 
3.94)**** 
2.94 (1.75, 
4.92)**** 
Factor 2 
(crowding, SES) 
  0.72 (0.45, 
1.15) 
0.52 (0.28, 
0.96)** 
0.43 (0.22, 
0.85)** 
MCV>94 fL 3.07 (0.99, 
9.54)* 
3.74 (1.004, 
13.91)** 
2.90 (0.92, 
9.12)* 
3.44 (0.87, 
13.55)* 
3.97 (0.88, 
17.87) 
N 100 100 100 100 100 
Area under the 
ROC 
0.703 0.848 0.725 0.858 n/a 
–2LL 102.3 82.4 100.4 77.5 531.61 
Random factor 
factory: 
Cov parameter 
estimate (std 
error) 
n/a n/a n/a n/a 0.357 
(0.735)  
1 Pseudo-log Likelihood for Proc glimmix 
* p-value ≥0.05 and <0.1; ** p-value<0.05; *** p-value<0.001; **** p-value<0.0001 
After analyzing the effect of all indicators of iron status (not shown), only 
hemoglobin was related to depressive mood. Assessment of curvilinearity yielded no 
significant findings. Similarly, only severe depressive mood, defined as BDI ≥ 29 
points, performed well in the models; while moderate depressive mood (BDI > 20 
points) did not (Appendix Table B.2). Likewise, reducing the potential outcome to no 
and mild depression versus severe depressive mood (excluding moderate depressive 
mood); or no and mild depression versus moderate depressive mood (excluding severe 
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depressive mood) did not add additional information (Appendix Table B.3). 
Hypotheses 2 and 3 postulated an effect of fatigue and potential confounders. Neither 
one affected the coefficient of hemoglobin in a substantial manner, nor in the expected 
direction (Table 3.5, Models 1–4). Interactions of iron status with MVC>94, factory, 
and oral contraceptive use were not significant (not shown). 
In summary, the preferred model (Table 3.5, Model 4) showed that each unit 
increase in hemoglobin (g/L) was associated with a 6% decrease in the odds ratio of 
severe depressive mood. When using IDeA (hemoglobin < 12.3 g/dL, and MCV 
and/or protoporphyrin beyond cutoff), the odds ratio of severe depressive mood was 
3.44 (CI 0.87, 13.63, p-value 0.07) compared to all other cases (Appendix Table B.4). 
Residual plots showed no outliers (not shown). All fixed models in Table 3.5 are 
significantly (p<0.05) different from each other, assuming a difference of degrees of 
freedom of at least 1. 
For a description of the results of the logistic regression analysis for the 
subsample with complete data, consult Appendix B, section 1.2.2, Results of 
subsample. 
Discussion 
In summary, in the present sample of female Mexican factory workers, 
hemoglobin was inversely associated with severe depressive mood. For every unit 
increase of hemoglobin (g/L), the odds ratio of severe depressive mood decreased 6%. 
Controlling for fatigue and potential confounders as covariates did not affect the 
coefficient of hemoglobin.  
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Limitations and plausibility 
Causality 
Since the present study is observational, we are limited to plausibility 
statements. In addition, no causal inferences can be drawn, since directionality cannot 
be established. A randomized, controlled trial would allow one to draw causal 
inferences, but only 1 out of 5 supplementation trials has shown that iron 
supplementation results in a reduction of depression scores [42-46]. Moreover, 
depressive disorders can be associated with weight gain or weight loss [53], which 
implies an alteration in diet and/or nutrient composition of the diet (e.g., a shift away 
from iron-rich foods, or vitamin C-rich foods that increase absorption of iron). The 
effect of depression on healthy eating or supplement use has been explored by Bowen 
et al. [233]; the authors have not found an association between depression and fruit 
and vegetable consumption. Moreover, observational studies are vulnerable to 
confounding; thus, association might be spurious if confounder control was 
inadequate.  
Past depression 
Past depression was not assessed in the present sample. Severe past mood 
disorder increases the likelihood of recurrence of depression [178]; past depression 
might affect eating behavior and thus iron status, even though, to our knowledge, no 
published study has investigated this relationship. Mean age of first onset of MDD is 
between 25 and 31 years of age in international samples [2]. In the US, lifetime 
prevalence of major depressive disorder (MDD) at between 18 and 29 years of age is 
15% [62]. Since the present sample was relatively young (mean age 27 years), the 
majority of participants who will experience MDD in their lifetime might therefore 
currently be experiencing their first episode or have yet to experience it. Thus, 
confounding by past depression might not be as severe as in an older sample. 
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Antidepressant intake due to past and/or current depression might have influenced the 
results, but the only woman reporting it was excluded. 
Validity of sample selection 
The final sample is only a subset of the women working in the factory and of 
the screened women. Thus, selection bias could be a problem. First, 69% of all women 
in the four factories participated in the screening stage. While this average between the 
four factories is acceptable, the individual percentages indicate that the factory Avi 
had only 32%, which is probably too low to be representative of a broader population. 
Differences between factories in the effect of hemoglobin on depressive mood were 
assessed during the analysis. Factory was controlled for in several ways, with no 
significant effect. Thus, even though the group from Avi may not be representative of 
the factory population, it did not differ from the other three factories with respect to 
the variables of interest. 
Women were selected for the final sample according to anemia status and 
matching criteria. While every anemic woman was included, non-anemic women were 
selected randomly in order to ensure a representative sample. Women in the final 
sample did not differ from women in the screening stage in select characteristics. It is 
therefore likely that the screening sample and the study sample are comparable.  
Validity of Mexican garment-worker sample 
The present sample of Mexican female garment-factory workers might only be 
representative of poor Mexican women in a semiurban environment. Albeit, in light of 
the scarcity of information on the relationship between iron status and depressive 
mood in developing countries, this study adds valuable information. 
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Validity of the Beck Depression Inventory (BDI) 
General 
The BDI was originally developed with a non-Hispanic White and African 
American sample [223, 224]. The BDI-II is a relatively new scale; therefore, the 
number of studies evaluating it is limited. In English-speaking samples that did not 
have a prior diagnosis of current depression, the validity of the BDI is high when 
assessing Chronbach’s alphas; effect of ethnicity, age, or gender; factor structure; level 
of depression; and discriminant validity from anxiety [172, 223, 234-237]. For more 
information on the validity of the BDI, please consult the internal validity section of 
this chapter.  
Hispanic 
A drawback of the Spanish version of the BDI-II is that cultural terms for 
mood disorders are not addressed in the translation. In Mexican culture the term 
“nervios” (loosely translated as “nerves”) indicates somatic disorders (such as 
gastrointestinal problems, vomiting, lump in throat, and headaches), dysthymia and 
major depression, and anxiety [184]. Somatization of dysthymia or major depression is 
frequent in Hispanic populations [157, 186, 187].  
A number of BDI validation studies have been undertaken in Hispanic 
populations, including Mexicans. In general, the validity of the Spanish BDI-II 
appears to be as high as that of the English-language version. Moreover, language of 
interview does not appear to affect test scores [238-242]. It is also noteworthy that 
exclusion of somatic questions did not improve the performance of the Spanish BDI-II 
[241].  
For associations between the BDI-II and the CESD in our data set, please 
consult the internal validity section of this chapter. 
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In summary, the BDI-II appears to be a good measure to assess depression in 
Spanish-speaking populations. Challenges to accurately assessing depression severity 
with the BDI-II in a Mexican population with low educational level might be the high 
item difficulty, which reduces understanding; lack of culturally specific terms for 
depression; and lack of discrimination between depression and anxiety. However, a 
misclassification of cases by the BDI-II would result in a weaker association between 
hemoglobin and severe depressive mood. We were, on the other hand, able to show a 
significant relationship between hemoglobin and depressive mood.  
Validity of the Fatigue Severity Scale (FSS) 
The FSS has been an established measure of fatigue but was developed for 
English-speaking patients and healthy control subjects [227]. The FSS is usually 
evaluated in comparison to clinical diagnosis. To our knowledge, in 2001, when this 
study was conducted, no fatigue scale existed in Spanish. The English version of the 
FSS has good validity in terms of Chronbach’s alphas; discrimination between 
fatigued and non-fatigued, and fatigued and depressed; test-retest reliability; and 
correlations with other fatigue scales [227, 243-246] (compare also the internal 
validity section of this chapter). However, our Spanish translation has not been 
validated in a broader population. Likewise, the concept of fatigue has to our 
knowledge not been explored in the Mexican population. Thus, the present study 
might not measure fatigue accurately. It should be kept in mind that the internal 
validity of the Spanish FSS appeared to be good (see the internal validity section of 
this chapter). Moreover, this study aimed at producing a short measure of fatigue 
severity, for which the FSS was deemed to be appropriate. 
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Substance abuse 
Substance abuse was not specifically assessed, although participants were 
asked about their alcohol and medication use. Substance abuse is associated with 
malnutrition and depression [53, 189, 190, 193-198, 204-206]; thus it is a potential 
confounder. While no women reported drinking more than 1.5 glasses of alcohol per 
day, abuse of substances other than alcohol might have increased the strength of the 
relationship between hemoglobin and depression. In addition, abuse of alcohol or 
medication might have been underreported. A review of the literature indicates that 
substance abuse in semirural settings close to Mexico City occurs predominantly in 
young Mexican males [247-249]; in young women, prevalence of abuse of substances 
other than medications is less than 1% to 2.81% [247, 249]. Substance abuse for both 
genders was 1.5% in metropolitan areas, and not significantly different or lower for 
the region that would include the state of Morelos, where the present study took place 
[247, 249]. Moreover, during the analysis phase, cases with high depression scores 
had been removed to test influential data points; results did not differ substantially. In 
summary, in this sample of rural, semiurban, and urban Mexican women, prevalence 
of substance abuse other than alcohol and medications might have affected the results, 
even though the likelihood is probably low, as a result of low reported prevalences. 
Premenstrual syndrome (PMS) and perimenopause 
No information was gathered relating to perimenopause. Menopausal women 
were excluded from the present sample, and the sample is relatively young (mean age 
of 27 years; 75th percentile 33 years), which makes perimenopause an unlikely 
contender for a confounder.  
Premenstrual syndrome and premenstrual dysphoric disorder (PMDD) have 
been shown to be associated with depressive mood [223, 234-236]. No information on 
either disorder or on the exact menstruation cycle was gathered. A review of the 
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literature did not yield information about the association between iron status and the 
likelihood of PMS. Iron indicator values are not affected specifically during the time 
of menstruation [207]. In conclusion, women who had PMDD and were assessed at 
that time of their cycle could have had higher depressive mood, but the hemoglobin 
values were probably not affected.  
Other nutrients that may cause depression 
A number of nutrients have been associated with depression and/or anemia, 
including zinc, folate, vitamin B12, and ω-3 polyunsaturated fatty acids (specifically 
docosahexanenoic acid) [158-163, 168]. Vitamin B12 and folate deficiency cause 
macrocytic anemia [8, 154]. In the present study, macrocytic anemics were excluded, 
and macrocytosis without anemia was statistically controlled for in the models. Intake 
of zinc or ω-3 polyunsaturated fatty acids, though, was not assessed. Prevalence of 
zinc deficiency was 30% in rural and urban Mexican women in 1999 [9]; considering 
the frequency of occurrence, a sizeable proportion of women in this sample might 
have been zinc deficient. Note, though, that Chapter 2 of this dissertation did not find 
an association between iron status, zinc intake, and severe depressive mood. 
Information on ω-3 polyunsaturated fatty acid status for Mexicans is only available for 
breast milk [250]. Mean concentration in Mexico is not significantly different from 
industrialized countries (mean % of total fatty acids is 0.26%) [250], albeit lower than 
the worldwide mean of 0.32% [208]. It is also important to keep in mind that the 
depression-lowering properties of ω-3 polyunsaturated fatty acids are inconsistent and 
controversial [210-212].  
In summary, if cases with low hemoglobin values were also deficient in zinc or 
ω-3 polyunsaturated fatty acids, either one of those two nutrients might have acted as a 
positive confounder.  
 86 
Internal validity 
Hemoglobin 
Hemoglobin and all other iron status measures were assessed with established 
methods of laboratory analysis. The National Mexican Institute of Public Health 
(INSP) laboratory that analyzed the blood samples had received excellent ratings by 
the CDC in terms of precision of measurements [251]. Hemoglobin, MCV, and 
protoporphyrin correlate significantly (p<0.0001), indicating that low hemoglobin 
values are accompanied by low MCV and high protoporphyrin values; correlations are 
of the magnitude of r=|0.67| to |0.70| (not shown). Having hemoglobin less than 123 
g/L was also significantly associated with being IDeA (p<0.0001, Fisher’s-Exact test; 
n=100) and IDA (p<0.0001 Fisher’s-Exact test; n=76). 
Beck Depression Inventory (BDI) 
The validity of the BDI has been explored extensively in previous studies. Our 
literature review shows that the BDI-II’s Chronbach’s alphas are high (between 0.73, 
0.89, and 0.95) [223, 234, 236]; scores were independent of ethnicity and age in three 
studies [223]; however, one study found significantly higher scores for women [223], 
while another identified lower scores for younger participants [223, 234-236]; the 
BDI-II correlates well with other depression scales (e.g., the Revised Hamilton 
Psychiatric Rating Scale for Depression has a correlation with the BDI-II of of r= 
0.71) [172, 237]; it consistently groups symptoms into 2 factors, affective-cognitive 
and somatic [172, 223, 237]; the scale has also been shown to differentiate between 
psychiatric and non-psychiatric populations, and can distinguish levels of depression 
severity [223, 237].  
Review articles dealt with the older version of the BDI. Identified limitations 
are that the factor structure is variable depending on population (between 2 and 9 
factors); that the high difficulty of the items reduces the usefulness as a simple field 
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tool [237]; and the discriminant validity in relation to anxiety [237]. Correlations 
between anxiety scales and BDI can be high in non-psychiatric populations (0.22 to 
0.82) [223, 237]. It should be noted that Beck et al. [223] state that the scale 
discriminates well when comparing mean scores of depressed (BDI-II) and anxious 
participants, although correlation between the BDI-II and anxiety scales (Beck 
Anxiety Inventory, Revised Hamilton Anxiety Rating Scale) is between r=0.47 and 
0.60. Moreover, the test-retest reliability of the English version of the BDI is 
controversial, since it is dependent on time interval [238-240]. 
Previous studies investigated the validity of the BDI scale in Spanish-speaking 
Puerto Rican, Spanish. and Argentinian populations [238-240]. All of them confirm 
high internal consistency (Chronbach’s alpha = 0.87 to 0.91) [240], independent of 
age, education, and income; high test-retest reliability [238]; and that the scale is 
highly correlated with other depression assessment instruments (Symptoms Scale 
Checklist-90) [238]; that likewise, in terms of criterion validity, groups at higher risk 
(women, young adults, and low SES) had higher scores than other groups [238-240]; 
and that factor analysis revealed 2 to 4 factor solutions [240-242]. The validity of the 
Spanish version of the BDI-II has only recently undergone an evaluation in Hispanic 
Americans of predominantly Mexican descent [240-242]. Chronbach’s alphas are high 
in Spanish speakers (0.89 to 0.95) [240, 242]; scores were independent of age, gender, 
and SES [242], while higher acculturation resulted in lower BDI scores in one of the 
studies [240], but not in the other [240]; test-retest reliability was good [240, 242]; a 2-
factor solution was favored [240, 242]; and language of interview made no significant 
difference in test scores [241]. Discrimination between anxiety and depression was 
assessed by Novy et al. [252]; they found a correlation of 0.60 between the Spanish 
versions of the Beck Anxiety Inventory and the BDI-II, although the authors interpret 
the correlation as low (an indicator of good discriminate validity) compared to higher 
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correlations between anxiety assessment tools of 0.77. Little information exists on the 
validity of the BDI in Mexicans in Mexico. A study from 1997 with middle-aged 
Mexican rheumathology patients from Mexico City shows that the agreement between 
clinical diagnosis of any depressive disorder and BDI was as follows: 
sensitivity=92%, specificity=86%, positive predictive value=0.80 [240]11; 
interestingly, the exclusion of somatic symptoms did not improve the validity of the 
BDI. This is of importance, since somatization is an important feature of depression in 
Hispanics [157, 186, 187]. 
In the present study, the BDI-II had a high Chronbach’s alpha (0.90). It 
correlated well with the CESD12 [156]: the Pearson correlation was 0.62 (p<0.001). 
When assessing sensitivity and specificity of the two depression scales, the CESD 
performed best at a cutoff of 21 (sensitivity=78%, specificity=92%) when compared to 
severe depressive mood of the BDI (not shown). When assessing moderate depressive 
mood, CESD cutoffs never rose above a sensitivity or specificity of 70% when 
compared to moderate depressive mood of the BDI. The expected association of the 
BDI-II with the FSS was found (r=0.50, Pearson correlation; p<0.0001).  
In summary, the Spanish BDI-II appears to be a valid tool for depression 
severity assessment in the present Mexican sample. 
Fatigue Severity Scale (FSS) 
The FSS has not been used in a Latin American population previously, and at 
the time of the present study (2001) it had not been translated into Spanish. The 
English version of the FSS has been shown to have a high Chronbach’s alpha (0.88 to 
0.94) [227, 243, 244]; to discriminate between fatigued and healthy subjects [227, 243, 
244]; to be correlated with most other fatigue scales (r=0.47 to 0.81) [243, 244] except 
                                                 
11 Sensitivity and specificity assessment with the BDI are rare, since it is usually compared to clinical 
diagnosis, not other scales. 
12 The CESD has experienced extensive use in Latin populations, including Mexico [218, 225, 226]. 
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the Fatigue Impact Scale (r=0.15) [227, 243]; and to be unidimensional (1 factor only) 
[227], although 2 factors were demonstrated by Hagell et al. [243]. In addition, it 
showed substantially reduced scores with improvement of fatigue in clinical patients 
[227] and good test-retest reliability [227, 244]; furthermore, the associations with 
depression (CESD) were relatively weak to moderate (0.2 to 0.46), depending on 
population tested [227, 245]; mean scores of the FSS for patients with severe fatigue 
were higher [243, 245]; and scores were independent of gender, but not of age [243]. 
In a Spanish-speaking population, the FSS correlated significantly with the Fatigue 
Impact Scale (r=0.68) [246].  
Since the FSS had previously not been validated in a Spanish-speaking 
population, we did a more extensive validation with our Spanish version. The FSS had 
a high internal consistency (Chronbach’s alpha = 0.78); and correlated significantly 
with a summary score of the three fatigue questions of the CESD (r=0.46; p<0.0001) 
(not shown). This strength of association was to be expected [227, 245]. As 
demonstrated in previously published studies that assessed the association between 
depression and fatigue [54-57], the FSS also showed a significant correlation with the 
BDI-II (Pearson correlation r=0.50; p<0.001). The FSS was created from a 29-item 
questionnaire [228] and represents the unidimensional fatigue severity factor. 
Principal component analysis with subsequent rotation (Varimax and Promax) with 
the criteria of a minimum Eigenvalue of 1 for factor determination revealed 2 factors. 
Factor 1 loaded 5 items that indicated more severe fatigue and interference with social 
functioning, factor 2 loaded motivational and exercise-related fatigue (Appendix Table 
B.5; Appendix E, Fatigue Severity Scale). The motivational item was previously 
reported as not fitting with the unidimensional assumption of the FSS [243]. The FSS 
was associated with time spent relaxing (r=0.25; p=0.07) in a subsample of 49 factory 
workers. FSS was not significantly associated with iron status (even when testing the 
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effect of matching, factory, covariates, and curvilinearity). In the best model, every 
unit rise in hemoglobin reduced the odds of a fatigue score above the 75th percentile 
of the FSS by 1.2%, p=0.21 (Appendix Table B.6). It is possible that fatigue in this 
sample of poor women is associated with factors other than iron status; these might act 
as confounders. Another explanation might be that this relatively young sample does 
not become fatigued enough to show an association between fatigue and hemoglobin. 
An indication might be the relatively low average score (3.8) compared to studies with 
fatigued subjects (4.6–6.6) [227, 243-245]. Last, the translated version might not 
measure the concept of severe fatigue accurately in Spanish-speaking Mexican 
women, consequently reducing the range of possible answers. 
In summary, fatigue severity appears to be measured appropriately by the FSS 
in the present sample, although the FSS is not unidimensional as originally intended, 
and it is not associated with iron status. 
Mechanisms 
Lower hemoglobin levels were associated with a higher risk of severe 
depressive mood in the present study. Animal studies indicate a biological 
explanation: serum ID translates directly into brain ID [22-24]. Moreover, iron is a 
cofactor in the synthesis of serotonin, dopamine, and norepinephrine [25-27]. 
Consequently, lower brain iron concentration should result in lower concentrations of 
at least one of the three neurotransmitters. Alteration of concentrations of serotonin, 
dopamine, and/or norepinephrine in the brain are implicated as a cause of depression 
[114, 122, 124-129], probably because of impaired signal transmission between nerve 
cells. Recently, a decrease of D2-like dopamine receptors has been shown in 
depressed patients [126, 127]. Findings for serotonin and norepinephrine, though, are 
inconsistent [28-32], with dopamine giving the best indication of ID-induced impaired 
nerve-signal transmission due to lower D2 dopamine receptor density and transport 
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downregulation [29, 32-36]. In addition, the activity of monoamine oxidase, which is 
involved in the breakdown of serotonin, seems to be reduced [28, 30].  
External validity 
Anemia was assessed by Hemocue; the prevalence was 11%. Compared to 
Shamah-Levy et al. [6], who found a prevalence of 16 to 21% in rural and urban non-
pregnant women in Mexico City and the central region with Hemocue in 1999, this 
value is lower. Mundo et al. [7] reported a prevalence of 14.7 to 16.8% in 2006. Iron 
status values of the venous blood sample analysis were not representative of the 
population of factory workers as a whole, since women who were identified as anemic 
by Hemocue were oversampled. Only 1% of the sample had transferrin saturation 
below the cutoff of 16% (Appendix Table B.9), which is extremely low compared to 
the 36 to 52% of the 1999 National Mexican Nutrition Survey [9]. 
Since anemic women were oversampled, and ID is associated with depressive 
mood in this analysis, the percentage of women suffering from severe depressive 
mood in the present sample (26%) is not representative of the overall population in the 
factories. Lifetime prevalence of MDD in unacculturated female Mexican American 
immigrants is 8.4%, and of dysthymia 1.6% [13]. Women in the Mexican state of 
Morelos, where the present study took place as well, had a prevalence of MDD in the 
last year of 5% [21]. In surveys assessing MDD in women in Mexico in general, the 
prevalence for the previous 12 months was 7.6%, and for the last 6 months was 5.7% 
[20, 21]; lifetime prevalence was between 7.8 and 15.9% [13, 20].  
The average fatigue score in the present sample was 3.8. Compared to means 
from other studies, it lies between the means of non-fatigued subjects and fatigued 
subjects. Non-fatigued participants have an average score of 2.3 to 3.1 [227, 243]. 
Fatigued and/or ill subjects have a mean FSS score of 4.6 to 6.6 [227, 243-245]. 
 92 
Hemoglobin and depressive mood showed a significant inverse association in 
the present sample. Observational studies in humans generally confirm an association 
between ID and depressive mood [37-40], with one exception [41]. In our analysis of 
the HHANES we showed a significant (p<0.05) decrease of the OR of depressive 
mood with every g/L increase in hemoglobin (Chapter 2). Five supplementation trials 
explored the same association, but 4 of the 5 trials had negative results [42-45]. All 
trials with negative results took place in industrialized countries with women who 
were not explicitly postpartum. Only one study with postpartum South African women 
showed a decrease in depression scores after iron supplementation, compared to 
placebo [46]. It is possible that the association between ID and depressive mood is 
strengthened in populations that are exposed to more, and to more severe stressors. 
Poverty and the postpartum period are considered such stressors, and they increase the 
risk of depression [53, 64-66, 86, 253-256].13 Biologically, chronic stressor exposure 
probably results in a downregulation of cortisol release [215, 216] and an upregulation 
of the immune system [119, 140]. Increased release of proinflammatory cytokines, 
which are part of the unspecific immune response of the body [138], is now thought to 
be one of the causes of depressive disorder [115, 120, 121]. Thus, assuming a 
synergistic relationship between stress and ID, the Mexican women in our study might 
have been more likely to show a statistically significant relationship between iron 
status and depressive mood.  
While fatigue did not affect the relationship of hemoglobin and depressive 
mood in the present study, a literature review revealed no other work that allowed for 
comparison of the results. The significant association between fatigue and depressive 
                                                 
13 Established risk factors for postpartum depression coincide with risk factors outside the postpartum 
period, such as low SES. However, pregnancy-specific risk factors are unwanted pregnancy, low birth-
weight babies, maternity blues, lack of social support, number of children, and a baby who cries a lot. 
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mood has previously been demonstrated by a number of other sources [58, 59, 179, 
244].  
In the present study, no association between perceived fatigue and iron status 
was detected. The published literature suggests that fatigue increases with iron 
deficiency [39, 43-45, 52]; however, two studies found no relationship between 
fatigue and iron status [38, 41]. Since the FSS appears to be a valid measure of fatigue 
severity, non-significance might be due to unaccounted confounders, lack of severe 
fatigue, or cultural bias.  
To our knowledge, no published study has assessed the effect of fatigue and 
SES covariates on the relationship between iron status and risk of depressive mood. 
We investigated the associations with the HHANES data set (Chapter 2). Our research 
shows that the inverse association between iron status and depressive mood is only 
minimally or is not affected by the inclusion of fatigue, SES, and ethnic group as 
independent variables. The OR of depressive mood decreased by 11% with every 100 
mg increase of body iron stores [155]. 
Clinical relevance 
Assessing the magnitude of the effect of low hemoglobin values on severe 
depressive mood would help to determine the potential effectiveness of iron 
supplementation as a therapy for depression. A literature review revealed only one 
randomized controlled trial assessing the efficacy of antidepressant therapy that can be 
compared with our type of analysis, although this study used a different depression 
scale (Hamilton Rating Scale for Depression). The authors [220] use the probability of 
remission after therapy as their outcome, and tested the antidepressants Duloxetine 
and Parocetine on a total of 367 patients with MDD. Depending on the dosage, 
Duloxetine increased the probability of remission by 21 to 28% compared to a 
placebo, while Paroxetine increased it by 17%. In the present study, when defining a 
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BDI score below 29 as remission (reference BDI score ≥ 29), we can estimate the 
potential effect of improving hemoglobin status. Hemoglobin (g/L) was the variable of 
interest; covariates were fatigue, factor 2, and MCV>94. The odds ratio of remission 
of severe depressive mood with a unit increase in hemoglobin was in this case 1.06 
(CI 1.02, 1.10). A change from a hemoglobin value of 100 g/L to 123 g/L would 
increase the probability of remission of severe depressive mood by 29.7 percent. This 
magnitude is comparable to the effect of antidepressant treatment in the 
aforementioned study. However, since our study was observational, it cannot 
conclusively answer the directionality of the association between hemoglobin values 
and depressive mood. Likewise, the definitions of remission in Detke et al.’s treatment 
trial (depression scores ≤ 7 points after 8 weeks of treatment) and in our study are very 
different. We compared the probability of remission in this group of poor Mexican 
women to the one in the HHANES, which is 3.2% (Chapter 2). The great difference in 
magnitude of the effect between the samples might be explained by the much higher 
stress exposure in Mexican factory workers (consult also the mechanisms section in 
this chapter), or by the greater homogeneousness of the Mexican sample that reduced 
extraneous variability.  
Conclusion 
In conclusion, a significant increase of risk of severe depressive mood with 
decreasing hemoglobin values was demonstrated in this sample of female Mexican 
garment-factory workers. The relationship persisted after controlling for fatigue and 
socioeconomic or lifestyle covariates. 
Comparison to the published literature invites speculation about the reasons 
why the present analysis supported the hypothesized association between hemoglobin 
and severe depressive mood:  
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o The sample of Mexican factory workers might have shown the association 
more clearly than a more advantaged population, because the magnifying 
effect of the stressor poverty might increase vulnerability to the negative 
effect of ID (compare Chapter 2 and Chapter 4). It is well documented that 
chronic stressor exposure raises the risk of depressive mood. Thus, women 
who are living in poverty and are ID are exposed to two risk factors, and 
this double exposure might increase their risk for depressive mood 
substantially (consult the mechanisms section of this chapter). 
o The magnitude of the probability of remission of severe depressive mood 
with improvement of hemoglobin levels to non-anemic levels is 
comparable to treatment with antidepressants. In more affluent nations, 
antidepressants are the best-known available treatment for depression; their 
administration is therefore normative. Poor developing nations might not 
be able to afford expensive treatment options; screening for ID of severely 
depressed women and administration of iron supplements might be an 
accepted treatment option or a preventative public health approach in 
financially constrained situations.  
Based on the results of the present analysis, it is recommended that future 
research 
o focus on severe depressive mood as an outcome  
o use continuous measures of iron status in addition to the traditional 
categorical cutoffs 
o target studies to poor populations, preferably in developing countries 
o compare effect of iron status supplementation on improvement of 
depression scores to antidepressant treatment. 
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Chapter 4: CORTISOL, IRON STATUS, AND SEVERE DEPRESSIVE MOOD 
IN FEMALE MEXICAN FACTORY WORKERS14 
Abstract 
Background: Stressor exposure increases the risk of depressive mood in iron 
deficient individuals. No study has investigated whether a biological marker of 
perceived stress such as cortisol shows a similar modifying effect. 
Objectives: To explore the modifying effect of stress on the relationship 
between iron deficiency and depressive mood. 
Methods: In 2001, an observational study with 48 Mexican female factory 
workers was conducted. Iron status was assessed via venous blood sample with 
measures of hemoglobin, mean corpuscular volume (MCV), and protoporphyrin. 
Severity of depressive mood was measured with the Spanish Beck Depression 
Inventory-II (BDI). Fatigue severity was assessed with a Spanish translation of the 
Fatigue Severity Scale. Internal stress was measured with salivary cortisol, sampled 3 
times a day (30 minutes, 3 and 7 hours after waking) on 2 randomly chosen workdays. 
For the statistical analysis, iron status was operationalized as a) the continuous 
variable hemoglobin (g/L) while controlling for macrocytosis, and b) the categorical 
variable iron depletion (hemoglobin<123 g/L, and MCV <80 fL and/or 
protoporphyrin>70 μg/dL; vs. hemoglobin ≥ 123g/L). Severe depressive mood was 
defined as BDI scores ≥ 29 points vs. the reference of < 28 points. Area under the 
cortisol concentration curve over the time of the day (AUC) was calculated; then the 
variable was dichotomized at the median. Values below the median were considered 
low, while variables equal to or greater than the median were considered high, 
reflecting hyper- or hypocortisolism at the extremes. Logistic regression was 
                                                 
14 Authors: Maike Rahn1, Sonia L. Hernandez Cordero2, Fabricio Campirano2, Juan A. Rivera2, 
Salvador F. Villalpando2, Jere D. Haas1. 1Division of Nutritional Sciencces, Cornell University, Ithaca, 
NY, 14853; 2 Research Center for Nutrition and Health, National Mexican Institute of Public Health. 
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performed with severe depressive mood as the outcome, and iron status, fatigue, 
macrocytosis, AUC cortisol, the interaction between AUC cortisol and iron status, and 
potential confounders such as socioeconomic status.  
Results: The sample of factory workers had a mean age of 29 years; mean 
BMI was 26 kg/m2. Thirty-one percent of the women had severe depressive mood. 
The percentage of anemia was 29%, and iron depletion with anemia was 25%. Mean 
hemoglobin concentration was 131 + 18 g/l, with a range between 8.8 and 16.1 g/l. 
The average Fatigue Severity Scale score was 4.1 + 1.6, reflecting moderate fatigue 
severity. Mean AUC cortisol was 16 + 15.4 nmol/L; the median was 14.1 nmol/L. The 
interaction between hemoglobin (continuous) and dichotomized AUC cortisol, and 
iron depletion (dichotomous) and dichotomized AUC cortisol had p-values of p=0.08. 
Cases with AUC cortisol levels below the median showed a significant 6% increase of 
the odds of severe depressive mood with each g/L decrease in hemoglobin (p-value of 
slope 0.04). No significant association was found in cases with AUC cortisol values 
above the median. The statistical model controlled for fatigue, crowding, and 
socioeconomic status. Macrocytosis was not a significant predictor of severe 
depressive mood in this model. 
Conclusion: AUC cortisol modified the effect of hemoglobin on severe 
depressive mood. Individuals with low AUC cortisol show a significant rise in risk of 
severe depressive mood with decreasing hemoglobin levels. 
Keywords: stress, cortisol, depression, hemoglobin, hypocortisolism, Mexico 
Introduction 
Iron is a cofactor in the synthesis of three neurotransmitters: serotonin, 
norepinephrine, and dopamine [25-27]; their change in concentration in the brain is 
associated with depression [114, 122, 124-129]. Consequently, iron deficiency (ID) is 
related to depressive mood in human observational studies [37-40]. Our analysis of the 
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association between risk of depressive mood and iron status with the Hispanic Health 
and Nutrition Examination Survey (HHANES) and Mexican women corroborates 
these findings (Chapter 2 and Chapter 3). However, supplementation trials have less 
consistent results. A total of 5 studies supplemented participants with iron, and 
compared depression scores between supplemented participants and controls at the 
end of the intervention [42-45]. In 4 of the studies, controls had received a placebo: in 
1 the control condition was an iron-rich diet [42-45]. Only 1 of the supplementation 
interventions was able to find a significant decrease in depression scores in the 
supplemented group [46]. Interestingly, this particular study took place in South 
Africa, with women less than 1 year postpartum [46]. All other trials with negative 
results were conducted in industrialized nations without a postpartum-inclusion 
criterion [42-45].  
In a previous study (Chapter 2), we were able to show a modifying effect of 
exposure to stressors on the relationship between iron stores [155] and severe 
depressive mood in Hispanic American women: poverty, lack of control over one’s 
health, and post-pregnant status increase the risk of severe depressive mood in ID 
women, while women who are not ID and/or not exposed to a stressor are at no 
increased risk (Chapter 2). Based on the results in Chapter 2, we suggest that stress 
and ID interact, so that women exposed to both risk factors face a much higher risk of 
depressive mood than women with exposure to only one or none of the factors. It is 
well known that the stress of poverty increases the risk of depression [64-66]; 
postpartum status can be a risk factor as well [53, 86, 253-256].15 The likely 
mechanism is that chronic stressor exposure results in a habituation of the stress 
system, reflected in a downregulation of cortisol [215, 216], and a chronic 
                                                 
15 While established risk factors of depression outside of the postnatal period (such as low SES) are by 
far the strongest determinants of postpartum depression, pregnancy-specific risk factors have been 
identified as well. These include unwanted pregnancy, low birth-weight babies, maternity blues, lack of 
social support, number of children, or a baby who cries a lot. 
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upregulation of the immune system [119, 140], thereby increasing the likelihood of 
depressive disorders [115, 120, 121]. Neurotransmitter concentrations are altered by 
both hypocortisolism and high concentrations of proinflammatory cytokines [66, 121, 
125, 130, 132, 133, 137]. Likewise, animal studies have shown that ID alters 
neurotransmitter availability in the brain [28, 29, 32-36], albeit without entirely 
consistent results [28-32].  
In the present study, we aimed to test for a synergistic relationship between 
iron status, stress, and depressive mood in a population from Mexico. Moreover, 
instead of using stressor exposure as an approximation of experienced stress, we 
employed a biological marker of stress, cortisol. We expect that ID women 
experiencing high stress levels are at higher risk for depressive mood than women who 
were not as stressed and/or not ID.  
Methods 
Location 
In the summer of 2001, an observational study with female garment-factory 
workers was undertaken. The factories were located in the Mexican state of Morelos, 
in the central mountainous region of Mexico, 50 miles south of Mexico City, at high 
elevation (1548 m or 4856 ft). The factories were part of a garment-factory complex 
(Ciudad de la Confeccíon) south of the city of Cuernavaca. Logistic and technical 
support for the research was provided by the Mexican National Institute of Public 
Health (INSP, Instituto Nacional de Salud Publica). The project had been approved by 
both the Human Research Review Boards at Cornell University and the INSP. 
Screening and matching 
A subsample of 48 women was randomly selected from a larger sample of 100 
participants (see Chapter 3). Women from 4 of 6 factories in the factory complex 
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participated in the three stages of the larger study. The screening stage consisted of a 
short assessment of a number of characteristics important for participant selection. 
These included hemoglobin status, which was assessed by HemoCue (HemoCue AB, 
Aengelholm, Sweden) from a sample of capillary blood, work type, number and ages 
of children, age of the participant, and whether she was lactating or pregnant. Women 
who were pregnant, younger than 18 years of age, or less than 1 year postpartum were 
not eligible for participation in the study.  
The initial prevalence of anemia of 11% during screening was lower than the 
originally anticipated 20 to 23% [6]. Therefore, a block design for sampling was used 
in which inclusion of women with anemia (defined as hemoglobin levels < 120 g/L) 
was given priority. Women without anemia (hemoglobin > 130 g/L) were matched to 
the anemic women based on the physical intensity of their work (important for the 
assessment of productivity),16 and family situation (mood component of the study). 
Family situation grouped women into a) younger than 40 years of age and having no 
children under 10, b) younger than 40 years of age and having children under 10, and 
c) older than 40 years. The clusters consisted of one anemic participant and two to 
three non-anemics who were randomly chosen from the pool of eligible non-anemic 
women. Once all women who wanted to participate were identified and matched, the 
next factory was approached. Anemic women who had no match in their factory were 
matched to non-anemics from a different factory. Thus, matched pairs might not have 
necessarily been nested within the same factory. Screening and matching procedures 
are also described in Chapter 3. 
Women who did not fit any of the inclusion criteria were excluded from further 
participation. After 3 weeks in the sampling pool, non-anemic cases were dropped. All 
                                                 
16 The study consisted of two parts. One part assessed the association between ID and productivity; the 
other investigated the relationship between ID and mood. This chapter will not report on the methods 
and results of the productivity study. For further information, please compare with Hernandez-Cordero 
et al. (2003) [221].  
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women who were excluded received information on their weight, height, body mass 
index (BMI), and hemoglobin status the next day. Women who had hemoglobin levels 
below 120 g/L, who were either dropped because of exclusion criteria or who 
completed the study, were counseled to see a physician and referred to the free 
medical clinical on site. They also received a month’s supply of iron supplement 
capsules with instructions on how to take them. Women whose hemoglobin levels 
were below 80 g/L or above 169 g/L were immediately counseled to see the physician 
on site. They were not included in the study.  
Data collection 
The second stage of the study included a venous blood draw, which was 
collected into vacutainer tubes. All blood samples were analyzed at the INSP. 
Hemoglobin [g/L] and mean corpuscular volume (MCV) [fL] were assessed in an 
automated system, Cell Dyn (Abott, Santa Clara, California, USA); protoporphyrin 
[μg/dL] concentrations was measured with a ZPP Hematofluorometer (AVIV 
Biomedical, Lakewood, New Jersey, USA). Based on the results of the analysis in 
Chapter 3, non-significant iron status measures such as ferritin and transferrin 
saturation were used only for internal validity assessments. All iron status indicators 
were evaluated as continuous and categorical variables. Cutoffs were as follows: 
hemoglobin < 123 g/L,17 protoporphyrin > 70 μg/dL, and MCV < 80 fL. In addition, 
composite measures were developed. Iron depletion without anemia (IDeNA) was 
defined as hemoglobin ≥ 123 g/L, and MCV and/or protoporphyrin beyond cutoff. 
Iron depletion with anemia (IDeA) was hemoglobin < 123 g/L, and MCV or 
protoporphyine beyond cutoff. All other cases with hemoglobin > 123 g/L and no 
IDeNA were defined as iron sufficient.  
                                                 
17 Because of the higher altitude of Cuernevaca, hemoglobin values are generally higher than at sea 
levels. Hence, the suggested cutoff for anemia is 123 g/L instead of the usual 120 g/L [222]. 
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Stage 2 also included an assessment of severity of depression with the Spanish 
version of the Beck Depression Inventory-II (BDI; The Psychological Corporation, 
Harcourt Brace & Company: San Antonio) [223] (Appendix E, Beck Depression 
Inventory). The BDI is a clinical screening tool that assesses presence and severity of 
depression [223, 224]. It contains 21 statements, each with 4 answer choices ranging 
in score from 0 to 3. The total additive score ranges from 0 to 63 points. The BDI 
provides cutoffs for minimal (score of 0–13), mild (score of 14–19), moderate (score 
of 20–28), and severe (≥29) depression. In order to assess the construct validity of the 
BDI, the Spanish version of the Center of Epidemiologic Studies Depression Scale 
(CESD) [225] was included as well (Appendix E, CESD). The CESD is a depression 
screening tool developed by Radloff et al. [156] for an English-speaking population. It 
consists of 20 items, and the Spanish version has been validated and used in Mexican 
populations [218, 225, 226]. Order of administration of depression scales was 
alternated for every new participant entering stage 2 of the study.  
Women who answered questions on the BDI related to suicide in the 
affirmative were referred to the free medical service in the Ciudad de la Confeccíon. 
They also received travel fare to a social service center that addressed mental health 
needs at no cost to their clients.  
The Fatigue Severity Scale (FSS) was used to assess fatigue [227] (Appendix 
E, Fatigue Severity Scale). The FSS was chosen because it is a short measure of 
fatigue severity; in addition, it has shown good differentiation between fatigue in non-
depressed and fatigue in depressed subjects [227]. It was originally developed from a 
29-item fatigue assessment instrument [228]. Participants estimate their range of 
fatigue from 1 to 7 in the past 2 weeks; a visual aid was provided that allowed 
participants to point to the level of fatigue they experienced. The final additive score 
of the 9-statement scale is divided by 9. However, no Spanish version of the FSS 
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existed in 2001; therefore, it was translated by a professional translator. The scale was 
subsequently back-translated into English by a bilingual speaker. Discrepancies were 
resolved by discussion with the translators and native speakers. This method was 
recommended by Brislin et al. [229].  
Additional questionnaires included a health history; a short food-intake record; 
a socioeconomic status (SES) evaluation originally developed for the Mexican 
National Nutrition Survey in 1999 [230]; information on the respondent’s living 
situation such as marital status, household composition, time spent in a second job, 
and paternal support with child care (Appendix E, Mexico 2001). Since only the SES 
evaluation was developed in Spanish at the INSP, all other questionnaires were 
translated with the aforementioned method [229]. All questionnaires were tested with 
volunteers in order to explore comprehension; they were then modified if necessary. 
Interviewers were trained for several days in the administration of the questionnaires; 
the training included mock interviews with the coordinators and volunteers of the 
INSP. All parts of the questionnaires were read to the respondent; thus it was ensured 
that semiliterate and illiterate women had a good understanding of the questions and 
answer options.  
Stage 3 of the study addressed the level of internal stress a participant 
experienced. A randomly selected subset of women with complete data from the 2nd 
stage was invited to the 3rd stage. The 3rd stage included 2 days of cortisol sampling, 
and the General Health Questionnaire (GHQ) that assesses emotional health [257, 
258] (Appendix E, GHQ). It was previously used successfully in conjunction with 
cortisol [100]. 
Cortisol from saliva samples was used as the biological marker of pereceived 
stress. Saliva samples were collected with sampling tubes called Salivettes (Sarstedt 
Corp, Newton, NC, USA). The tubes contain a polyester swab on which participants 
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chewed to generate saliva; the saliva was then deposited into the tube by spitting. The 
sampling scheme called for 4 samples per day for 2 days. Sampling days were chosen 
randomly from the 5 workdays of the week. For each woman, sampling intervals were 
timed according to time of morning waking. The intervals were the same for each 
participant in order to generate comparable curves: 30 min after waking,18 3 hours 
after waking, 7 hours after waking, and 10 hours after waking. Sampling was timed to 
exclude lunchtime and to leave at least an hour after lunch. Women were advised not 
to eat for half an hour before sampling, since food intake increases cortisol levels 
[260]. Since the first sample was to be taken at home, women had one practice session 
on the afternoon before the sampling day. They were then sent home with one 
Salivette, and filled it the next morning while recording the actual time of sampling; 
the interviewer collected the filled Salivette on the morning of the sampling day. 
Times of waking and of first saliva collection were recorded, and interviewers 
calculated the subsequent times of sampling for the day. The women received the 
projected sampling times on a piece of paper in order to assure compliance with the 
sampling times. Interviewers came to the women at their workplace to take the next 
sample. At that time women were also reminded of the next sampling time. At the end 
of the day, women were asked to report any events during the day that they 
experienced as stressful and their time of occurrence (Appendix E, Mexico 2001, 3rd 
stage). Cortisol samples were refrigerated in the factory and frozen upon arrival at the 
INSP. Cortisol is very stable and easily withstood the short transports from the 
participant’s home to the factory, and from the factory to the INSP [261]. The frozen 
cortisol was analyzed with a radioimmunoassay using cortisol labeled with 125 Iodine, 
in a solid phase system. The kit used was Cort-CT2, purchased from Schering-
CisBiorad International, Gif-Sur-Yvette Cedex, France. Variability (coefficient of 
                                                 
18 Saliva cortisol levels are at their highest peak 30 min after waking [259, 260]. 
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variation) within cortisol sample assessments was 5.4%, between cortisol samples 
7.3%, at a level of 52.3 nmol/L [262]. 
In order to further assess the validity of cortisol, a Spanish version of the GHQ 
was administered to the participants after completing the second cortisol sampling day 
[257, 258]. The GHQ is a tool for detecting a range of psychiatric disorders in the 
general population. It contains 28 statements that assess frequency of symptoms [258]. 
The GHQ incorporates the domains of somatic symptoms, anxiety and insomnia, 
social dysfunction, and severe depression. Answer categories vary according to 
question but generally range from “not at all” to “much more than usual.” The final 
additive score ranges from 0 to 63, and the higher the score, the worse the general 
health. The Spanish version was originally developed for Hispanic Americans, 
including Mexican Americans [257].  
After completion of the interview and cortisol sampling, participants received 
information on their weight, height, BMI, and iron status. Upon completion of the 
study within a factory, an item considered useful by the factory workers themselves 
was donated (e.g., a microwave or a first aid kit).  
Cortisol: Data cleaning and preliminary analysis 
While 67% of the sample had complete information on cortisol and time of 
sampling, 33% had no recorded time for some or all of their cortisol values. For the 
missing times, the mean of the available sampling time for all subjects was inserted. 
Mean actual sampling times were very close to the sampling times that were projected 
by the interviewers (Appendix Table C.1). However, time of sampling after waking 
was self-reported, and misreporting of the self-reported sampling time is common 
(about 38%) [263]. Each participant’s individual curve of cortisol concentration over 
the adjusted time of sampling per day was plotted; spikes in the cortisol curves were 
compared with self-reports of stressful events of the day. On only one occasion could 
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a spike on sampling time be explained by a stressful event that occurred 2–30 minutes 
prior to sampling.19 In this case, the curve was smoothed between sampling times 2 
and 4. All other data points remained unchanged. Undetectable levels of cortisol (<0.5 
nmol/L) were set at 0.05 nmol/L in order to include data points in the analysis. 
Cortisol values below the 5th and above the 95th percentile were compared with the 
reported literature in order to confirm that they were not due to measurement error. No 
values were excluded on that basis. 
Three methods of assessment of high- and low-cortisol groups were tested: 1) 
area under the timed concentration curve (AUC), 2) cortisol values 30 minutes after 
waking, and 3) slopes of cortisol concentration over time. The final preferred method 
was area under the curve for three sampling times (AUC3) (30 min after waking, 2nd 
and 3rd samples in factory). The reason for excluding the 4th sampling time was that 
16% of the sample had an unexplained increase of cortisol concentrations between 
sampling time 3 and 4 that exceeded 1 unit of cortisol. Since women were paid by the 
quantity of completed garments, it is possible that stress increased toward the end of 
the workday, when women tried to meet their production goals. In order to reduce this 
additional external source of variability, only the first 3 sampling times were used. 
AUC3 was calculated with the pharmacological program pkexamine of the statistical 
Stata software, version 9.0 [265]. When 2 days of sampling were available (83% of the 
sample), the mean between the two curves was taken. Otherwise, the AUC3 of the one 
available day was used. From here on, only the results for AUC3 with the combination 
of recorded and estimated time of sampling will be reported. The variable will be 
called AUC3E (area under the concentration curve, for 3 samples, with actual and 
estimated times). For information on calculation, methods, and results of all cortisol 
                                                 
19 Saliva cortisol levels reflect spikes of plasma cortisol within 1 to 2 minutes; cortisol generally is 
highest 3 to 4 minutes after an exposure to an acute stressor. [260, 264] 
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measures, please see Appendix C, section 1.2, Methods and results of cortisol 
measures.  
Statistical analysis 
Statistical analysis was carried out with SAS 9.1 [176]. The two main outcome 
variables were severe depressive mood (BDI ≥ 29 points), with no to moderate 
depressive mood (0–28 points) as a reference; and moderate and severe depressive 
mood (BDI ≥ 20 points), with no to mild depressive mood (0–19 points) as reference. 
Moreover, two additional outcome variables contrasted severe depressive mood (≥29 
points) with no to mild (0–19 points), and moderate depressive mood (20–28 points) 
with no to mild (0–19 points). 
To account for the study design, statistical modeling was performed with 
several procedures. The higher design level of “factory” was adjusted for with a mixed 
model procedure for logistic regression (proc glimmix). Matching was controlled for 
by inserting the matching criteria as control variables into the model. The magnitude 
of the effect of the variable factory and of the matching criteria was assessed. Models 
were developed according to the statistical importance of the variables and their 
impact on the coefficient of the iron status variable.  
Iron status measures were the independent variables of main interest. All iron 
status indicators were tested as both continuous and categorical variables. Composite 
indicators were tested as well (see above). Curvilinear relationships of the continuous 
iron status indicators were assessed. Covariates were initially entered individually; 
subsequently, all variables with a p<0.2 were tested in various combination, in order to 
explore their importance.  
Covariates of interest included personal physical characteristics, lifestyle and 
family situation, and SES. More specifically, they were a) physical or demographic 
characteristics: BMI; age; medications taken; oral contraceptive use; alcohol use; b) 
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family situation: marital status; number of children under 5, 10, or 18 years of age; 
whether the partner helps with the children; whether the woman lives with family, 
friends, and if yes, with whom; or alone,; c) work: physical strenuousness of the work 
at the factory; whether the woman worked in a second job, and if yes, how many days 
of the week; d) SES: quality of the roof, walls, and floor; water source; sanitation; 
household income; number of possessions; crowding (number of rooms – number of 
persons living in home); and whether the kitchen was separate or not, or no kitchen 
existed. In addition, factors that summarized wealth (factor 1), crowding in the 
household and SES (factor 2), and the presence of young children, paternal support, 
and working in a second job (factor 3) were included. These factors had been 
generated for the larger sample in Chapter 3. For a more specific description of the 
variables, consult Appendix E, Mexico 2001.  
Folate and vitamin B12 deficiency are associated with depression [160-163, 
231]. Moreover, folate and vitamin B12 deficiency cause macrocytosis [8, 154]. 
Therefore, cases with MCV>94 fL [154] were identified as macrocytic and potentially 
folate or vitamin B12 deficient. Cases with anemia (hemoglobin < 123 g/dL) and 
macrocytosis were considered to be folate-deficient anemic or vitamin-B12-deficient 
anemic, and were excluded. Models assessing the effect of MCV>94 fL were treated 
as follows: cases with high MCVs were initially excluded from the statistical analysis; 
subsequently, MCV>94 fL was included as a control variable while maintaining 
sample size.  
AUC3E cortisol was dichotomized with the median as the cutoff. Women with 
AUCE cortisol below the median were considered to have low cortisol levels, while 
women with values equal to or above the median had high cortisol. The variable was 
inserted as a modifier of the effect of iron status on depressive mood, while controlling 
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for fatigue, other potential covariates, and MCV>94 fl. Interactions were considered 
influential with a p-value<0.2. All aforementioned measures of iron status were tested.  
The model’s residual plots were investigated for outliers. In order to explore 
the relative importance of specific cases, observations were excluded and the model 
rerun; odds ratios of the reduced data set were compared with those of the full data set. 
Exclusion was based on extreme values of depression scores or iron status indicators, 
high residual values, and cortisol values above the 95th or below the 5th percentile. 
Best models were chosen based on theoretical considerations, results from Chapter 3, 
significance of the variables, significance of the models, and parsimoniousness.  
Sample selection 
A total of 100 women participated in the 2nd part of the study. Figure 4.1 
describes the selection of the final sample of 48 cases of the 3rd stage.  
Results 
Descriptive statistics 
The distribution of cases between factories was as follows: 10% from Avi, 
21% from CIM, 19% from Phantom, and 50% from Unger. A comparison between the 
women of the subsample and those who participated in the screening stage only 
showed that the subsample was older (29 vs. 27 years of age, p<0.05) and included a 
lower proportion of single women and a higher proportion of women who were 
divorced, separated, single mothers, or widowed (p<0.05; Appendix Table C.2). 
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Figure 4.1: Sample selection. 
100 original sample 
58 randomly selected for stage 3 
52 
50 
49 
- only 1 morning cortisol sample n=1 
- blood in saliva n=1 
48 
- not located, or on vacation, n=2 
Sample with cortisol, hemoglobin, MCV 
and protoporphyrin 
-     refused n=6 
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A comparison between the subsample of 48 women and those excluded from 
the larger group (n=52) found that women in the subsample were significantly 
(p<0.05) older (29 vs. 25 years of age) and that a significantly greater proportion had 
CESD scores above 16 (71% vs. 48%; Appendix Table C.3). In addition, FSS scores 
were higher in the subsample, with a p-value of 0.06 (mean 4.1 vs. 3.5). Moreover, the 
subsample had a higher proportion of women who were married and a smaller 
proportion of women who were single (p=0.05).  
Percentage of depressive mood was – based on the BDI – 25 for severe and 31 
for moderate depressive mood (Table 4.1), which was comparable to levels in the 
larger sample (Chapter 3). The recommended cutoff of 16 points for the CESD [156] 
placed 71% of the sample in the depressive range. Actual cortisol values ranged from 
0.5 to 32 nmol/L for the morning sample, and from undetectable levels to 17.9 nmol/L 
for the rest of the day. Means were 5.2 nmol/L for the morning sample, 2.3 nmol/L for 
sample 2, 1.9 nmol/L for sample 3, and 2.4 nmol/L for sample 4 (Appendix Table 
C.4). AUC3E cortisol ranged from 1.5 to 84.6 nmol/L. Twenty-nine percent of the 
sample was anemic, and 25% of the participants suffered from iron depletion with 
anemia (IDeA; Table 4.2). Hemoglobin ranged from 8.8 to 16.1 g/L (not shown). 
Twenty-three percent had MCV>94 fl (meaning macrocytosis, an indication for folate 
and/or vitamin B12 deficiency; Table 4.2) [154]. Fifty-eight percent of the participants 
were overweight or obese (Table 4.3). Factor 2 (which reflected crowding and SES) 
was below 0, but did not differ significantly from the larger sample (Appendix Table 
C.3). Eight percent of the sample used oral contraceptives (not shown). Alcohol 
consumption was low, with the highest amount consumed being 3 glasses per week 
(not shown).  
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Table 4.1: Subject characteristics, mood; mean (SD), median, 25th and 75th 
percentile, or %; n=48. 
Variable Mean (SD)  Median 25th p. 75th p. % of whole 
sample 
BDI 22.9 (13.7) 21 14 33.5  
Fatigue 4.1 (1.6) 4.1 3.0 5.3  
CESD-20a 23.0 (11.7) 23.5 15 28.5  
% BDI moderate 
score 20–28 
    25% 
% BDI severe ≥29     31% 
% CESD-20 > 16     71% 
Cortisol (AUC3E) 
nmol/L 
16.0 (15.4) 14.1 6.3 17.0  
a The Spanish version of the Center of Epidemiologic Studies Scale (CESD) [156] was used as a 
validation tool in this study; a score above 16 is the recommended cutoff for depressive disorders. 
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Table 4.2: Subject characteristics, iron status; mean (SD), median, 25th and 75th 
percentile, or %; n=48; iron depletion is defined as hemoglobin < 12.3 g/dl, and MCV 
or protoporphyrin beyond cutoff. 
Variable Mean (SD)  Median 25th p. 75th p. % of whole sample 
Hemoglobin g/L 131 (18) 134 121 143  
MCV fL/l 88.4 (9.8) 91.0 85.4 93.7  
Protoporphyrin μg/dL 87.6 (82.4) 54.2 34.2 110.7  
% Hemoglobin < 
12.3 g/dL 
    29% 
% MCV < 80 fL     19% 
% Protoporphyrin > 
70 μg/dL 
    37% 
% Iron depletion with 
anemia 
    25% 
% MCV or 
protoporphyrin 
beyond cutoff; but 
hemoglobin > 12.3 
g/dL 
    12.5% 
% MCV>94 fLa     23% 
a indicator of macrocytosis, therefore potential folate and/or vitamin B12 deficiency [154] 
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Table 4.3: Subject characteristics, demographics; mean (SD), median, 25th and 75th 
percentile, or %; n=48. 
Variable Mean (SD)  Median 25th p. 75th p. % of whole sample 
Age yrs 28.9 (8.7) 27.5 21 36  
BMI kg/m2 26.1 (4.2) 25.2 24.0 29.2  
Factor 2 (crowding, 
SES) 
–.1 (1.0) 0.2 –0.8 0.6  
% BMI > 25 kg/m2     58% 
% BMI > 30 kg/m2     17% 
% Household income 
< 4377 pesosa 
    92% 
% Dirt floor     12.5% 
% Dirt floor, walls 
and roof plastic, 
asbestos, or metal 
    2.1% 
a equivalent of US $157/month in summer of 2001; national poverty line level 1 for Mexican 
households in 2000 [232] 
Interaction model: Stress as a modifier 
AUC3E cortisol was a borderline significant (p=0.08) modifier of the effect of 
hemoglobin on severe depressive mood (Figure 4.2). While the low-cortisol group had 
a significant (p<0.05) increase in the risk of severe depressive mood with decreasing 
hemoglobin values, the high-cortisol groups showed no such association. With every 
unit increase in hemoglobin (g/L), the odds ratio of severe depressive mood decreased 
by 6% (Table 4.4, Model 1). This association was also demonstrated with IDeA, 
which operationalized hemoglobin as a categorical variable: women with low cortisol 
and IDeA had an odds ratio of severe depressive mood that was 6.3 times greater than 
the reference (no IDeA, high cortisol). All other groups with only one or no risk factor 
did not differ from the reference (Table 4.4, Model 2; Appendix Figure C.1). 
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Figure 4.2: Odds ratio (OR) of severe depressive mood; modifying effect of AUC3E 
cortisol below (continuous line) or equal to and above the median (dashed line). 
Statistical model includes centered hemoglobin, AUC3E cortisol, fatigue, and factor 2. 
p-value of interaction = 0.08. 10th–90th percentile of hemoglobin. 
0
1
2
3
4
90 100 110 120 130 140 150 160
OR of 
severe 
depressive 
mood 
Hemoglobin g/L 
OR=0.94, p=0.04 
OR=1.02, p=0.6 
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Table 4.4: Logistic regression models, with outcome Beck Depression Inventory 
(BDI) severe depressive mood (≥29); modifier of hemoglobin is the dichotomous 
AUC3E cortisol (< or ≥ median); log OR (log SE); p-value; n=48; all fixed factor 
models; n=48. c = area under the ROC curve. 
Variables Model 1 Model 2 
I –3.511 (1.487) –3.364 (1.376) 
Centered hemoglobin g/L (continuous) –0.066 (0.033); p=0.04  
Iron depletion with anemia (IDeA) 
(categorical) 
 1.854 (1.18); p=0.1 
Fatigue 0.540 (0.278); p=0.05 0.509 (0.262); p=0.05 
Factor 2 (crowding, SES) –1.182 (0.500); p=0.018 –1.088 (0.456); p=0.01 
AUC3E cortisol nmol/L  –0.160 (0.781); P=0.8 0.226 (0.847); p=0.7 
Interaction (cortisol*hemoglobin) 0.082 (0.048); p=0.08 –3.263 (1.89); p=0.08 
N 48 48 
c 0.806 0.824 
–2LL 45.2 46.4 
 
Comparison between mixed and fixed factor models demonstrated that no 
additional explanatory power is added by inserting factory as a random factor 
(Appendix Table C.6). MCV>94 fL was not significant. Thus, the most parsimonious 
model was a simple logistic regression fixed factor model. The effect for hemoglobin 
was not curvilinear (not shown).  
While the interaction between AUC3E cortisol and hemoglobin was 
significantly associated with risk of severe depressive mood, its association with 
moderate depressive mood was not significant (Appendix Table C.7).  
Moreover, since hypocortisolism is associated with fatigue [120, 121, 123], the 
influence of fatigue on the interaction in the model with severe depressive mood was 
assessed (Appendix Table C.8). However, fatigue had no important effect, whereas 
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factor 2 (crowding, SES) acted as a negative confounder. The impact of factor 2 was 
further explored: associations of factor 2 with depressive mood, hemoglobin levels, 
and AUC3E cortisol were assessed. We found that inclusion of factor 2 (crowding, 
SES) controlled for an SES difference that improved depressive mood and hemoglobin 
values in women with high AUC3E cortisol. Specifically, mean scores of factor 2 
differed by severity of depressive mood; women with severe depressive mood had a 
mean score of factor 2 of –0.52, while those with BDI scores indicating no to 
moderate depressive mood had a mean score of factor 2 of 0.09 (p of t-test = 0.05; not 
shown). Moreover, mean hemoglobin differed significantly, with factor 2 being below 
or above the median, but only in the group with high AUC3E cortisol (t-test p<0.05). 
Women with AUC3E cortisol below the median had a t-test p-value of 0.4 for the 
difference in means of hemoglobin due to factor 2. Mean hemoglobin for women with 
high AUC3E cortisol and factor 2 below the median (indicating lower SES) was 126 
g/l, while the mean value of hemoglobin for women with high AUC3E cortisol and 
factor 2 equal to or above the median (indicating higher SES) was 143 g/l. Thus, the 
introduction of factor 2 into the regression equation controlled for confounding due to 
SES differences in women in the high AUC3E cortisol group; as a result, the distinct 
effect of hemoglobin on risk of severe depressive mood within the cortisol groups 
could emerge. 
Since age and marital status were significantly different in this subgroup 
compared with the larger sample and the screening group, the two variables were 
included in the analysis. They were not significant. Likewise, oral contraceptive use 
did not affect the interaction. 
Discussion 
In summary, the biological marker of stress, cortisol, was indeed a modifier of 
the effect of hemoglobin on risk of severe depressive mood in the present sample of 
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Mexican factory workers. Women who had low cortisol experienced a 6% decreased 
odds of depressive mood for every g/L rise of hemoglobin. However, women with 
high cortisol showed no association between hemoglobin values and risk of severe 
depressive mood. 
Limitations and plausibility 
Causality 
Because of its observational nature, the present research is a study of the 
plausibility of a relationship between iron status and depressive mood. No causal 
inferences between the exposure to iron deficiency and an increased risk of depressive 
mood can be drawn, since directionality cannot be established. While it is assumed 
that iron deficiency causes depressive mood, only 1 out of 5 supplementation trials has 
shown this [42-46]. Moreover, depressive disorders can be associated with weight gain 
or weight loss [53], which implies a change in diet and/or nutrient composition of the 
diet (e.g., a shift away from iron-rich foods, or vitamin-C-rich foods that increase 
absorption of iron). The effect of depression on healthy eating or supplement use has – 
to our knowledge – been explored once. Bowen et al. [233] found no association 
between depression and fruit and vegetable consumption. In addition, observational 
studies are vulnerable to confounding, and associations may be spurious if confounder 
control was inadequate. Last, we cannot exclude the possibility that hemoglobin was a 
modifier of the association between cortisol and risk of depressive mood, which would 
be contrary to our assumption.  
Past depression 
Past depression was not assessed in the present study. It is known that a severe 
mood disorder in the past increases the likelihood of recurrence of depression [178]. In 
addition, past depression might affect eating behavior and, consequently, iron status. 
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To our knowledge, no published study has investigated this relationship. It should be 
noted that the present sample was relatively young (on average 29 years of age). Since 
the first episode of major depressive disorder (MDD) occurs between 25 and 31 years 
of age in international samples [2], it is possible that some women in the present 
sample had not had a past episode of MDD; they were either free of depressive mood 
at the time of the interview or experienced their first bout of the disorder at that time. 
In comparison, in the US, lifetime prevalence of MDD is 15% between 18 to 29 years 
of age [62]. In conclusion, confounding by past depression is probably not as severe as 
it would be in an older sample.  
Validity of sample selection 
The final sample is a subset of the women working in the garment factories, 
and of the screened participants. Sixty-nine percent of all women in the four factories 
volunteered to take part in the screening stage. While the average participation 
between the four factories is acceptable, the individual percentages indicated that the 
factory Avi had a much lower percentage (32%), which is probably too low to be 
representative of a broader population. However, differences between factories were 
controlled for in several ways during the analysis, with no significant effect. Thus, 
even though the group from Avi was small, it apparently did not differ from the other 
three factories with respect to the variables of interest.  
Random selection of participants from the screening sample most likely 
reduced the likelihood of additional bias (aside from potential self-selection bias 
during the screening stage). Nevertheless, women in the final subsample differed from 
women in the screening stage and from the larger sample in age and marital-status 
distribution. These two variables were added to the models and did not impact the 
coefficient of hemoglobin. Moreover, when comparing the main effect model in the 
larger sample of n=100 (outcome severe depressive mood; independent variables were 
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hemoglobin, FSS, factor 2 for SES and crowding, and MCV>94fL; Chapter 3) to the 
present subsample of n=48, the effect of hemoglobin was comparable (Table 3.2; 
Appendix Table C.6; consult also the internal validity section of this chapter). 
Validity of Mexican garment-worker sample 
The present sample of Mexican female factory workers showed a strong 
modifying effect of stress on the relationship between hemoglobin and depressive 
mood. The result might not be representative for other populations, specifically since 
the overall exposure to the stress of poverty in this population was very high. 
However, in light of the paucity of information in developing countries, this study 
adds valuable information and should be a good reference for future research 
conducted in similar settings. 
Validity of the Beck Depression Inventory (BDI) 
General 
Originally, the BDI was developed with a non-Hispanic White and African 
American sample [223, 224]. The BDI-II is relatively new (from 1996); therefore, the 
number of studies evaluating it is not as extensive.  
English-speaking samples without a prior diagnosis of current depression show 
good validity of the BDI (consult the internal validity section of this chapter).  
Hispanic  
A disadvantage of the Spanish version of the BDI-II is that cultural terms for 
mood disorders are not addressed. In Mexican culture, for example, the term “nervios” 
(loosely translated as “nerves”) indicates somatic disorders (such as gastrointestinal 
problems, vomiting, lump in throat, and headaches), dysthymia, MDD, and anxiety 
[184]. Moreover, somatization of dysthymia or major depression is frequent in 
Hispanic populations [157, 186, 187].  
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A number of BDI validation studies have recently been undertaken in Hispanic 
population, including Mexicans. The validity of the Spanish BDI-II appears to be as 
high as the English-language version (consult the internal validity section of this 
chapter). Importantly, language of interview does not appear to affect test scores [238-
242]. It is also noteworthy that the exclusion of somatic questions did not improve the 
performance of the Spanish BDI-II in a sample of Mexican patients [241]. This 
indicates that somatic symptoms might not be necessary in order to assess depression 
severity with the BDI in Mexicans accurately, even though somatization of depressive 
mood in Hispanics is frequent [157, 186, 187]. However, our present sample of 
younger, healthy Mexican women is not well comparable to that of Novy et al. [241]. 
In summary, the BDI-II appears to be a good tool to assess depressive mood in 
a Spanish-speaking population. Drawbacks are 1) the high item difficulty, which 
might result in a lack of accuracy in assessing depression severity in a Mexican 
population with little education; 2) the lack of culturally specific terms for depression; 
and 3) a potentially low discriminant validity between depression and anxiety. 
However, misclassification by the BDI-II would result in a weaker association 
between hemoglobin and severe depressive mood in women with low cortisol values. 
Nevertheless, we were able to show a significant relationship.  
Validity of the Fatigue Severity Scale (FSS) 
The fatigue measure we employed in the present study is an established tool; 
however, it has been developed for English-speaking patients [227]. Validity of the 
FSS is generally evaluated by comparing its scores with the clinical diagnosis of 
fatigue. In 2001, no fatigue scale existed – to our knowledge – in Spanish. Thus, 
translation of the FSS was required. The English version of the FSS has good validity 
in terms of internal consistency (Chronbach’s alphas); discriminant validity 
(distinction between fatigued and depressed); known group validity (discrimination 
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between fatigued and non-fatigued); test-retest reliability; and criterion validity 
(correlations with other fatigue scales) [227, 243-246]. However, our Spanish 
translation has not been validated in a broader population. Thus, the present study 
might not have measured fatigue severity accurately. It should be kept in mind, 
though, that our assessment of the Spanish FSS indicated good internal validity of the 
scale (consult internal validity section, Chapter 3). Moreover, this study aimed at 
producing a short measure of fatigue severity, for which the FSS was deemed to be 
appropriate. 
Substance abuse 
We did not assess legal substance abuse or illegal drug use, but participants 
were asked about their alcohol and medication use. Substance abuse is associated with 
malnutrition and depression [53, 179, 189, 190, 193-198, 204-206]; thus it is a 
potential confounder. None of the women reported drinking more than 1.5 glasses of 
alcohol per day, and women who took mood-altering drugs such as valium or 
antidepressants were excluded from the sample. However, abuse of alcohol or 
medication might have been underreported. Past traumatic events can cause both 
hypocortisolism and self-medicating substance abuse [266]. Past substance abuse is 
also associated with impaired cortisol responsiveness to stress [267]. Thus, more 
substance abuse might have occurred in the low-cortisol group. It should be noted, 
though, that abuse of illegal substances in semirural settings close to Mexico City 
occurs predominantly in young Mexican males [247-249]; in young women, 
prevalence of abuse of substances other than medications ranges from less than 1% to 
2.81% [247, 249, 268]. Illegal-substance abuse for both genders was 1.5% in 
metropolitan areas, and not significantly different or lower for the region that would 
include the area where the present study took place [247, 249, 268]. Moreover, during 
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the analysis phase, cases with high depression scores had been removed to test 
influential data points; results did not differ substantially. 
In summary, substance abuse in the present sample might have strengthened 
the association between hemoglobin and depressive mood in hypocortisolaemic 
women. However, the likelihood of this occurring is low, since the prevalence of 
illegal substance use in Mexican women is low. 
Perimenopause, premenstrual syndrome (PMS), and premenstrual dysphoric 
disorder (PMDD) 
Although menopausal women were excluded from the present sample, we 
collected no information related to perimenopause. However, the present sample is 
relatively young (mean of 29 years; 75th percentile 36 years), which means that it is 
unlikely that any woman is in perimenopause. PMS and PMDD are associated with 
depressive mood [223, 234-236]. However, no information on either disorder or on 
exact menstruation cycle was gathered. A literature review did not provide 
information on the association between iron status and PMS or PMDD. Women who 
had PMS or PMDD could also have had lower hemoglobin values, but this would 
have to be a chance occurrence. Generally, iron status is not lower at time of 
menstruation than at any other time during the monthly cycle [207]. It appears, in 
summary, unlikely that the association between depressive mood and hemoglobin was 
affected by perimenopause, PMS, or PMDD. 
Other nutrients that may cause depression 
Other nutrient deficiencies are considered potential causes of depressive mood, 
namely deficiencies of zinc, folate, vitamin B12, and ω-3 polyunsaturated fatty acids 
(specifically docosahexanenoic acid) [158-163, 168]. An indicator for vitamin B12 
and folate deficiency is macrocytic anemia [8, 154]. Therefore, we excluded 
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macrocytic anemics and controlled statistically for macrocytosis without anemia 
(MCV>94 fL). However, the final model did not include this control variable, because 
of non-significance (p>0.3, not shown). 
Intake of zinc or ω-3 polyunsaturated fatty acids was not assessed. The 
prevalence of zinc deficiency was 30% in rural and urban Mexican women in 1999 
[9]; considering the frequency of occurrence, a sizeable proportion of women in this 
sample might have been zinc deficient. However, Chapter 2 of this dissertation did not 
report an association between iron status, zinc intake below the recommended amount, 
and severe depressive mood in US Hispanic women. No information on ω-3 
polyunsaturated fatty acid status for Mexicans is available except in breast milk [250]. 
Mean concentration in breast milk in Mexico is not significantly different from that in 
industrialized countries (mean % of total fatty acids is 0.26%) [250], albeit lower than 
the worldwide mean of 0.32% [208]. It is important to keep in mind that results about 
the depression-lowering properties of ω-3 polyunsaturated fatty acids are inconsistent 
and controversial [210-212].  
In summary, while folate or vitamin B12 deficiency probably did not affect the 
results of this analysis, low intake of zinc or ω-3 polyunsaturated fatty acids might 
have. The most likely impact would have been from zinc deficiency. If low 
hemoglobin values correlated with zinc deficiency, zinc would have acted as a positive 
confounder.  
Cortisol measure 
We employed a biological marker of stress in the present analysis. Cortisol 
values are known to vary greatly between subjects [269, 270], to be responsive to 
acute stressors [215, 271], to be modified by affect [106, 272] and to show high day-
to-day variation within subjects [269, 273]. Moreover, two phenomena, 
hypocortisolism and hypercortisolism, have been observed to be associated with stress 
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and mood disorder. Cortisol concentrations increase with acute stress [215, 264] 
and/or melancholic MDD [96, 113, 122, 144], while chronic stress [102, 119] and 
atypical MDD are associated with lower than normal cortisol values and/or decreased 
stress responsitivity [96, 113, 122, 144, 215]. Consequently, we explored a large 
number of analysis methods to determine the complex relationship between cortisol 
and depressive mood. The traditional way of analyzing salivary or plasma cortisol is to 
calculate the area under the concentration curve over time [260, 273, 274]. However, 
other methods have been used, namely reporting only morning cortisol [100, 102, 259, 
273, 275], evening cortisol [100, 276], averages throughout the day [102, 106, 277], 
and calculating intercepts [102] and change of cortisol (slopes) over time [99, 102, 
276, 278]. Inaccurate self-reporting of time of sampling in a free-living sample has 
also been demonstrated [263].  
In light of the analysis and interpretation issues of this measure, we set out to 
employ a conservative, hypothesis-driven approach in order to reduce the probability 
of type I error. Each participant had, at a minimum, 3 samples per day. Averaging of 
cortisol values over 2 days was used in order to increase accuracy. We preferred to 
dichotomize participants into two broad groups in order to avoid the influence of 
extreme mean AUC3E cortisol values. Acute stressor exposure during the day was 
recalled at the end of the workday in order to account for spikes in the cortisol curve 
due to acute stress. Time of sampling in this sample was only self-reported in the 
morning; especially on day 2 it had a very low variation around the projected time of 
sampling (Appendix Table C.1), which might indicate either exceptionally timely 
sampling or untruthful reporting. In addition, time of sampling had been estimated in a 
subset of the data set. Thus, some inaccuracies in the AUC3E cortisol variable might 
have been introduced. However, variation around the morning sample of the first day 
of sampling was less than 15 minutes.  
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Classification of cases into high- and low-cortisol groups based on the median 
necessarily resulted in misclassification of participants with “normal” cortisol levels, 
which presumably would be around the median. Thus, both groups were probably a 
mix of extreme and normal values of AUC3E cortisol. Nevertheless, the dichotomous 
variable AUC3E cortisol modified the association between hemoglobin and severe 
depressive mood, indicating that the effect was strong enough to be detected despite 
the misclassification. 
Last, a different interpretation of low AUC3E cortisol is noteworthy: while 
hypocortisolism is thought to be a result of chronic stress, it also occurs with past 
severe trauma, potentially resulting in depression and/or posttraumatic stress disorder 
[279-281]. Thus, women with low AUC3E cortisol values in our sample might in fact 
have suffered from the consequences of trauma. In this case, the interpretation of the 
modifier changes slightly because low cortisol values might be a result not only of 
poverty but also of trauma. However, since higher trauma frequency is associated with 
poverty [282], the two are difficult to differentiate.  
In summary, sampling and summarization methods of low and high cortisol 
values were used that increase accuracy. However, because of the variable nature of 
cortisol assessments, misclassification was possible. Nevertheless, the interaction 
between hemoglobin and AUC3E cortisol was be significant, and internal validity 
assessment showed consistency of results. 
Internal validity 
Hemoglobin 
All iron status measures including hemoglobin were assessed with established 
methods of laboratory analysis. The responsible laboratory at INSP had received 
excellent ratings by the Centers for Disease Control for its precision of measurements 
[251]. Hemoglobin, MCV, and protoporphyrin correlated significantly (p<0.0001), 
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indicating that low hemoglobin values are accompanied by low MCV and high 
protoporphyrin values; correlations were of the magnitude of r=|0.67| to |0.70| (not 
shown). Indeed, having hemoglobin values <123 g/L is significantly associated with 
IDeA (p<0.0001) and IDA (p<0.0001). 
Iron depletion anemia (IDeA) 
IDeA was defined as a hemoglobin level < 123 g/L, plus MCV and/or 
protoporphyrin beyond cutoff (MCV < 80 fL, protoporphyrin > 70 μg/dL). However, 
the conventional definition of iron deficient anemia (IDA) is anemia (hemoglobin < 
123 g/L), plus at least two additional indicators beyond cutoff (using, e.g., ferritin < 12 
μg/L, transferrin saturation < 16%, protopophyrin > 70 μg/dL, and MCV< 80 fL) [8]. 
In a small sample of factory workers, all four iron status measures were available, and 
the effect of the interaction between IDA and AUC3E cortisol was assessed. However, 
although all variables showed the effect in the expected direction, effect size was 
much diminished. The log OR of the interaction was only 0.323, and the p-value of the 
interaction was 0.8. This result might be due to the small sample size (n=32); only 7 of 
the 32 cases had IDA, thus splitting them in the interaction with the dichotomous 
AUC3E cortisol into a cell size of 4 cases with low and 3 cases with high cortisol.  
Beck Depression Inventory (BDI) 
The validity of the BDI has been extensively explored. The internal 
consistency of the English version of the BDI-II is high (Chronbach’s alphas are 
between 0.73 and 0.95) [223, 234, 236]. Assessments of known group validity 
generally show that BDI scores are independent of ethnicity [223, 283] and age [234-
236, 283]; however, one study identified an association between age and scores [223]. 
Studies are inconsistent concerning gender differences in scores: either women have 
higher scores [223] or no difference was observed [234, 236, 283]. The BDI-II 
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correlates well with other depression scales (e.g., the Revised Hamilton Psychiatric 
Rating Scale for Depression has a correlation with the BDI-II of r= 0.71), an indicator 
of good criterion validity [172, 237]; factor analysis consistently groups symptoms 
into 2 factors, affective-cognitive and somatic [172, 223, 237]; and the scale has also 
been shown to differentiate between psychiatric and non-psychiatric populations, and 
to be able to distinguish levels of depression severity [223, 237].  
All identified review articles concerned the older version of the BDI, and they 
dispute a number of the aforementioned validity assessments. Described limitations 
are 1) that the factor structure is variable depending on the study population (between 
2 and 9 factors); 2) that the high difficulty of the items reduces the usefulness as a 
simple field tool [237]; and 3) the insufficient discriminant validity in relation to 
anxiety [237]. 
Correlations between anxiety scales and BDI can be high in non-psychiatric 
populations (r=0.22 to 0.82) [223, 237]. However, Beck et al. [223], who developed 
the instrument, state that the scale discriminates well when comparing mean scores of 
depressed (BDI-II) and anxious participants; correlation between the BDI-II and 
anxiety scales (Beck Anxiety Inventory, Revised Hamilton Anxiety Rating Scale) is 
between r=0.47 and 0.60. Test-retest reliability is likewise controversial since it is 
dependent on time interval [238-240]. 
For the older Spanish version of the BDI, validity assessments took place in 
Puerto Rican, Spanish, and Argentinian populations [238-240]. They confirm 1) high 
internal consistency (Chronbach’s alpha=0.87 to 0.91) [238, 239, 284]; 2) high test-
retest reliability [238]; 3) that the scale has high criterion validity with other 
depression assessment instruments (Symptoms Scale Checklist-90) [238]; 4) that, 
likewise, in terms of known group validity, groups at higher risk (women, young 
adults, and low SES) had higher scores [238-240]; and 5) that factor analysis generates 
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2 to 4 factor solutions [240-242]. Only recently has the newer Spanish version of the 
BDI-II been validated in Hispanic Americans of predominantly Mexican descent [240-
242]. Chronbach’s alphas in those studies are high in exclusive Spanish speakers (0.89 
to 0.95) [240, 242]. Scores are independent of age, gender, and SES [242]. 
Acculturation results in slightly lower BDI scores in one of the studies [241], while the 
other shows no association [242]. Test-retest reliability is good [240, 242], and a 2-
factor solution was favored [240, 242]. Language of interview makes no significant 
difference in test scores [241]. Novy et al. [241] assessed discrimination between 
anxiety and depression and found a correlation of 0.60 between the Spanish versions 
of the Beck Anxiety Inventory and the BDI-II. The authors interpret the correlation as 
low and as an indicator of good discriminate validity. Only one study with middle-
aged Mexican rheumatology patients assesses the validity of the Spanish BDI in 
Mexico [252]. The agreement in this study between clinical diagnosis of any 
depressive disorder and BDI was as follows: sensitivity=92%, specificity=86%, 
positive predictive value=0.80. Interestingly, the exclusion of somatic symptoms did 
not improve the validity of the BDI. This is of importance, since somatization is an 
important feature of depression in Hispanics [157, 186, 187]. 
Chapter 3 describes the assessment of validity of the Spanish version of the 
BDI-II for the present population; we concluded that the instrument was a valid 
measure of depression severity in the larger sample; therefore, no extensive 
assessments will be conducted in the present subsample. The Chronbach’s alpha in the 
present subsample of 48 cases was 0.90. 
Fatigue Severity Scale (FSS) 
Validity assessments of the English version of the FSS show a high internal 
consistency (Chronbach’s alpha is between 0.88 and 0.94) [227, 243, 244] and a good 
discrimination between fatigued and healthy subjects [227, 243-245]. The correlation 
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with other fatigue scales is moderate to high (0.47 to 0.81) [243, 244], except for the 
Fatigue Impact Scale (r=0.15) [244]. The scale is unidimensional (1 factor only), as 
expected in one study [227]; however, 2 factors were demonstrated by Hagell et al. 
[243]. The FSS showed substantially reduced scores with improvement of fatigue in 
clinical patients [227]; a good test-retest reliability [227, 244]; and its association with 
depression (CESD) is weak to moderate (0.2 to 0.46), depending on the population 
tested [227, 245]. The scale’s scores were independent of gender, but not of age [243]. 
In a Spanish-speaking population, the FSS correlated significantly with the Fatigue 
Impact Scale (r=0.68) [246].  
We extensively validated our Spanish version of the FSS (Chapter 3), and 
concluded that the FSS is a valid tool for assessing fatigue severity in the present 
sample. The Chronbach’s alpha in the present subsample of n=48 was 0.8. 
Cortisol 
Saliva cortisol varies greatly within and between subjects [269, 270, 273]. The 
overall diurnal pattern of cortisol should be a negative slope throughout the day [260]. 
We confirmed this overall pattern with our sample. The slope of cortisol over time was 
estimated with mixed regression methodology, controlling for intercept, day, and 
factory as random factors. Cortisol values were log-transformed because of a skewed 
distribution and a curvilinear relationship with time. Overall slope was –0.13 when 
using 3 timed samples, assuming a non-linear decrease (p<0.001); when using 4 timed 
samples the slope was –0.08 (p<0.001). Thus, cortisol values show the expected 
diurnal decline in the overall sample.  
AUC3E cortisol’s association with chronic stressors and with physical and 
mental health indicators was investigated  to assess the validity of the biological 
marker of perceived stress. Specifically, association with household composition, 
paternal help with children, marital status, SES indicators, C-reactive protein (CRP), 
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white blood cell count, BMI, fatigue, age, crowding, symptoms from the GHQ,20 and 
symptoms from the medical checklist were assessed (Appendix Table C.10). Chi-
square tests showed that a significantly (p<0.05) higher proportion of women in the 
low-cortisol group felt more “nervous and uptight all the time” than usual; in addition, 
they suffered from “pains in [their] head” and “a feeling of tightness and pressure in 
[their] head” more often than usual (for statement and answer choices, consult 
Appendix E, General Health Questionnaire). Women with low cortisol levels also 
experienced more or about the same amount of satisfaction with “how they have 
carried out [their] task[s].” Hypocortisolism is frequently associated with chronic pain 
[120, 285]. In fact, Elwan et al. [286] demonstrate lower cortisol levels in the 
cerebrospinal fluid in headache patients compared to controls. While the medical 
checklist requested recall of illnesses, only respiratory infections had a sufficient 
number of cases to attempt analysis (n=14).21 The association was not significant. No 
other variables were significantly related to AUC3E cortisol.  
Time of sampling was predicted rather than measured in 33% of the cases. 
Hence, models were rerun with the group (n=36) that had all measured data on cortisol 
and time of sampling. Appendix Figure B.2 demonstrates that hemoglobin and risk of 
severe depressive mood have a significant inverse association only in women with low 
cortisol (p-value of interaction < 0.05; Appendix Table C.11, Model 4). Thus, logistic 
regression results between the 36- and 48-case cortisol samples are virtually the same 
(see also Figure 4.2). 
Factor 2 incorporated crowding and SES; it was a strong negative confounder 
of the interaction between AUC3E cortisol and hemoglobin (Appendix Table C.7). 
Factor 2 originated from a factor analysis with the larger sample of n=100 (Chapter 3). 
                                                 
20 The GHQ statements were in this case considered separately (Appendix E, General Health 
Questionnaire). 
21 Illnesses reported were asthma (n=2), lung disease (n=2), respiratory illness (n=14), cardiovascular 
illness (n=2), rheumatic illness (n=2), hypertension (n=7), diarrhea (n=8), diabetes (n=0), other (n=0). 
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There was no significant difference between the mean of factor 2 of the present 
subsample and factor 2 of the excluded cases of the larger sample (Appendix Table 
C.3). When using the variable crowding as a replacement for factor 2, neither 
crowding nor the interaction was significant. That leads us to conclude that the 
importance of factor 2 lies not only in its information on household composition, but 
also in its socioeconomic dimension (see results of factor analysis, Chapter 3).  
We also assessed whether the impact of iron status in severe depressive mood 
was altered as a result of subsample selection. Therefore, the main effects of 
hemoglobin, fatigue, and factor 2 (crowding, SES) on severe depressive mood in the 
cortisol subsample (n=48) were compared with the effects in the larger sample 
(Appendix Table C.6). While hemoglobin did not reach significance, coefficients of 
all variables had comparable values (see Table 3.4). 
Mechanisms 
In the low-cortisol group, lower hemoglobin levels were associated with a 
higher risk of severe depressive mood, while in the high-cortisol group no such 
relationship was found (Figure 4.2; Appendix Figure C.1). According to our 
hypothesis, we expected to see this association: more highly stressed (in this case 
chronically stressed) individuals with ID should have a higher risk than all the other 
groups.  
Depressive disorder is associated with alterations in neurotransmitter 
concentrations in the brain. Specifically, serotonin, norepinephrine, and dopamine are 
implicated [114, 122, 124-129].  
ID is correlated with higher depression scores in a number of human 
observational studies [37-40]. Iron is a cofactor in the synthesis of serotonin, 
dopamine, and norepinephrine [25-27]; consequently, ID should result in altered 
concentrations of one or several of these neurotransmitters in the brain. In animal 
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studies, though, findings for serotonin and norepinephrine, at least, are inconsistent 
[28-32]. Serotonin concentrations have been shown to decrease with ID [28] or to 
remain unchanged [29]. Activity of tryptophane hydroxylase, the iron-dependent 
enzyme that is part of the pathway that converts tryptophane to serotonin, remains 
unchanged [28, 30]. Serotonin metabolites increase [30] or decrease [30] with ID. 
Norepinephrine has rarely been studied. It remains unchanged [30] or is higher [31, 
32] in ID rats. Indeed, dopamine gives the best indication that ID induces changed 
nerve-signal transmission as a result of lower dopamine receptor density and 
dopamine transporter downregulation [29, 32-36]. A number of animal studies also 
show that the activity of monoamine oxidase, which is involved in the breakdown of 
serotonin, dopamine, and norepinephrine, is reduced [28, 30].  
Hypocortisolism has been associated with chronic stress [102, 119, 123, 215, 
216] and a higher risk of atypical MDD [96, 113, 122]. A biological explanation for 
the association between hypocortisolism and MDD is that chronic upregulation of the 
immune system mediates these two phenomena [115, 130-134]. It is thought that 
hypocortisolemic individuals experience an upregulation of their non-specific plasma 
immune response, and thus of their proinflammatory cytokine, tumor necrosis factor, 
interleukin 1, and interleukin 6 [115, 119, 120, 130, 136, 140]. This upregulation finds 
its counterpart in the brain [125, 133, 137]. Elevated cytokine concentrations in the 
brain reduce serotonin availability [121, 122, 145]. Norepinephrine concentrations, on 
the other hand, appear to be higher [6, 7, 9, 130, 132].  
As a consequence, the increase in the risk of severe depressive mood in 
individuals with exposure to both low hemoglobin and low cortisol levels might have 
been due to a critical change in neurotransmitter concentrations in the synaptic cleft. 
Individuals with exposure to only one or no risk factor did not experience this 
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alteration of available neurotransmitters to the same extent. Thus, their risk of 
depression was not significantly different.  
External validity 
Hemocue was used to assess anemia (hemoglobin < 120 g/L), and its 
prevalence was 11% in the screening sample (see Chapter 3). This value was lower 
than the prevalence of 16 to 21% in rural and urban non-pregnant women in Mexico 
City and the central region of Mexico in 1999 [13]. Mundo et al. [21] reported a 
prevalence of anemia of 14.7 to 16.8% in 2006. Iron status values of the venous blood 
sample analysis were not representative of the population of factory workers as a 
whole, since women who were identified as anemic by Hemocue were oversampled. 
In addition, since anemic women were oversampled, and ID was associated with 
depressive mood in this analysis, the percent of women suffering from severe 
depressive mood in the present sample (31%) is not representative of the overall 
population in the factories. Lifetime prevalence of MDD in unacculturated female 
Mexican American immigrants is 8.4%, and of dysthymia 1.6% (assessed with the 
Composite International Diagnostic Interview Schedule [CIDI]) [13, 20]. In the 
Mexican state of Morelos, where the present study took place, the prevalence of MDD 
(based on the Diagnostic and Statistical Manual of Mental Disorders [DSM-IV]) in 
women is 5% within the year prior to interview [21]. In all of Mexico, prevalence of 
MDD in women for the last 12 months prior to interview is 7.6%, and for the last 6 
month is 5.7% (measured with the Composite International Diagnostic Interview 
[CIDI]) [20]; lifetime prevalence is 15.9% [20]. 
In the present sample, the mean fatigue score was 4.1. Compared with other 
studies, this value is between the means of non-fatigued subjects and fatigued subjects. 
Non-fatigued participants have an average score of 2.3 to 3.1 [227, 246]. Fatigued 
and/or ill subjects have a mean FSS score of 3.9 to 6.9 [227, 243-246]. 
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AUC3E cortisol modified the effect of hemoglobin on severe depressive mood, 
insofar as only individuals with low cortisol levels had a significant inverse 
association of hemoglobin with risk of depressive mood. To our knowledge, no 
published study assessed this relationship; however, we found that Hispanic American 
women of the HHANES who were exposed to both chronic stressors and ID showed a 
higher risk of severe depressive mood compared to their peers (Chapter 2). When we 
revisit the results of the 5 iron supplementation trials that investigated the decrease of 
depressive mood after supplementation, we can find further corroboration of our 
findings. While 4 of the 5 trials had negative results [42-45], the one study finding a 
decrease in depression scores after iron supplementation compared to placebo was 
undertaken with postpartum South African women [46]. This specific sample is not 
only poor, but also focuses on mothers with young infants; both poverty and early 
postpartum status are known to raise the risk of MDD [53, 64-66, 86, 253-256]. 
Few studies publish information on mean AUC cortisol. Moreover, 
comparisons of the values of AUC3E cortisol of our sample to the published literature 
are affected by the length of the sampling day. In other words, in the same sample 
AUC cortisol estimates for a sampling day that lasts from 8 a.m. to 8 p.m. are likely to 
be higher than for a sampling day that lasts from 8 a.m. to 3 p.m. Nevertheless, mean 
AUC3E cortisol (16.0 nmol/L; range 1.53 to 84.61) appears to be low in our sample, 
when comparing it to Li et al.’s [274] work. The authors report an AUC cortisol of 
44.75 in their sample of 3276 British women, with a range of 6 to 300 nmol/L. The 
authors sampled within a 3-hour interval (45 minutes after awakening to 3 hours after 
the first sample).  
Clinical relevance 
One way to determine the clinical significance of our findings is to compare 
them with the effect on antidepressant therapy on remission of MDD. We found one 
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randomized controlled trial assessing the efficacy of antidepressant therapy with the 
outcome being the probability of remission. The treatment trial uses a different 
depression scale (Hamilton Rating Scale for Depression). The authors [220] 
investigate the probability of remission after therapy, testing the antidepressants 
Duloxetine and Parocetine on a total of 367 patients with MDD. Depending on the 
dosage, Duloxetine increases the probability of remission by 21 to 28% compared to a 
placebo, while Paroxetine increases it by 17%. In the present study, when defining a 
BDI score below 29 as remission (reference BDI score ≥ 29), we were able to estimate 
the potential effect of improving hemoglobin status from 100 to 123 g/L (from 
moderate anemia to not clinically anemic) in hypocortisolemic individuals. Covariates 
were fatigue, and factor 2 (representing crowding and SES). The variable MCV>94 fL 
was not significant. The odds ratio of remission of severe depressive mood with a unit 
increase of hemoglobin was 1.07 (CI 1.001, 1.14; not shown). One interpretation of 
this finding is that the change from a hemoglobin value of 100 g/L to 123 g/L would 
increase the probability of remission of severe depressive mood by 28%. This 
magnitude is comparable to the effect of antidepressant treatment in the Detke et al. 
[220] study. However, the definition of remission in Detke et al.’s trial (depression 
scale score of ≤ 7 points after 8 weeks of treatment) and in our study are very 
different; thus, comparison of outcomes is impaired. 
Conclusion 
In conclusion, we found that a biological marker of perceived stress modified 
the effect of hemoglobin on severe depressive mood. Specifically, in women with low 
cortisol, the risk of severe depressive mood decreased with increasing hemoglobin 
levels. No significant effect could be found in hypercortisolemic women. 
This observational study provides promising implications for future research 
and treatment.  
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First, it suggests target groups for the exploration of the biological association 
between ID and depression, namely women who experience chronic stress. Including 
measures of chronic stress is advisable in order to tease out the effect of iron 
supplementation in subgroups.  
Second, supplementation trials should be undertaken that focus on stressed 
populations in order to further elucidate the association between ID and depressive 
mood. Specifically, the issue of spurious associations due to uncontrolled confounders 
and reverse causality needs to be resolved. A comparison to antidepressant therapy as 
a control condition is suggested.  
Third, the results suggest that severely depressed women could benefit from 
iron supplementation, provided they are ID as well. Conversely, iron sufficiency could 
protect against the development of severe depressive mood, even in the face of 
stressor exposure. The public health relevance of this finding is high, since iron 
supplementation might reduce the risk of severe depressive mood in stressed women. 
Since women living in poverty might not be able to afford antidepressant therapy that 
reduces the severity of their depression, iron supplementation provides an inexpensive 
alternative.  
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Chapter 5: CONCLUSION AND RECOMMENDATIONS 
In conclusion, iron deficiency (ID) is associated with depressive mood, despite 
the statistical control of potential confounders and fatigue. Moreover, stressor 
exposure and cortisol as a biological marker of chronic stress modify the association 
of iron status and the risk of depressive mood substantially.  
Suggestions addressing the design of future studies would be to  
o use both categorical and continuous measures of iron status. This includes 
composite measures such as iron stores [155, 217] or the categorical mean 
corpuscular volume (MCV) or ferritin model of ID determination [8] 
o further explore whether fatigue might be a mediator between iron status 
and depressive mood with samples and scales that are different from the 
ones in the present dissertation 
o include moderate as well as severe levels of depressive mood in the 
analysis. This would preclude a depression assessment tool, such as the 
CESD, that does not offer cut-points for severity of depressive mood 
For future research, an inclusion of stress assessment and a focus on specific 
subgroups is suggested. We propose that iron supplementation trials be undertaken to 
confirm and extend our findings.  
o Iron supplementation trials should be conducted with women who are 
exposed to chronic stressors, in order to ensure a measurable 
supplementation effect compared to placebo. Stress might be defined as 
poverty, or a more sophisticated screening process might be used.  
o Control conditions in iron supplementation trials might not only be 
placebo, but standard therapy (antidepressants). 
o Iron supplementation trials would also help to minimize the threat of 
unmeasured confounders to the results, since randomization usually 
 139 
ensures equal distribution of confounders in both groups. Additionally, it 
addresses the question of reverse causality, since a time order of change in 
iron status is imposed by the iron supplementation.  
o It is advisable to measure stress and immunological markers at the 
beginning and end of the iron supplementation, in order to enhance the 
biological explanation of the mechanisms. Stress should be assessed via 
questionnaire and/or cortisol, in order to measure perceived stress. A 
convenient immunological marker may be C-reactive protein, which is now 
a convenient field method. Best would be pro-inflammatory cytokines, 
since they appear to be the direct mediators between stress and depressive 
mood.  
o Specifically, we would expect that in a stressed sample the decline of 
depression scores would be more pronounced with iron supplementation 
than in a non-stressed sample. In a chronically stressed sample, perceived 
stress and stressor exposure should remain high, and cortisol levels should 
remain low throughout the study period. Likewise, the immune system 
should remain upregulated. Improvement in iron status should reflect 
successful supplementation, and the magnitude of the iron status 
improvement should be reflected by a significant decrease in depression 
scores. 
o While iron supplementation addresses one component of the synergistic 
relationship between stress and iron deficiency, another option would be to 
modify the contribution of stress. This might be possible with behavioral 
intervention, or by treated depressed participants with proinflammatory 
cytokine antagonists. 
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Appendix A: IRON DEFICIENCY AND DEPRESSIVE MOOD IN HISPANIC 
AMERICAN WOMEN (HHANES) 
1.1 Figures and Tables 
Table A.1: Odds ratios of depressive mood when covariates were included in the 
basic model (depressive mood = intercept + iron stores/100 + previous-week’s 
fatigue). Logistic regression model with CESD-17 as dependent variable (event 
defined as being in the upper 90th percentile of the distribution). Odds ratios (OR), 
lower and upper limit of confidence intervals (CI) of odds ratio. The models are 
adjusted for stratification, clustering (PSUs), and relative weights. Ref PR=reference 
Puerto Rican. 
Covariates 
included into 
basic model 
OR of iron 
stores/100 
CI of iron 
stores/100 
OR of 
covariates 
CI of 
covariates 
Living space 0.90 0.83,0.97 0.85 0.76,0.95 
Spouse in house 0.89 0.82,0.96 0.50 0.33,0.76 
Ethnic group (Ref 
PR):  
Cuban 
Mexican 
Undetermined 
0.89 0.81,0.97  
0.64 
0.39 
0.28 
 
0.25, 1.62 
0.24, 0.64 
0.12, 0.64 
All covariates out 0.89 0.82, 0.97   
All covariates in 0.89 0.82, 0.97   
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Figure A.1: Odds ratio of depressive mood with iron stores < –200 mg or > –200 mg, 
grouped by space availability. Logistic regression model with CESD-17 as dependent 
variable (event defined as being in the upper 90th percentile of the distribution). 
Covariates were previous-week’s fatigue, marital status, and ethnic group. The model 
is adjusted for stratification, clustering (PSUs), and relative weights. Group size in 
bars. P-value of difference from reference group (ref), and any difference with 
significance below 0.05 shown by different letters. 
Crowded living space (number of persons in household equal or greater than 
number of rooms) and iron stores smaller than –200 mg increased the odds of 
depressive mood by 600% when compared to the reference group. The overall 
interaction had a p-value of 0.1, while the group comparison between high risk and 
reference is significant at a p-value of 0.001. Having less space available was 
identified as an indicator of low SES, based on the results of the factor analysis. 
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Figure A.2: Odds ratio of depressive mood with iron stores < -200 or > -200 mg, 
grouped by living with spouse or not. Logistic regression model with CESD-17 as 
dependent variable (event defined as being in the upper 90th percentile of the 
distribution). Covariates were previous-week’s fatigue, space available, and ethnic 
group. The model is adjusted for stratification, clustering (PSUs), and relative weights. 
Group size in bars. P-value of difference from reference group (ref), and differences 
with significance below 0.05 shown by different letters. 
Women who do not have the spousal support in the same household and are 
severely ID have odds of depressive mood that are more than 400% greater than the 
reference group. The overall interaction was significant at a p-value of p=0.1; the 
comparison between highest risk group and reference group had a p-value of 0.03. 
Living with the spouse in the house was found to be an indicator of higher SES when 
performing a factor analysis.  
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Figure A.3: Odds ratio of depressive mood with space in household, grouped by iron 
stores (mg) < -200mg or > -200 mg. Logistic regression model with CESD-17 as 
dependent variable (event defined as being in the upper 90th percentile of the 
distribution). Covariates were previous-week’s fatigue, marital status, and ethnic 
group. The model is adjusted for stratification, clustering (PSUs), and relative weights. 
Women with iron stores less than –200 mg have a greater increase of risk of 
depressive mood with reduced space in their household than women with iron stores 
greater than or equal to –200 mg. 
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Figure A.4: Odds ratio of depressive mood with iron stores (mg), grouped by hours of 
sleep less than 6 or greater or equal to 6. Logistic regression model with CESD-17 as 
dependent variable (event defined as being in the upper 90th percentile of the 
distribution), n=1373. Covariates were previous-week’s fatigue, space available, 
marital status, and ethnic group. The model is adjusted for stratification, clustering 
(PSUs), and relative weights. 
Women who slept less than 6 hours over the last 24 hours had a significantly 
different slope of iron stores’ effect on depressive mood than women who slept 6 or 
more hours (p=0.08, Appendix Figure A.6). While women with less than 6 hours of 
sleep over the last 24 hours showed an increase of depressive mood with lowering iron 
stores, women who slept 6 hours or more appeared to have the opposite relationship. 
Note that the overall interaction p-value addresses the difference in slopes, while the 
p-values of the subgroup slopes inform about the difference from a slope from 0. The 
slope of the sleep-deprived subgroup was not significant from 0, albeit the sample size 
was only 74 cases. 
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Table A.2: Odds ratios of depressive mood when covariates were included in the 
basic model (depressive mood = intercept + iron stores/100 + previous-week’s 
fatigue). Logistic regression model with CESD-17 as dependent variable (event 
defined as being in the upper 90th percentile of the distribution). Odds ratios (OR), 
lower and upper limit of confidence intervals (CI) of odds ratio. The models are 
adjusted for stratification, clustering (PSUs), and relative weights. Ref PR=reference 
Puerto Rican. 
Covariates 
included in basic 
model 
OR of iron 
stores/100 
CI of iron 
stores/100 
OR of 
covariates 
CI of 
covariates 
Living space 0.90 0.83,0.97 0.85 0.76,0.95 
Spouse in house 0.89 0.82,0.96 0.50 0.33,0.76 
Ethnic group (Ref 
PR):  
0.89 0.81,0.97   
Cuban   0.64 0.25, 1.62 
Mexican   0.39 0.24, 0.64 
Undetermined   0.28 0.12, 0.64 
All covariates out 0.89 0.82, 0.97   
All covariates in 0.89 0.82, 0.97   
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Table A.3: Comparison between final sample of 1375 cases and the excluded 1528 
respondents. Means or percentages. Sample size varies in the excluded group 
depending on availability of variables. No adjustment for sampling procedures. 
Significance testing with t-test or Chi-square test. 
 Final sample 
n=1375 
Excluded respondents total 
n=1528 
Variables   N of variable 
Mean age (yrs) 33 * 35 1528 
Mean hemoglobin 
(g/L) 
134 133 758 
Mean ferritin µg/L 39 35 488 
Mean CESD score 10 10 472 
% Above CESD 16 18 19 472 
% Above CESD 23 11 11 472 
% Above 90th 
percentile of CESD-17 
9 9 472 
% Ethnic group   1522 
      Puerto Rican 23 23  
      Cuban 12 15  
      Mexican 52 50  
      Undetermined 13 12  
% Poverty index ratio 
< 130% 
44 44 1262 
*p<0.05 
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Table A.4: Classification as depressed by the CESD-20 with cutoff of 23 points, and 
the CESD-17 with cutoff above the 90th percentile. 
CESD-20 CESD-17 
≤90th percentile >90th percentile 
≤23 1248 0 
>23 20 108 
 
 
Table A.5: Classification as depressed by the CESD-20 with cutoff above the 90th 
percentile, and the CESD-17 with cutoff above the 90th percentile. 
CESD-20 CESD-17 
≤90th percentile >90th percentile 
≤90th percentile 1216 3 
>90th percentile 6 105 
 
 
Table A.6: Comparison of cases of CESD-17 (90th percent cutoff) and DIS (current 
major depression). 
 DIS current 
major depression 
DIS no current 
major depression 
Total 
CESD-17 > 90 
percentile 
32 99 131 
CESD-17 < 90 
percentile 
8 1236 1244 
Total 40 1335 1375 
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Table A.7: Logistic regression model with high previous-week’s fatigue as dependent 
variable (event defined as being in the upper quartile of the distribution, score > 5), 
n=1375. Odds ratios (OR), and lower and upper limit of confidence intervals (CI) of 
odds ratio. The models are adjusted for stratification and clustering (PSUs), and 
relative weights. c = area under the ROC curve. 
Variable Model 
 OR CI 
Intercept 0.0009 0.0002, 0.003 
Iron stores (mg)/100 1.06 1.002,1.12 
Depressive mood (CESD-17) 1.19 1.16,1.22 
Poverty index ratio < 130% 1.96 1.24, 3.09 
Age (yrs) 1.05 1.02,1.07 
–2LL 376 
c 0.901 
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Figure A.5: Odds ratio of high previous-week’s fatigue with iron stores (mg), grouped 
by age less than 38 years or greater or equal to 38. Logistic regression model with 
previous-week’s fatigue as dependent variable (event defined as being in the upper 
90th percentile of the distribution, score > 5). Covariates were CESD-17, and poverty 
index ratio < 130%. The model is adjusted for stratification, clustering (PSUs), and 
relative weights. 
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Table A.8: Logistic regression model with CESD-20 as dependent variable (event 
defined as a score greater than 23), n=1375. Odds ratios (OR), and lower and upper 
limit of confidence intervals (CI) of odds ratio. The models are adjusted for 
stratification and clustering (PSUs), and relative weights. c = area under the ROC 
curve. 
Variable Model 
 OR CI 
Intercept   
Iron stores (mg)/100 0.95 0.91, 0.99 
Living space  0.84 0.78, 0.92 
Spouse in house (Ref not) 0.45 0.29, 0.68 
Ethnic group (ref PR) 
Cuban 
Mexican 
Undetermined 
 
0.41 
0.35 
0.33 
 
0.21, 0.78 
0.23, 0.53 
0.16, 0.68 
–2LL 789 
c 0.705 
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1.2 Supportive Analysis 
1.2.1 Factor analysis 
Methods 
In order to explore the relationship between covariates, and to address the 
problem of colinearity, a factor analysis was performed with SAS Statistical Software 
[155]. It included variables coding for SES, stressors, and ethnic status with sufficient 
sample size (greater than 1000 cases). Specifically, the following variables were 
included: whether received food stamps were not sufficient, and additional money had 
to be spent (yes/no); any health insurance (yes/no); married with spouse in the 
household (yes/no); poverty index ratio (<130%, 130–300%, >300%); education (no 
high school, high school, college, graduate); crowding in household (same number of 
rooms and household members or more rooms than members vs. more members than 
rooms); residence (urban, central city; central city; rural); ethnic group (Puerto Rican, 
Cuban, Mexican); language of interview (Spanish vs. English); whether a complete 
kitchen was available (yes/no); past depression (yes/no); and less than 6 hours of sleep 
(yes/no). All variables were coded in such a way that the higher values corresponded 
to potentially better emotional health status than the lower values. For example, Puerto 
Ricans are known in this sample to have higher rates of depression than Mexicans and 
Cubans, and were therefore coded as “1,” Cubans as “2,” and Mexicans as “3.” 
Likewise, a poverty index ratio above 300% received the categorical code “3,” while a 
poverty index ratio below 130% was coded “1.” Variables with a factor loading 
smaller than |4| were not considered high enough to be part of the interpretation. 
Factors were rotated with the Promax function, allowing for correlation between 
factors. Best factor models were decided on the basis of successful summarization of 
variables, and interpretability of factors. 
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Results and discussion 
Factor analysis was performed as a confirmation of the covariates living space, 
spouse in house, and ethnic group that were included in the final model (Table 2.4, 
Model 4). A total of 1141 cases had complete information on all the variables included 
in the factor analysis. Three factors emerged: SES associated with being married and 
having the spouse in the same household, SES associated with the subject’s own 
achievements, and a third factor related to ethnic group (Appendix Table A.9).  
While both SES measures included poverty index ratio, the factor SES based 
on spouse in the same household is also associated with receiving food stamps, and 
with access to health care. The factor SES based on the participant’s achievements 
includes years of education completed, spouse not in household, poverty index ratio, 
language of the interview, and number of rooms available to the persons living in the 
household. The third factor, ethnic status, is as much a reflection of the ethnic group 
as of the sampling design: Puerto Ricans and Cubans were approached in the 
metropolitan regions of New York City and Miami, while Mexicans in the Southwest 
were more likely to live in rural settings. Language of interview loads high in the 
factors SES based on the participant’s achievements and ethnic status, meaning that 
Spanish speakers are more likely to have fewer years of education and to have a lower 
poverty index ratio; and to be Puerto Ricans and live in an urban center. The variables 
past depression, complete kitchen, and hours of sleep less than six dropped out of the 
analysis because of low factor loadings (<|4|). The three factors coincided with the 
three significant covariates included into the final logistic model (Table 2.4, Model 4); 
thus ethnic status, marital status, and crowding appear to each be a representative of 
these factors. The resulting factor scores were weakly correlated, between 0.02 and 
0.18 (Appendix Table A.10), as a result of the performed oblique rotation method.  
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Table A.9: Factor analysis, factor loadings. 
Variable Factor 
poverty 
based on 
marital 
status 
Factor 
poverty 
based on 
subject’s 
achievements 
Factor ethnic 
status 
Foodstamp recipient, not sufficient to 
cover food expenses 
0.75 0.09 0.04 
Any health insurance 0.74 0.21 –0.06 
Spouse in household vs. other options 0.68 –0.38 0.03 
Poverty index ratio (<130%, 130 to 
300%, >300%) 
0.65 0.45 –0.03 
Education 0.26 0.71 0.05 
Living space in household 0.03 0.69 –0.09 
Area of residence  –0.07 0.03 0.76 
Ethnic group 0.29 –0.26 0.69 
Language of interview 0.16 –0.51 –0.60 
Variance explained 2.1 1.7 1.4 
 
Table A.10: Correlation between factor scores. Correlation coefficients and p-values. 
 SES marital 
status 
SES subject’s 
acievements 
Ethnic status 
SES marital status 1 0.10 (0.0003) 0.18 (<0.0001) 
SES subject’s 
achievements 
 1 0.02 (0.4) 
Ethnic group   1 
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1.3 Effect of Iron Stores with Severity of Depressive Mood 
An additional analysis investigated whether the relationship between 
depressive mood and iron stores was the same at all levels of severity of depressive 
mood. To this purpose, the outcome CESD-17 was split into three levels: scores from 
0 to 9 (which corresponds to below the 70th percentile of the CESD-17), mid-range 
scores from 10 to 20 (percentiles 70 to 90 in the CESD-17), and greater than or equal 
to 21 (greater than the 90th percentile). Corresponding scores of the CESD-20 would 
be scores from 0 to 11 (below the 70th percentile), scores from 11 to 25 (the 70th to 
90th percentile), and scores greater than 25 (greater than the 90th percentile). Cases 
with low-level depression were used as a reference group in a logistic regression 
model. Two models with two outcome variables were run: one with the event group as 
mid-level depression, and one with the event group as high-level depression (effect of 
iron stores with severity of depressive mood, Appendix Table A.11). All models were 
adjusted for stratification, clustering, and probability of selection. All models 
contained the independent variables selected for the final Model 4 shown in Table 2.4. 
The group that qualified as having no depressive mood contained 972 cases, the mid-
level depressive mood group had 266 cases, and the high level depressive mood group 
had 131 cases. The odds of depression in the logistic regression model decreased by 
3% with every 100 g increase of iron stores in the model with mid-level depressive 
mood. The odds of depressive mood in the logistic regression model decreased by 8% 
with every 100 g increase of iron stores in the model with high-level depressive mood. 
Thus, there is a progression in the effect of ID on depressive mood. It should be noted 
that the strongest effect (an 11% decrease) of iron stores is found when combining 
low-grade and moderate depressive mood, and contrasting those groups with high-
level depressive mood (Table 2.4, Model 4). 
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Table A.11: Results of analysis of low versus moderate or high depressive mood. 
Logistic regression model with CESD-17 as dependent variable. Odds ratios (OR), 
lower and upper limit of confidence intervals (CI) of odds ratio. The models are 
adjusted for stratification, clustering (PSUs), and relative weights. Ref PR=reference 
Puerto Rican; c = area under the ROC curve. 
Variable  Low and moderate 
depressive mood 
Low and high  
depressive mood 
  OR CI DEF OR CI DEF 
Intercept  2.70 1.92, 3.79  .049 0.03, 0.08  
Iron stores 
(mg)/100 
 0.97 0.94, 0.99  0.92 0.84, 0.99  
Last 
week’s 
fatigue 
 1.57 1.47, 1.68  2.74 2.46, 3.06  
Living 
Space  
 0.91 0.84,0.99  0.79 0.73, 0.86  
Spouse in 
house (Ref 
other) 
 0.64 0.43, 0.96  0.36 0.18, 0.75  
Ethnic 
group (ref 
PR) 
Cuban 
Mexican 
Other 
0.43 
0.59 
0.46 
0.25, 0.73 
0.39, 0.89 
0.27, 0.77 
 0.49 
0.32 
0.13 
0.13, 1.82 
0.19, 0.54 
0.034, 0.49 
 
–2LL  1147 300 
c  0.743 0.960 
 
Since the effect size of iron stores on moderate depressive mood was very 
small (OR=0.97), we decided to instead test interactions between iron stores and 
potential stressors while using moderate depressive mood as an outcome (Appendix 
Table A.12). Hypothetically, the association between iron stores and moderate 
depressive mood should be stronger in groups exposed to stressors. Only two of the 
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tested interactions (Appendix Table A.12, Model 1), with the stressors having < 6 
hours of sleep over the last 24 hours and being married with the partner living in the 
same household vs. other, turned out to be significant. 
Table A.12: Results of interactions between select potential stressors and iron stores. 
Logistic regression model with CESD-17 as dependent variable. Outcome reference is 
CESD-17 0 to 69th percentile; Model 1 presents moderate depressive mood (CESD-17 
70th–90th percentile) as event of interest; Model 2 presents high depressive mood 
(CESD > 90th percentile). Covariates were previous-week’s fatigue, ethnic group, and 
– depending on model – marital status and crowding. Displayed are p-values of 
interaction between iron stores (continuous iron stores mg/100; or categorical iron 
stores < –200 mg vs. ≥ –200 mg) and potential stressors. The models are adjusted for 
stratification, clustering (PSUs), and relative weight.  
Stressor variable Model 1 (n=1238) 
Low versus moderate depressive 
mood 
Model 2 (n=1103) 
Low versus high depressive mood 
 Continuous iron 
stores mg/100 
Categorical 
iron stores </≥ 
–200 mg 
Continuous iron 
stores mg/100 
Categorical 
iron stores </≥ 
–200 mg 
Poverty index < 130% 0.7 0.14 0.2 0.06 
Married vs. other 0.001 0.7 0.5 0.28 
Crowding 0.2 0.4 0.4 0.18 
Post-pregnant 0.6 0.4 0.66 0.26 
Postpartum 0.7 0.7 0.9 0.7 
Ethnic group 0.7 0.9 0.6 n/a (0 cells) 
High control over 
health vs. other 
0.9 0.4 0.7 0.06 
Hours of sleep < 6 0.006 0.28 0.2 0.3 
Food stamps not 
enough for food 
expenses (yes/no) 
0.5 0.7 0.4 0.3 
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Appendix Figure A.6 shows that living with a spouse increased the risk of 
moderate depressive mood for Hispanic women by 6 percent for every 100 mg 
decrease in iron stores. This result is in contrast to the results with severe depressive 
mood: living with one’s spouse had a protective effect against severe depressive mood 
when iron stores were low (Appendix Figure A.2). Appendix Figure A.7 shows that 
having less than 6 hours of sleep during the previous 24 hours increased the risk of 
moderate depressive mood by 14% for every 100 mg decrease in iron stores. 
Compared to results with severe depressive mood (Appendix Figure A.8), this result is 
more consistent with our expectations that the stressor lack of sleep would increase the 
risk of depressive mood. Note, though, that this relationship was based on a subsample 
size of n=55 and concurrent short-term assessments of mood and sleep deprivation. 
In summary, the effect of stressors – when comparing the effect of iron stores 
on severe and moderate depressive mood – was inconsistent. Moreover, in models 
with moderate depressive mood as an outcome, only two interactions were significant. 
Thus, the consistency between interactions with the outcome of moderate depressive 
mood was limited.  
Model 2 in Table A.12 showed that the reduced sample size (the 266 cases 
with moderate depressive mood were excluded) affects the significance of the 
interactions with the full sample size. Only the interactions with the stressors poverty 
index < 130% and low control over one’s health demonstrated a low p-value. 
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Figure A.6: Odds ratio of moderate depressive mood with iron stores (mg), grouped 
by married living with spouse or other. Logistic regression model with CESD-17 as 
the dependent variable (event being defined as the 70th–90th percentile of 
distribution). Covariates were previous-week’s fatigue, space available, marital status, 
and ethnic group. Model was adjusted for stratification, clustering, and relative 
weights. 
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Figure A.7: Odds ratio of moderate depressive mood with iron stores (mg), grouped 
by hours of sleep (<6, or ≥6). Logistic regression model with CESD-17 as the 
dependent variable (event being defined as the 70th–90th percentile of distribution), 
n=1298. Covariates were previous-week’s fatigue, space available, marital status, 
ethnic group, and hours of sleep < 6. Model was adjusted for stratification, clustering, 
and relative weights. 
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1.4 Role of Relative Weight 
In the present analysis it became apparent that the probability of selection 
based on chronological age (which is expressed in the survey design variable “relative 
weight”) was important. Statistically adjusting for relative sampling weight increased 
the strength of the effect of iron stores on depressive mood: the odds ratio of iron 
stores/100 mg changed from 0.92 without relative weight adjustment (Appendix Table 
A.13) to 0.89 with adjustment for weight (Table 2.4, Model 4). Iron stores remained 
significant in both models. A possible explanation is that participants 20 to 44 years of 
age had a lower probability of selection [155], and that adjustment for relative 
sampling weight increased their influence on the analysis. An interaction between 
chronological age and iron stores (p=0.06) showed that women younger than 35 have 
an increasing probability of depressive mood with decreasing iron stores compared to 
a weaker relationship in women older than 35 years of age (Appendix Figure A.8). 
The cutoff of age 35 was chosen because it had the highest level of significance, even 
though it does not coincide with the cutoff for sampling probability. The p-value of the 
interaction between age at 45 and iron stores was p=0.6 (model not shown). A number 
of possible explanations were explored. Chronological age might represent 
perimenopausal status (see Chapter 2, discussion section). Women in perimenopause 
could have a higher probability of depressive mood but lower prevalence of ID than 
women of a younger cohort. Their relationship between iron stores and depressive 
mood might be expected to be weaker than in younger women. Other additional 
variables were investigated as modifiers of the effect of iron stores in models without 
relative sample weight adjustment. Oral contraceptive use has been shown to increase 
the likelihood of depression in women with ID [287], but in our sample no significant 
interaction was found (model not shown). Buffering of the relationship between iron 
stores and depressive mood by personal characteristics was also explored. Higher 
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control over one’s situation has been shown to be such a buffer [288]. The HHANES 
survey had one variable coding for control over health (“How much control do you 
think you have over your health?”). No interaction between iron stores and control 
over one’s health was found in the unweighted model (model not shown). 
Table A.13: Unweighted final model. Logistic regression model with CESD-17 as 
dependent variable (event defined as being in the upper 90th percentile of the 
distribution). Odds ratios (OR), and lower and upper limit of confidence intervals (CI) 
of odds ratio. The models are adjusted for stratification and clustering (PSUs). Ref PR 
= reference Puerto Rican, c = area under the ROC curve. 
Variable  Model 
  OR CI 
Intercept  0.038 .025, .057 
Iron stores 
(mg)/100 
 0.92 0.85, 0.99 
Last week’s 
fatigue 
 2.10 1.94, 2.27 
Living space   0.81 0.73, 0.90 
Spouse in 
house (Ref 
other) 
 0.46 0.26, 0.81 
Ethnic group 
(ref PR) 
Cuban 
Mexican 
Other 
0.90 
0.43 
0.31 
0.13, 0.74 
–2LL  464 
c  0.937 
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Figure A.8: Odds ratios of depressive mood in interaction between iron stores (mg) 
and chronological age (yrs). Logistic regression model with CESD-17 as dependent 
variable (event defined as being in the upper 90th percentile of the distribution). 
Covariates were previous-week’s fatigue, space available, marital status, and ethnic 
group. The model was adjusted for stratification and clustering (PSUs).  
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Appendix B: IRON DEFICIENCY AND DEPRESSIVE MOOD IN FEMALE 
MEXICAN GARMENT WORKERS 
1.1 Figures and Tables 
Table B.1: Comparison between all participants in screening stage, and study 
participants; mean (SD), or %; t-test or Chi-square test. 
Variable Screening Sample p-value 
N 237 100  
Age (years) 25.5 (8.6) 27.1 (7.8)  0.11 
Height (m) 1.52 (0.57) 1.51 (0.56) 0.15 
Weight (kg) 59.5 (11.8) 58.4 (9.7) 0.4 
Marital status % 
Married or living 
with partner 
Single  
Other 
 
26 
 
64 
10 
 
28 
 
56 
16 
0.19 
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Table B.2: Logistic regression models: outcome BDI moderate and severe depressive 
mood (BDI ≥ 20) vs. none to mild (BDI < 20); OR (CI); n=100; c = area under the 
ROC curve. 
Variables Fixed factor models Mixed 
model 
  Model 1 Model 2 Model 3 Model 4 Model 5 
Intercept 1.06 (0.68, 
1.66) 
0.10 (0.07, 
0.38)*** 
1.06 (0.63, 
1.47) 
0.10 (0.03, 
0.36)*** 
0.08 (0.02, 
0.33)*** 
Centered hemoglobin 
g/L 
0.99 (0.96, 
1.01) 
0.99 (0.96, 
1.02) 
0.99 (0.96, 
1.01) 
0.99 (0.96, 
1.02) 
0.99 (0.74, 
1.02) 
Fatigue  1.89 (1.36, 
2.63)*** 
 1.91 (1.37, 
2.67)*** 
1.96 (0.72, 
2.78)*** 
Factor 2 
(crowding/SES) 
  1.03 (0.69, 
1.54) 
0.90 (0.57, 
1.41) 
0.87 (0.55, 
1.37) 
MCV>94 fL 0.93 (0.36, 
2.41) 
0.75 (0.26, 
2.15) 
0.93 (0.36, 
2.44) 
0.73 (0.25, 
2.11) 
0.84 (0.28, 
2.52) 
N 100 100 100 100 100 
c 0.522 119.8 0.517 0.736 n/a 
–2LL 137.7 0.731 137.7 119.5 426.0a 
Random factor factory: 
Cov parameter estimate 
(std error) 
n/a n/a n/a n/a 1.23 E –18 (.) 
a Pseudo-log Likelihood for Proc Glimmix 
*p<0.05; **p<0.001; ***p<0.0001 
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Table B.3: Odds ratio (OR) of depressive mood when compared to no or mild 
depressive mood (score < 20); assessed were moderate (20–28), or severe depressive 
mood (≥29); n=100. c = area under the ROC curve. 
Variables Outcome moderate (20–28) 
vs. none or mild (<20) 
Outcome severe (≥29) vs. 
none or mild (<20)  
Intercept 0.11 (0.02, 0.54)** 0.00 (0.00, 0.05)**** 
Centered hemoglobin g/L 1.02 (0.98, 1.07) 0.95 (0.91, 0.99)** 
Fatigue 1.58 (1.04, 2.40)** 2.80 (1.69, 4.64)**** 
Factor 2 (crowding/SES) 1.39 (0.70, 2.76) 0.56 (0.30, 1.06)* 
MCV>94 fL 0.25 (0.05, 1.16)* 2.21 (0.50, 9.67) 
N 74 75 
c 0.710 0.863 
–2LL 83.6 64.3 
*p-value ≥0.05 and <0.1; **p<0.05; ***p<0.001; ****p<0.0001 
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Table B.4: Odds ratio (OR) of severe depressive mood (≥29) with categorical iron 
depletion anemia (IDeA); fixed factor model. c = area under the ROC curve. 
Variables OR (CI) 
Intercept 0.005 (0.00, 0.05)**** 
Iron depletion anemiaa 3.44 (0.87, 13.63)* 
Fatigue 2.41 (1.59, 3.65)**** 
Factor 2 (crowding/SES) 0.53 (0.30, 0.95)** 
MCV>94 fL 2.49 (0.69, 9.02)* 
N 100 
c 0.826 
–2LL 84.9 
a hemoglobin<12.3 g/L and MCV and/or protoporphyrin beyond cutoff 
* p-value ≥ 0.05 and <0.1; ** p<0.05; ***p<0.001; ****p<0.0001 
 
 167 
 
 
 
 
 
 
Table B.5: Results factor analysis of FSS – validation; varimax rotationa; refer also to 
Appendix E, Fatigue Severity Scale; bolded numbers have factor loadings ≥ |4|. 
Variable Factor 1 Factor 2 
1. low motivation 0.19 0.50 
2. exercise fatigues –0.2 0.83 
3. easily fatigued 0.33 0.62 
4. interferes with physical 
functioning  
–0.20 0.83 
5. causes frequent problems 0.65 0.16 
6. prevents sustained physical 
functioning 
0.65 0.16 
7. interferes with duties 0.77 0.12 
8. among most disabling 
symptoms 
0.74 0.09 
9. interferes with social 
functioning 
0.83 0.18 
Variance explained 3.00 1.78 
a note that the oblique Promax rotation (not shown) gave virtually identical results 
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Table B.6: Odds ratio (OR) of a fatigue score (FSS) above the 75th percentile; OR 
(CI), p-value, n=100. c = area under the ROC curve. 
Variables OR (CI) p-value 
Intercept 9.0 (4.05, 20.12) <0.0001 
Centered hemoglobin g/L 0.98 (0.94, 1.01) 0.21 
BDI ≥ 29 0.05 (0.01, 0.20) <0.0001 
Factor 2 (crowding/SES) 0.49 (0.27, 0.90) 0.02 
N 100  
c 0.803  
–2LL 86.5  
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1.2 Supportive Analysis 
1.2.1 Methods for subsample: Iron status  
In addition to hemoglobin, MCV, and protoporphyrin, transferrin saturation, 
ferritin, and C-reactive protein were measured. Serum iron and total iron binding 
capacity was determined with atomic absorption spectrometry with an Analyst 300 
Spectometer (Perkin-Elmer, Norwalk, CT, USA). Transferrin saturation (%) was the 
ratio of serum iron and total iron binding capacity. Commercial kits were used to 
measure the serum concentrations of ferritin [μg/L], (Dade Behring Inc, Newark, DE 
19714, USA), and C-reactive protein (CRP) [mg/dL]22 by nephelometry, using 
monoclonal antibodies (Behring Nephelometer 100 Analyzer, Behring Laboratories, 
Messer Grisheim Gmbh, Frankfurt, Germany). Ferritin was set to missing for the 2 
cases with C-reactive protein > 10mg/dL and ferritin values >12 µg/L. Thus, high 
ferritin levels whose elevation could be due to acute phase response were not included 
in the analysis.  
All iron status indicators were evaluated as continuous and categorical 
variables. Cutoffs for the additional iron measures were ferritin <12 µg/L and 
transferrin saturation < 16%. The composite indicators of iron status were iron 
deficiency without anemia (IDNA), iron deficiency anemia (IDA), and iron stores. 
IDNA was defined as hemoglobin above 12.3 and at least two indicators of IDNA 
(MCV, protoporphyrin, ferritin, and transferrin saturation) beyond the cutoff. IDA was 
based on a hemoglobin value below 123 g/L and at least 2 indicators of IDNA beyond 
the cutoff. All other cases with hemoglobin greater than or equal to 12.3 g/dL and no 
IDNA were defined as iron sufficient. A continuous composite of iron status was iron 
stores [mg] [276]; this measure incorporates hemoglobin, ferritin, transferrin 
saturation, and protoporphyrin in a 3-step formula based on cutoff. The resulting score 
                                                 
22 CRP is a clinical indicator of a systemic response of the body to infection (also called acute phase 
response). 
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ranges from negative to positive value. A value equal to or above 0 indicates iron 
sufficiency, a value between 0 and –300 mg indicates IDNA, and a value smaller than 
–300 mg indicates IDA. 
Methods for subsample: Sample selection 
The final subsample of 76 participants contained information on five iron 
status indicators: hemoglobin, MCV, protoporphyrin, ferritin, and transferrin 
saturation (Appendix Figure B.1). While no difference in iron and mood parameters 
was found between the sample of 100 cases and the subsample of 76 cases, age was 
significantly higher in the excluded group of 24 cases (Appendix Table B.7).  
1.2.2 Results of subsample 
Results of the analysis with the subsample are displayed in Appendix Table 
B.8, Appendix Table B.9, Appendix Table B.10, and Appendix Table B.11. Of the 
iron status measures, only hemoglobin had a significant effect on depressive mood. 
All other measures (singular and composite) were not significant.  
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Figure B.1: Sample selection. 
1 
118 
115 
113 
109 
82 
79 
78 
- 3 missing depression scale 
- 2 missing fatigue scale 
- 4 missing hemoglobin, MCV, protoporphyrin 
- 20 missing ferritin and transferrin sat. 
- 1 missing ferritin 
- 2 excluded ferritin because of high CRP 
- 4 missing transferrin saturation 
- 1 age 17 yrs. 
- 1 antidepressant meds. 
- 1 antianxiety meds. 
- 1 missing marital status 
76 
- 2 macrocytotic anemia 
Randomly selected subsample with complete iron 
status indicators 
Full sample please refer to chapter 3, methods 
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Table B.7: Subject characteristics comparison between samples of 100 and 76 cases; 
means (SD) or percentages; t-test, Chi-square test or Fisher’s-Exact test. 
Variable Sample of n=76 Excluded n=24 p-value 
Hemoglobin (g/L) 132 (15) 130 (18) 0.6 
MCV fL 88.5 (8.7) 89.5 (8.2) 0.6 
Protoporphyrin 82.7 (71.2) 67.0 (52.0) 0.3 
Age (yrs) 26 (8) 31 (7) 0.01 
BMI kg/m2 25.6 (4.3) 25.8 (4.0) 0.8 
Fatigue 3.7 (1.5) 4.0 (1.4) 0.3 
% iron depletion with 
anemiaa  
23% 17% .5 
% iron depletion, but 
no anemiab 
17% 8% .2 
MCV > 94 fL 22% 25% .7 
BMI > 25kg/m2 51% 50% .9 
BMI > 30kg/m2 12 21 .2 
Severe depressionc 26% 25% .8 
Moderate depressiond 28% 17% .4 
Household income < 
4377 pesose 
91% 96% 0.4 
%dirt floor 9% 12% 0.7 
a MCV and/or protoporphyrin beyond cutoff, plus hemoglobin < 123g/L  
b MCV and/or protoporphyrin beyond cutoff, but hemoglobin ≥ 123g/L  
c BDI ≥ 29 points 
d BDI 20–28 points 
e equivalent of $157/month in summer of 2001; household poverty line level 1 in 2000 in Mexico 
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Table B.8: Subject characteristics, general; mean (SD), median, 25th and 75th 
percentile, or %; n=76. 
Variable Mean (SD)  Median 25th p. 75th p. % of whole sample 
Age (yrs) 26 (7.7) 23 19 32  
BMI kg/m2 25.6 (4.3) 25.1 22.8 28.3  
Factor 2 0.0 (0.97) 0.2 –0.5 0.7  
% BMI > 25 kg/m2     51% 
% BMI > 30 kg/m2     12% 
% Household income 
< 4377 pesosa 
    91% 
% Dirt floor     9% 
% Dirt floor, walls, 
and roof plastic, 
asbestos, or metal 
    1% 
a equivalent of $157/month in summer of 2001; national poverty line for Mexican households in 2000 
[232] 
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Table B.9: Subject characteristics, iron status; mean (SD), median, 25th and 75th 
percentile, or %; n=76. 
Variable Mean (SD)  Median 25th p. 75th p. % of whole sample 
Hemoglobin g/L 132 (15) 134 123 140  
MCV fL/l 88.5 (8.7) 91.5 84.3 93.6  
Protoporphyrin μg/dL 82.8 (71.2) 57.5 36.7 96.2  
Ferritin μg/L 32.4 (29.7) 20.6 14.2 41.0  
Transferrin saturation 
% 
32.3 (9.8) 31.9 25.2 36.4  
Iron stores mg 238.6 (330.2) 208.3 41.1 473.5  
% Hemoglobin < 
12.3 g/dL 
    24% 
% MCV < 80 fL     16% 
% Protoporphyrin > 
70 μg/dL 
    41% 
% Ferritin < 12 μg/L     17% 
% Transferrin 
saturation <16% 
    1% 
% IDAa     22% 
% IDNAb     30% 
% MCV>94c     22% 
a iron deficiency anemia, with hemoglobin <123 g/L, plus at least 2 indicators of iron deficiency (MCV, 
ferritin, transferrin saturation, or protoporphyrin) beyond cutoff 
b iron deficiency without anemia, with hemoglobin ≥123 g/L, but at least 2 indicators of iron deficiency 
(MCV, ferritin, transferrin saturation or protoporphyrin) beyond cutoff 
c indicator of macrocytosis, therefore potential folate and/or vitamin B12 deficiency 
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Table B.10: Subject characteristics, mood; mean (SD), median, 25th and 75th 
percentile, or %; n=76. 
Variable Mean (SD)  Median 25th p. 75th p. % of whole sample 
Beck Depression 
Inventory 
23.1 (14.2) 21.0 14.0 29.5  
Fatigue 3.7 (1.5) 3,3 2,4 5.1  
CESD-201 19.7 (10.7) 18 12.5 25  
% Beck Depression 
Inventory moderate 
score 20–28 
    28% 
% Beck Depression 
Inventory severe ≥ 29 
    26% 
% CESD-20a > 16     58% 
a Center of Epidemiologic Studies – Depression scale 
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Table B.11: Logistic regression model. Odds ratio (OR) of severe depression (BDI ≥ 
29). N=76; fixed factor models. c = area under the ROC curve. 
Variable Model 1 Model 2 Model3 
Intercept 0.002 (0.00, 
0.03)**** 
0.002 (0.00, 
0.03)**** 
0.003 (0.00, 
0.04)**** 
Centered hemoglobin g/L 0.93 (0.88, 0.98)**   
IDeA (iron depletion anemia) 
vs. nota 
 3.30 (0.65, 16.71)  
IDA vs. notb   5.97 (1.02, 
34.87)** 
Fatigue 2.85 (1.65, 
4.90)*** 
2.57 (1.59, 
4.11)*** 
2.42 (1.51, 
3.88)*** 
Factor 2 (crowding, SES) 0.85 (0.39, 1.85) 0.73, (0.35, 1.52) 0.75 (0.36, 1.58) 
MCV>94 6.73 (1.16, 
39.01)** 
3.56 (0.75, 16.96) 3.76 (0.83, 17.06)* 
N 76 76 76 
c 0.890 0.854 0.879 
–2LL 54.0 61.55 59.5 
a defined as hemoglobin<12.3 g/L, and MCV and/or protoporphyrin beyond cutoff 
b defined as hemoglobin<12.3 g/L, and 2 of 4 iron deficiency indicators (MCV, protoporphyrin, 
transferrin saturation, Ferritin) beyond cutoff 
*p-value ≥ 0.05 and <0.1; **p<0.05; ***p<0.001; ****p<0.0001 
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Appendix C: CORTISOL, IRON STATUS, AND SEVERE DEPRESSIVE 
MOOD IN FEMALE MEXICAN FACTORY WORKERS 
1.1 Tables and Figures  
Table C.1: Time in hours of cortisol sampling time by sampling day (1 and 2), and 
sample per day (1 to 4). Time was digitalized for easier interval calculation (e.g., 30 
min = 0.5). Actual sampling time (n=36), and actual and programmeda sampling time 
(n=48). 
Day Sample 
Mean (SD) 
digitalized actual 
time 
Mean (SD) 
digitalized actual and 
programmed time 
1 1 0.49 (0.20) 0.49 (0.19) 
 2 3.05 (0.24) 3.05 (0.22) 
 3 7.05 (0.19) 7.05 (0.16) 
 4 10.05 (0.18) 10.05 (0.17) 
2 1 0.49 (0.099) 0.40 (0.09) 
 2 2.99 (0.28) 2.98 (0.23) 
 3 7.00 (0.29) 7.01 (0.24) 
 4 9.99 (0.22) 9.99 (0.18) 
a Programmed time refers to cases that had times of actual sampling missing. The average time of 
available actual time values for that particular day and sampling time was inserted instead. 
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Table C.2: Comparison between all participants in screening stage, and study 
participants; mean (SD), or %; t-test or Chi-square test. 
Variable Screening Sample p-value 
N 237 48  
Age (years) 25.5 (8.6) 28.9 (8.7) 0.01 
Height (m) 1.52 (0.57) 1.51 (0.53) 0.15 
Weight (kg) 59.5 (11.8) 59.7 (10.1) 0.4 
Marital status % 
Married or living 
with partner 
Single  
Other 
 
26 
 
64 
10 
 
28 
 
44 
19 
0.02 
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Table C.3: Subject characteristics comparison between sample of 100 and 48 cases; 
displayed are the subsample of 48 cases and the remaining 52 cases from stage 2 that 
were excluded; means (SD) or percentages; t-test, Chi-square test or Fisher’s-Exact 
test. 
Variable Sample of n=48 Excluded n=52 p-value 
Hemoglobin (g/L) 131 (18) 132 (14) 0.7 
MCV fL 88.4 (9.8) 89.0 (7.2) 0.7 
Protoporphyrin µg/dL 
 
87.6 (82.4) 71.0 (49.0) 0.2 
Age (yrs) 29 (9) 25 (7) 0.02 
BMI kg/m2 26.1 (4.2) 25.2 (4.1) 0.2 
Fatigue 4.1 (1.6) 3.5 (1.4) 0.06 
Factor 2 (crowding, SES) –0.1 (1.0) 0.1 (1.0) 0.3 
% Iron depletion with 
anemiaa  
25 17 0.3 
% Iron depletion, but no 
anemiab 
12.5 17 0.6 
% MCV > 94 fL 23 23 0.7 
% BMI > 25kg/m2 58 44 0.16 
% BMI > 30kg/m2 17 11 0.4 
% Severe depressionc 31 21 0.2 
5 Moderate depressiond 25 25 0.9 
% CESD > 16 71 48 0.02 
% Household income  
< 4377 pesose 
92 92 0.9 
% Dirt floor 12.5 7.7 0.4 
% Marital status 
Married 
Single 
Disruptedf 
 
37.5 
44 
19 
 
19 
67 
13 
0.05 
a MCV and/or protoporphyrin beyond cutoff, plus hemoglobin < 123g/L  
b MCV and/or protoporphyrin beyond cutoff, but hemoglobin ≥ 123g/L  
c BDI ≥ 29 points 
d BDI 20–28 points 
e equivalent of $157/month in the summer of 2001; national poverty line level 1 for Mexico in 2000 
f separated, single mother, divorced, or widowed 
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Table C.4: Cortisol values (nmol/L) for samples 1–4 for both days; mean (SD), 
median, minimum, and maximum. 
Sample Mean (SD) 25th 
percentile 
50th 
percentile 
75th 
percentile 
Minimum Maximum 
1 5.2 (5.5) 2 3.2 5.7 0.5 32 
2 2.3 (2.6) 0.87 1.9 2.5 Undet.a 14.0 
3 1.9 (1.8) 0.6 1.6 2.4 Undet. 12.0 
4 2.4 (3.1) 0.7 1.6 2.6 Undet. 17.9 
a undetectable level 
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Figure C.1: Odds ratio (OR) of severe depressive mood; modifying effect of cortisol 
below (LO) or above (HI) median. Statistical model includes iron depletion anemia 
(IDeA), cortisol, fatigue, and factor 2 (crowding, SES). Cell size is textbox. P-
interaction = 0.08. 
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Table C.5: Logistic regression models with outcome risk of severe depressive mood 
(≥29); fixed factor (Model 1) and mixed model with random factor factory (Model 2); 
log OR (log SE); n=48. c = area under the ROC curve. 
Variables Model 1 Model 2 
Intercept –3.511 (1.487) –3.964 (1.651) 
Centered hemoglobin g/L –0.066 (0.033); p=0.04 –0.067 (0.034); p=0.05 
Fatigue 0.540 (0.278); p=0.05 0.676 (0.309); p=0.03 
Factor 2 (crowding, SES) –1.182 (0.500); p=0.018 –1.400 (0.535); p=0.01 
AUC3E cortisol nmol/L –0.160 (0.781); P=0.8 –0.035 (0.807); p=0.9 
Interaction (hemoglobin*cortisol) 0.082 (0.048); p=0.08 0.08 (0.049); p=0.1 
N 48 48 
c 0.806 n/a 
–2LL 45.2 243.2a 
Random factor factory: Cov parameter 
estimate (std error) 
N/a 0.793 (1.44) 
a Pseudo-log Likelihood for Proc glimmix 
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Table C.6: Logistic regression models, excluding cortisol variable, for comparison with effect sizes of large sample (n=100) in 
Table 3.4; outcome BDI severe depressive mood; OR (CI); n=48. c = area under the ROC curve. 
Variables Fixed factor models Mixed model 
  Model 1 Model 2 Model 3 Model 4 
Intercept 0.03 (0.002, 0.45) 0.03 (0.002, 0.46) 0.03 (0.002, 0.45) 0.02 (0.001, 0.45) 
Centered hemoglobin g/L 0.97 (0.93, 1.01)a 0.97 (0.94, 1.01)c  0.97 (0.93, 1.01)d 
Iron depletion with anemia (IDeA)   1.42 (0.31, 6.52)  
Fatigue 1.78 (1.03, 3.08) 1.74 (1.02, 2.96) 1.73 (1.04, 2.89) 1.95 (1.09, 3.49) 
Factor 2 (crowding, SES) 0.42 (0.19, 0.92) 0.42 (0.19, 0.93) 0.43 (0.20, 0.92) 0.34 (1.14, 0.81) 
MCV>94 fL 1.55 (0.25, 9.62)b    
N 48 48 48 48 
c 0.785 0.787 0.748 n/a 
–2LL 48.6 48.9 50.6 233.4e 
Random factor factory: 
Cov parameter estimate (std error) 
n/a n/a n/a 0.800 (1.32)  
a p=0.15 
b p=0.6 
c p=0.17 
d P=0.18 
e Pseudo-log Likelihood for Proc glimmix 
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Table C.7: ln OR of severe depressive mood (BDI ≥ 29); comparison between 
interaction model with, and without fatigue and/or factor 2 (crowding, SES). ln OR (ln 
SE), p-value; independent variables in full model were centered hemoglobin, fatigue, 
factor 2 (crowding, SES), AUC3, and interaction; MCV>94 not included due to p-
value>0.3; n=48. c = area under the ROC curve. 
Variables Model 1 Model 2 Model 3 Model 4 
Intercept –3.511 (1.487) 
p=0.01 
–1.007 (0.559) 
p=0.07 
–1.982 (1.103) 
p=0.07 
–0.770 (0.489) 
p=0.1 
Centered hemoglobin g/L –0.066 (0.033) 
p=0.04 
–0.062 (0.030) 
p=0.03 
–0.047 (0.028) 
p=0.09 
–0.050 (0.027) 
p=0.06 
Fatigue 0.540 (0.278) 
p=0.05 
 0.286 (0.228) 
p=0.2 
 
Factor 2 (crowding, SES) –1.182 (0.500) 
p=0.01 
–0.847 (0.426) 
p=0.04 
  
AUC3E cortisol nmol/L –0.1717 
(0.779) p=0.8 
–0.319 (0.734) 
p=0.6 
–0.288 (0.698) 
p=0.6 
–0.317 (0.685) 
p=0.6 
Interaction 
(hemoglobin*cortisol) 
0.082 (0.048) 
p=0.08 
0.079 (0.044) 
p=0.07 
0.039 (0.040) 
p=0.3 
0.047 (0.039) 
p=0.2 
c 0.806 0.765 0.690 0.612 
–2LL 45.250 49.6 53.0 54.7 
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Table C.8: ln OR of depressive mood. Comparing none to mild depressive mood 
(<20) with moderate and severe depressive mood (≥20) (Model 1); none and mild 
depressive mood (<20) with severe depressive mood (≥29) (Model 2); and none to 
mild depressive mood (<20) with moderate depressive mood (20–28) (Model 3); all 
values ln OR (ln SE); n=48. c = area under the ROC curve. 
Variable Outcome moderate and 
severe depressive mood 
Outcome severe 
depressive mood 
Outcome moderate 
depressive mood 
 Model 1 Model 2 Model 3 
Intercept –2.161 (1.119)** –3.483 (1.531)*** –7.195 (3.602)*** 
Centered hemoglobin g/L –0.021 (0.026) –0.051 (0.033)* 0.201 (0.133)* 
Fatigue 0.488 (0.238)*** 0.633 (0.306)*** 1.308 (0.699)** 
Factor 2 (crowding, SES) –0.312 (0.341) –0.945 (0.485)** 1.152 (0.834)( 
Cortisol AUC3E nmol/L 0.704 (0.653) 0.063 (0.832) 2.107 (1.119)** 
Interaction 
(hemoglobin*cortisol) 
0.038 (0.038) 0.068 (0.047)* –0.049 (0.079) 
c 0.698 0.808 0.857 
–2LL 58.3 37.9 33.6 
N 48 36 33 
*p<0.2; **p<0.1; ***p<0.05 
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1.2 Methods and Results of All Cortisol Measures 
1.2.1 Morning cortisol 
The women collected morning cortisol at home, 30 minutes after waking. They 
also recorded time of waking and actual sampling time. When cortisol was sampled at 
exactly 30 minutes after waking, the true cortisol value was used. If time of sampling 
deviated, cortisol concentrations for the 30-minute morning wakingwere predicted 
individually per case per day from the existing values for the day (50% of the cases). 
When day 1 and day 2 had values for morning cortisol, the mean between those two 
predicted values was taken (92% of the cases). Otherwise the one available day was 
used. The means, standard deviations, and coefficients of variation (for log-
transformed values) for partially predicted and for the unpredicted morning cortisol 
are shown in Appendix Table C.9. Mean and median cortisol values of the unpredicted 
and partially predicted morning cortisol are comparable. Morning cortisol had 49 
cases (1 case more than the AUC estimates), since one participant had a morning 
cortisol but was not available for samples during the workday. 
Morning cortisol variables were then dichotomized (below the median, or 
equal to or above the median) and entered as a modifier of the effect of hemoglobin 
into the logistic regression model (Appendix Table C.10). The interaction between 
morning cortisol and hemoglobin was not significant. This might be due to the high 
variability of morning cortisol (compare coefficient of variation in Appendix Table 
C.9). Higher variability of cortisol might be due to individual morning stressors and 
sleep quality [287, 289], time of awakening [288, 290], or time of [290] start of the 
workday. On the other hand, one study found no effect of time of awakening, sleep 
duration, and use of an alarm clock on the cortisol awakening response [259]. 
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1.2.2 Area under the curve (AUC) 
AUC was assessed twice, for a concentration curve that used the first 3 saliva 
samples of a day, and one that used all 4 samples. AUC was calculated with the 
pharmacological program pkexamine of the statistical Stata software version 9.0 [265]. 
When 2 days of sampling were available (83% of the sample), the mean between the 
two curves was used. Otherwise the AUC of the available day was taken.  
Descriptive statistics are presented in Appendix Table C.9. While mean AUC 
for 4 samples had higher values, CVs were lower. Means, standard deviations, and 
coefficients of variation between the smaller group with both cortisol values and 
sampling times (n=36) were comparable to the larger sample, where some of the 
sampling times had to be estimated (n=48). The effect of AUC with 3 or 4 samples in 
the interaction with hemoglobin was equivalent (Appendix Table C.11). When 
plotting the interaction with AUC with 3 samples (AUC3) without inserting missing 
times of sampling (Appendix Figure C.2) or with AUC with 3 samples with some of 
the times being estimated (AUC3E; see Figure 4.1), the interaction is comparable. 
While the lower cortisol group has a significant increase in risk of severe depressive 
mood with decreasing hemoglobin, no significant effect of hemoglobin on risk of 
severe depressive mood can be found with the high-cortisol group. 
1.2.3 Individual slopes 
Another method of distinguishing individuals with low and high cortisol is by 
estimating the slope of their diurnal rhythm over the day [99, 102, 276, 278]. Low-
cortisol subjects were assumed to have lower morning cortisol values and therefore 
flatter slopes [276]. Individual slopes of cortisol values over time at three sampling 
time points per day (30 minutes, 3 hours, and 7 hours after waking) were estimated 
with mixed regression model methods (SAS, version 9.1, proc mixed; [176]). Cortisol 
was log-transformed (natural logarithm) to adjust for skewness of the outcome and 
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non-linearity of the diurnal curve. Time of sampling was reported as estimated average 
time if reported time was not available; otherwise the actual reported time of sampling 
was used (total sample size was 48 observations). The method resulted in a slope and 
intercept estimate per subject per day; the mean of the slopes for 2 days (if available) 
was calculated; otherwise the slope of 1 day was used. The overall effect (slope) of 
time of sampling on log cortisol was –0.124 nmol/L (p<0.0001); median of the slopes 
was –0.0085, minimum –0.114, and maximum 0.135 (not shown). Slope was 
dichotomized as smaller than the median, and greater than or equal to the median. This 
dichotomous variable was inserted as a modifier of hemoglobin into the logistic 
regression model with severe depressive mood as an outcome. Covariates were fatigue 
and factor 2 (crowding, SES). The interaction was not significant (p=0.49; not shown). 
A reason for the negative result might be that cortisol values over the day are too 
variable in this sample to obtain an accurate estimate of the diurnal cortisol curve per 
subject; therefore, cases might have been misclassified. Appendix Table C.10 shows 
the cross-tabulation of true/false positive and negative values between the 
dichotomous variable of cortisol slopes and AUC3E cortisol. Correct classification of 
cases by the dichotomized cortisol slope variable into the low (sensitivity) and high 
(specificity) cortisol categories is only 54% when using AUC3E cortisol as the gold 
standard. Another reason could be that that evening cortisol levels – which are usually 
the lowest values in the curve – needed to be collected in order to get the maximum 
possible decline of the curve [276]. The result would be a greater variability of slopes, 
and a potentially better distinction between individuals with low and high cortisol.  
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Table C.9: Comparison of means, SD, coefficients of variation (CV), and medians of 
cortisol measures. 
Variable N Mean SD CV Median 
ln (morning cortisol 30 min after 
wake up)a nmol/L 
49 1.35 0.70 52 1.25 
ln (morning cortisol approx. 30 min 
after wake up)b nmol/L 
49 1.26 0.72 57 1.21 
ln (AUC, 3 samples)c nmol/L 36 2.58 .7 27 2.69 
ln (AUC, 3 samples, predicted time)d 
nmol/L 
48 2.47 .76 31 2.64 
ln (AUC, 4 samples)e nmol/L 36 3.0 .7 23 3.13 
ln (AUC, 4 samples, predicted time)f 
nmol/L 
48 2.47 .73 25 2.97 
Morning cortisol 30 min after wake 
upg nmol/L 
49 5.08 4.6  3.50 
Morning cortisol approx. 30 min after 
wake uph nmol/L 
49 4.72 4.4  3.34 
AUC, 3 samplesi nmol/L 36 17.36 16.4  14.7 
AUC, 3 samples, predicted timei 
nmol/L 48 15.97 15.4  14.13 
AUC, 4 samplesj nmol/L 36 25.62 20.1  22.97 
AUC, 4 samples, predicted timek 48 22.64 17.6  19.5 
a log transformed morning cortisol, collected 30 minutes after wake up, actual time of sampling for all 
cases 
b log transformed morning cortisol, collected 30 minutes after wake up, actual time of sampling for 
cases with exactly 30 minutes after wake up collection; predicted cortisol value for cases with earlier or 
later time of collection 
c log transformed area under the curve (AUC) for 3 samplings per day; only values with both time of 
sampling and cortisol 
d log transformed AUC for 3 samplings per day; if time of sampling was missing, but cortisol assessed, 
mean time of sampling was inserted 
e log transformed AUC for 4 samples per day; only values with both time of sampling and cortisol 
f log transformed AUC for 4 samples per day; if time of sampling was missing, but cortisol assessed, 
mean time of sampling was inserted 
f morning cortisol, collected 30 minutes after wake up, actual time of sampling for all cases 
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g morning cortisol, collected 30 minutes after wake up, actual time of sampling for cases with exactly 
30 minutes; if time of sampling was missing, but cortisol assessed, mean time of sampling was inserted 
h AUC for 3 samplings per day; only values with both time of sampling and cortisol 
i AUC for 3 samplings per day; if time of sampling was missing, but cortisol assessed, mean time of 
sampling was inserted 
j AUC for 4 samples per day 
k AUC for 4 samples per day; if time of sampling was missing, but cortisol assessed, mean time of 
sampling was inserted 
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Table C.10: Association of low or high AUC3E cortisol with participant 
characteristics; means (SD) or %; t-test for continuous variables, Wilcoxon 2-sample 
test for GHQ and GHQ modules; Chi-square or Fisher’s-Exact test for categorical 
variables. 
 AUC3E < median, 
n=24 
AUC3E ≥ median, 
n=24 
p-value 
Physical health 
Age 30 (8) 27 (9) 0.2 
BMI kg/m2 26 (4) 25 (4) 0.2 
FSS 4.1 (1.6) 4.0 (1.6) 0.7 
CRP mg/L 1 (1) 1 (1) 0.9 
White blood cells 103 µL 6 (2) 8 (3) 0.1 
% Oral contraceptive use 8 8 1 
% BMI > 25 kg/m2 67 50 0.2 
% BMI > 30 kg/m2 21 12 0.7 
% respiratory illness 21 37 0.2 
GHQ 
GHQ 28 (13) 25 (13) 0.3 
GHQ anxiety 8 (5) 7 (4) 0.2 
GHQ depression 4 (5) 3.5 (4) 0.8 
GHQ social functioning 6 (2) 8 (3) 0.1 
GHQ somatic 9 (5) 8 (4) 0.2 
% more headachea 65 21 0.002 
% more pressure in the heada 52 21 0.02 
a GHQ somatic 
b GHQ anxiety 
c GHQ social functioning 
d GHQ depression 
e widowed, single mother, divorced, separated 
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Table C.10 (Continued) 
 AUC3E < median, 
n=24 
AUC3E ≥ median, 
n=24 
p-value 
GHQ (continued) 
% more hot/cold spellsa 52 29 0.1 
% more nervousb 48 17 0.02 
% much less satisfiedc 22 50 0.04 
% keeping busierc 35 21 0.2 
% life is hopelessd 17 4 0.1 
SES and household composition 
Crowding –0.7 (2) –1 (2) 0.6 
Factor 1 (wealth, SES) 0.1 (1) 0.04 (0.8) 0.8 
Factor 2 (crowding, SES) –0.1(1) –0.1 (0.9) 0.9 
Factor 3 (life stage) –0.2 (1) –0.2 (1) 0.9 
% kids under 5 years 21 25 0.7 
% kids under 10 years 33 33 1 
% kids under 18 years 46 50 0.7 
% father helps with child care 33 29 1 
% living alone 26 39 0.3 
%disrupted marital statuse 29 8 0.1 
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Table C.11: Log OR of severe depressive mood (BDI ≥ 29); interaction between 6 
cortisol measures and hemoglobin; log OR (log SE); MCV>94 was included when 
p<0.3. c = area under the ROC curve. 
Variable Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 
Intercept –3.296 
(1.344)*** 
–3.821 
(1.460)*** 
–3.521 
(1.481)*** 
–5.755 
(2.543)*** 
–3.531 
(1.529)*** 
–5.392 
(2.587)*** 
Centered hemoglobin 
g/L 
–0.015 
(0.028) 
–0.038 
(0.027)* 
–.066 
(0.033)*** 
–0.108 
(0.049)*** 
–0.062 
(0.029)*** 
–0.107 
(0.049)*** 
Fatigue 0.552 
(0.264)*** 
0.616 
(0.281)*** 
0.540 
(0.278)** 
0.813 
(0.458)** 
0.648 
(0.302)*** 
0.780 
(0.456)** 
Factor 2 (crowding, 
SES) 
–0.661 
(0.394)** 
–0.722 
(0.382)** 
–1.182 
(0.500)*** 
–1.586 
(0.671)*** 
–1.202 
(0.464)*** 
–1.558 
(0.668)*** 
MCV>94 fl    1.528 
(1.229) 
 1.391 
(1.287) 
MOCP nmol/L 0.090 
(0.724) 
     
MOC nmol/L  0.413 
(0.724) 
    
AUC3E nmol/L   –0.177 
(0.779) 
   
AUC3 nmol/L    0.603 
(0.979) 
  
AUC4E nmol/L     –0.556 
(0.759) 
 
AUC4 nmol/L      0.277 
(1.044) 
Interaction 
(hemoglobin* 
cortisol) 
–0.018 
(0.039) 
0.028 
(0.042) 
0.082 
(0.048)** 
0.125 
(0.06)*** 
0.081 
(0.046)** 
0.126 
(0.062)*** 
c 0.771 0.755 0.806 0.685 0.834 0.864 
–2LL 51.8 51.3 45.2 29.9 44.3 29.8 
n 49 49 48 36 48 36 
Note: MOCP: morning cortisol with some predicted cortisol values for 30 minutes after wake-up; 
MOC: morning cortisol; AUC3P: AUC, 3 samples, predicted times if necessary; AUC3: AUC, 3 
samples; AUC4P: AUC, 4 samples, predicted times if necessary; AUC4, 4 samples 
* p-value<0.2; ** p-value<0.1; *** p-value<0.05 
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Figure C.2: Odds ratio (OR) of severe depressive mood; modifying effect of AUC3 
cortisol below (continuous line) or above median (dashed line) of AUC3E cortisol. 
Statistical model includes centered hemoglobin, cortisol, fatigue, MCV>94 fL, and 
factor 2 (crowding, SES). p-interaction = 0.02. n=36; sample includes only recorded 
times of sampling for cortisol; 10th–90th percentile of hemoglobin. 
OR=0.90, p=0.02 
OR=1.02, p=0.6 
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Table C.12: Assessment of correct classification of cases into low and high cortisol 
by the dichotomized cortisol slope over time of day variable. Gold standard is of the 
dichotomized area under the curve (AUC3E) cortisol variable. Listed are number of 
cases that are true and false positive, and true and false negative.  
Slope of cortisol concentrations 
over time 
Area under the curve cortisol (AUC3E cortisol  
 <median ≥median total 
<median True positive = 13 False positive = 11 24 
≥median False negative = 11 True negative =13 24 
total 24 24 48 
Note: Sensitivity = true positive/(true positive + false negative) = 54%; Specificity = true negative/(true 
negative + false positive) = 54% 
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Appendix D: DIAGNOSIS OF MOOD DISORDERS RELATED TO 
DEPRESSION 
Based on Diagnostic and statistical manual of mental disorders. DSM-IV-TR [53].  
 
Major depressive episode (total of 5 or more symptoms) 
 
One or more depressive episodes for at least 2 weeks per episode 
Symptoms: 
o At least: 
o Depressed mood 
or  
o Loss of interest and pleasure 
o Plus 3–4 additional:  
o Significant weight loss or gain 
o Insomnia or hypersomnia 
o Agitation or retardation 
o Fatigue 
o Worthlessness or guilt 
o Concentration difficulties or indecisiveness 
o Thoughts of death, suicidal ideation, suicide attempt, or plan for 
committing suicide 
o The symptoms cause clinically significant distress or impairment in social, 
occupational, or other important areas of functioning 
o The symptoms are not account for by bereavement 
 
Melancholic feature specifier: 
o Either one of the following:  
o loss of pleasure or lack of reactivity to usually pleasurable stimuli  
o Plus 3 or more of the following: 
o Depressed mood 
o Depression worse in the morning 
o Early morning awakening 
o Psychomotor retardation or agitation 
o Anorexia or weight loss 
o Guilt 
 
Atypical feature specifier 
o Mood reactivity 
o Plus 2 or more of the following 
 Weight gain or increase in appetite 
 Hypersomnia 
 Leaden paralysis 
 Sensitivity to interpersonal rejection 
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Postpartum onset specifier: 
o Onset within 4 weeks postpartum 
 
Minor depressive episode (total of 2–4 symptoms)  
Included in depressive disorder not otherwise specified23 
 
One or more depressive episodes for at least 2 weeks per episode 
Symptoms: 
o At least 
o Depressed mood 
or 
o Loss of interest or pleasure 
o Plus 1–3 additional: 
o Weight change 
o In- or hypersomnia 
o Agitation or retardation 
o Fatigue 
o Worthlessness or guilt 
o Concentration difficulties 
o Thoughts of death 
 
Research criteria for minor depressive disorder 
o At least 2 but nor more than 5 of the following symptoms present during 2-
week period; one of the symptoms has to be depressed mood or loss of interest 
or pleasure 
o Plus 1–4 additional ones: 
o Depressed mood 
o Loss of interest or pleasure 
o Weight loss or weight gain 
o Insomnia or hypersomnia 
o Psychomotor agitation or retardation 
o Fatigue or loss of energy 
o Feelings of worthlessness, guilt 
o Diminished ability to concentrate, or indecisiveness 
o Recurring thought of death, suicidal ideation, suicide attempt, plan to 
commit suicide 
 
Dysthymia (total of 3 or more symptoms) 
 
At least 2 years of depressive symptoms 
Plus symptoms: 
o Poor appetite or overeating 
o Insomnia or hypersomnia 
                                                 
23 Disorders that are included in this category include premenstrual dysphoric disorder, minor 
depressive episode. 
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o Low energy or fatigue 
o Low self-esteem 
o Poor concentration or difficulty making decisions 
o Feelings of hopelessness 
 
Atypical feature specifier (total of 3 symptoms): 
o Mood reactivity 
plus 
o increased apetite or weight gain 
o hypersomnia 
o leaden paralysis 
o extreme sensitivity to interpersonal rejection 
 
Alternative criteria B for dysthymic disorder 
o presence, while depressed of 3 or more of the following 
o low self-esteem or self-confidence, feelings of inadequacy 
o pessimism, despair, hopelessness 
o loss of interest or pleasure 
o social withdrawal 
o chronic fatigue or tiredness 
o guilt, brooding 
o irritability or excessive anger 
o decreased activity, effectiveness, productivity 
o difficulty in thinking, reflected by poor concentration, memory or 
indecisiveness 
 199 
Appendix E: INSTRUMENTS 
1. Diagnostic Interview Schedule, Depression Module 
 
1. Are you in one of these spells of feeling low and disinterested and having some of 
these problems now? 
o Yes/no 
 
2. When did you last spell like that end? 
o Within last 2 weeks 
o Within last month 
o Within last 6 months 
o within last year 
o more than a year ago 
 
(if more than a year ago) 
3. How old were you then 
o Age 
 
4. The lifetime DSM-III diagnosis of major depressive episode 
o No diagnosis 
o Non-severe diagnosis 
o Severe diagnosis 
o Severe bereavement 
o Non-severe bereavement 
 
5. Age last depressive symptoms occurred if ever met criteria for any major depressive 
episode 
o 10–38 years old 
o last episode within last 2 weeks 
o last episode within 2 weeks to 1 month ago 
o last episode within 1 to 6 months ago 
o last episode 7 months to 1 year ago 
 
6. Total number of positive depression symptoms groups ever. The dysphoria symptom 
is also included. 
o 0–9 
 
7. Age last depressive symptoms occurred if ever met criteria for any single episode of 
major depressive episode 
o 10–38 years old 
o last episode within last 2 weeks 
o last episode within 2 weeks to 1 month ago 
o last episode within 1 to 6 months ago 
o last episode 7 months to 1 year ago 
 
8. Age last depressive symptoms occurred if ever met criteria for any recurrent episode 
of major depressive episode 
Coded as depressed 
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o 10–38 years old 
o last episode within last 2 weeks 
o last episode within 2 weeks to 1 month ago 
o last episode within 1 to 6 months ago 
o last episode 7 months to 1 yr ago 
 
• Variable coding:  
o Current major depression: suffering from current major depression 
requires answering yes to question 1, or within the last 2 weeks in 
question 2, plus a diagnosis as depressed in question 4. 
o Past major depression: requires answering within the last months to 
more than a year in question 2, plus a diagnosis as depressed in 
question 4. 
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2. Lifetime Fatigue Score, Diagnostic Interview Schedule 
 
From the sleep summary 
 
o Have you ever had a period of two weeks or longer when you were sleeping too 
much? 
o No [0] 
o Yes [1] 
 
From the tired out summary 
 
o Has there ever been a period lasting two weeks or more when you felt tired out all the 
time?  
o No [0] 
o Yes [1] 
 
From the slow/restless summary 
 
o Has there ever been a period of two weeks or more when you talked or moved more 
slowly than is normal for you? 
o No [0] 
o Yes [1] 
 
Total fatigue score = sum 
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3. Center of Epidemiology Studies–Depression scale (CESD)  
 
During the last week: 
 
• I was bothered by things that usually don’t bother me. 
o Rarely or some of the time (less than 1 day) [0] 
o Some or a little of the time (1–2 days) [1] 
o Occasionally or a moderate amount of the time (3–4 days) [2] 
o Most or all of the time (5–7 days) [3] 
 
• I did not feel like eating: my appetite was poor. 
o Rarely or some of the time (less than 1 day) [0] 
o Some or a little of the time (1–2 days) [1] 
o Occasionally or a moderate amount of the time (3–4 days) [2] 
o Most or all of the time (5–7 days) [3] 
 
• I felt that I could not shake off the blues even with the help from my family or friends. 
o Rarely or some of the time (less than 1 day) [0] 
o Some or a little of the time (1–2 days) [1] 
o Occasionally or a moderate amount of the time (3–4 days) [2] 
o Most or all of the time (5–7 days) [3] 
 
• I felt I was just as good as other people. 
o Rarely or some of the time (less than 1 day) [3] 
o Some or a little of the time (1–2 days) [2] 
o Occasionally or a moderate amount of the time (3–4 days) [1] 
o Most or all of the time (5–7 days) [0] 
 
• I had trouble keeping my mind on what I was doing. 
o Rarely or some of the time (less than 1 day) [0] 
o Some or a little of the time (1–2 days) [1] 
o Occasionally or a moderate amount of the time (3–4 days) [2] 
o Most or all of the time (5–7 days) [3] 
 
• I felt depressed. 
o Rarely or some of the time (less than 1 day) [0] 
o Some or a little of the time (1–2 days) [1] 
o Occasionally or a moderate amount of the time (3–4 days) [2] 
o Most or all of the time (5–7 days) [3] 
 
• I felt that everything I did was an effort. 
o Rarely or some of the time (less than 1 day) [0] 
o Some or a little of the time (1–2 days) [1] 
o Occasionally or a moderate amount of the time (3–4 days) [2] 
o Most or all of the time (5–7 days) [3] 
 
• I felt hopeless about the future. 
o Rarely or some of the time (less than 1 day) [0] 
o Some or a little of the time (1–2 days) [1] 
 203 
o Occasionally or a moderate amount of the time (3–4 days) [2] 
o Most or all of the time (5–7 days) [3] 
 
• I felt my life had been a failure. 
o Rarely or some of the time (less than 1 day) [0] 
o Some or a little of the time (1–2 days) [1] 
o Occasionally or a moderate amount of the time (3–4 days) [2] 
o Most or all of the time (5–7 days) [3] 
 
• My sleep was restless. 
o Rarely or some of the time (less than 1 day) [0] 
o Some or a little of the time (1–2 days) [1] 
o Occasionally or a moderate amount of the time (3–4 days) [2] 
o Most or all of the time (5–7 days) [3] 
 
• I was happy. 
o Rarely or some of the time (less than 1 day) [3] 
o Some or a little of the time (1–2 days) [2] 
o Occasionally or a moderate amount of the time (3–4 days) [1] 
o Most or all of the time (5–7 days) [0] 
 
• I talked less than usual. 
o Rarely or some of the time (less than 1 day) [0] 
o Some or a little of the time (1–2 days) [1] 
o Occasionally or a moderate amount of the time (3–4 days) [2] 
o Most or all of the time (5–7 days) [3] 
 
• I felt lonely. 
o Rarely or some of the time (less than 1 day) [0] 
o Some or a little of the time (1–2 days) [1] 
o Occasionally or a moderate amount of the time (3–4 days) [2] 
o Most or all of the time (5–7 days) [3] 
 
• People were unfriendly. 
o Rarely or some of the time (less than 1 day) [0] 
o Some or a little of the time (1–2 days) [1] 
o Occasionally or a moderate amount of the time (3–4 days) [2] 
o Most or all of the time (5–7 days) [3] 
 
• I enjoyed life. 
o Rarely or some of the time (less than 1 day) [3] 
o Some or a little of the time (1–2 days) [2] 
o Occasionally or a moderate amount of the time (3–4 days) [1] 
o Most or all of the time (5–7 days) [0] 
 
• I had crying spells. 
o Rarely or some of the time (less than 1 day) [0] 
o Some or a little of the time (1–2 days) [1] 
o Occasionally or a moderate amount of the time (3–4 days) [2] 
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o Most or all of the time (5–7 days) [3] 
 
• I felt sad. 
o Rarely or some of the time (less than 1 day) [0] 
o Some or a little of the time (1–2 days) [1] 
o Occasionally or a moderate amount of the time (3–4 days) [2] 
o Most or all of the time (5–7 days) [3] 
 
• I felt that people disliked me. 
o Rarely or some of the time (less than 1 day) [0] 
o Some or a little of the time (1–2 days) [1] 
o Occasionally or a moderate amount of the time (3–4 days) [2] 
o Most or all of the time (5–7 days) [3] 
 
• I could not get going 
o Rarely or some of the time (less than 1 day) [0] 
o Some or a little of the time (1–2 days) [1] 
o Occasionally or a moderate amount of the time (3–4 days) [2] 
o Most or all of the time (5–7 days) [3] 
 
CESD Total Score = sum 
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4. Beck Depression Inventory (BDI) 
 
English  
 
Oral administration: 
This is a questionnaire. On the questionnaire are groups of statements. I will read a 
group of statements; then I would like you to pick out the one statement in each group 
that best describes the way you have been feeling during the past 2 weeks, including 
today. Now which of the statements best describes the way you have been feeling 
during the past 1 week, including today? 
 
1. Sadness 
I do not feel sad (0) 
I feel blue or sad a large part of the time (1) 
I feel sad the whole time (2) 
I feel so sad or unhappy that I can’t stand it (3) 
 
2. Pessimism 
I am not pessimistic about the future (0) 
I feel more discouraged about my future than is normal (1) 
I feel that things don’t turn out well for me (2) 
I feel that the future is hopeless and that things cannot improve (3) 
 
3. Past failure 
I do not feel like a failure (0) 
I feel I have failed more than an average person (1) 
As I look back at my life I can see a lot of failure (2) 
I feel I am a complete failure as a person (3) 
 
4. Loss of pleasure 
I obtain as much pleasure as before in the things that I enjoy (0) 
I don’t enjoy the things the way that I used to (1) 
I don’t get satisfaction out of anything any more (2) 
I am dissatisfied with anything (3) 
 
5. Guilty feelings 
I don’t feel I am being punished (0) 
I feel guilty for many things that I have done or should to have done and did not I do 
(1) 
I feel bad or unworthy practically all the time (2) 
I feel as though I am very bad or worthless (3) 
 
6. Punishment feelings 
I don’t feel as I am punished (0) 
I feel like am being punished or will be punished (1) 
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I feel I deserve to be punished (2) 
I feel that I am being punished for live (3) 
 
7. Self dislike 
I do not feel disappointed in myself (0) 
I am disappointed with myself (1) 
I am disgusted with myself (2) 
I hate myself (3) 
 
8. Self criticalness 
I don’t feel any worse than anybody else (0) 
I am very critical of myself for my mistakes (1) 
I blame myself for everything that goes wrong (2) 
I have many bad faults (3) 
 
9. Suicidal thoughts or wishes 
I do not have any thoughts of harming myself (0) 
I have thoughts of harming myself but I would not carry them out (1) 
I would like to kill myself (2) 
I would kill myself if I could (3) 
 
10. Crying 
I don’t cry anymore than usual (0) 
I cry more now than I used to (1) 
I cry all the time now (2) 
I feel like I would like to cry, but I can’t (3) 
 
11. Agitation 
I am no more restless or tense than normal (0) 
I get restless or tense more easily than I used to (1) 
I am that restless or agitated that it is difficult for me to remain quit (2) 
I am that restless or agitated that I have to keep moving or doing something constantly 
(3) 
 
12. Loss of interest 
I have not lost interest in other people or activities (0) 
I am less interested in other people or activities than I used to be (1) 
I have lost most of my interest in other people or activities (2) 
I have difficulties to be interested in anything (3) 
 
13. Indecisiveness 
I make decisions about as well as ever (0) 
It is more difficult for me to make decisions than usual (1) 
I have much greater difficulties making decisions then usual (2) 
I can’t make decisions at all anymore (3) 
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14. Worthlessness 
I do not feel as if I am worthless (0) 
I do not think of myself as worthy and useful as before (1) 
I feel worthless in comparison to others (2) 
I feel completely worthless (3) 
 
15. Loss of energy 
I have as much energy as before (0) 
I have less energy than I used to (1) 
I have not enough energy to do many things (2) 
I have not enough energy left for anything (3) 
 
16. Changes in sleeping patterns 
I can sleep as well as usual (0) 
I sleep a bit more than usual or I sleep a bit less than usual (1) 
I sleep much more than usual or I sleep much less than usual (2) 
I sleep all day or I wake up 1–2 hours earlier and cannot go back to sleep (3) 
 
17. Irritability 
I am no more irritable than usual (0) 
I am more irritable than usual (1) 
I am much more irritable than usual (2) 
I am irritable most of the time (3) 
 
18. Changes in appetite 
I did not experience any change in appetite (0) 
My appetite is a little less than it used to be or my appetite is a little bigger than it used 
to be (1) 
My appetite is much worse now than it used to be or my appetite is much bigger now 
than it used to be (2) 
I have no appetite at all anymore or I want to eat all the time (3) 
 
19. Concentration difficulty 
I can concentrate as well as always (0) 
I cannot concentrate as well as I am used to (1) 
It is difficult for me to focus for most of the time (2) 
I feel like I cannot concentrate on anything (3) 
 
20. Tiredness or fatigue 
I no not get any more tired or fatigued than usual (0) 
I get tired or fatigued more easily than I used to (1) 
I get tired or fatigued by many things even before I start doing them (2) 
I get tired or fatigue by most of the things even before I start doing them (3) 
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21. Loss of interest in sex 
I have not noticed any recent change in my interest in sex (0) 
I am less interested in sex than I used to be (1) 
I am much less interested in sex now (2) 
I have lost interest in sex completely (3) 
 
BDI Total Score = sum 
 
 
 209 
5. Fatigue Severity Scale (FSS) 
 
Over the last 2 weeks: 
 
1. My motivation is lower when I am fatigued. 
2. Exercise brings on my fatigue. 
3. I am easily fatigued. 
4. Fatigue interferes with my physical functioning. 
5. Fatigue causes frequent problems for me. 
6. My fatigue prevents sustained physical functioning. 
7. Fatigue interferes with carrying out certain duties and responsibilities. 
8. Fatigue is among my three most disabling symptoms. 
9. Fatigue interferes with my work, family, or social life. 
 
FSS Total Score = sum/9 
 210 
6. General Health Questionnaire (GHQ) 
 
Over the past few weeks, have you: 
 
• Been feeling perfectly well and in good health? 
o Better than usual (0) 
o Same as usual (1) 
o Worse than usual (2) 
o Much worse than usual (3) 
• Been feeling in need of some medicine to pick you up? 
o Not at all (0) 
o No more than usual (1) 
o Somewhat more than usual (2) 
o Much more than usual (3) 
• Been feeling run down and out of sorts?  
o Not at all (0) 
o No more than usual (1) 
o Somewhat more than usual (2) 
o Much more than usual (3 
• Felt that you are ill? 
o Not at all (0) 
o No more than usual (1) 
o Somewhat more than usual (2) 
o Much more than usual (3) 
• Been getting pains in your head? 
o Not at all (0) 
o No more than usual (1) 
o Somewhat more than usual (2) 
o Much more than usual (3) 
• Been getting a feeling of tightness or pressure in your head? 
o Not at all (0) 
o No more than usual (1) 
o Somewhat more than usual (2) 
o Much more than usual (3) 
• Been having hot and cold spells? 
o Not at all (0) 
o No more than usual (1) 
o Somewhat more than usual (2) 
o Much more than usual (3) 
• Lost much sleep over worry? 
o Not at all (0) 
o No more than usual (1) 
o Somewhat more than usual (2) 
o Much more than usual (3) 
• Had difficulty staying asleep? 
o Not at all (0) 
o No more than usual (1) 
o Somewhat more than usual (2) 
o Much more than usual (3) 
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• Felt constantly under strain? 
o Not at all (0) 
o No more than usual (1) 
o Somewhat more than usual (2) 
o Much more than usual (3) 
• Been getting edgy and bad tempered? 
o Not at all (0) 
o No more than usual (1) 
o Somewhat more than usual (2) 
o Much more than usual (3) 
• Been getting scared or panicky for no good reason? 
o Not at all (0) 
o No more than usual (1) 
o Somewhat more than usual (2) 
o Much more than usual (3) 
• Found everything getting on top of you? 
o Not at all (0) 
o No more than usual (1) 
o Somewhat more than usual (2) 
o Much more than usual (3) 
• Been feeling nervous and uptight all the time? 
o Not at all (0) 
o No more than usual (1) 
o Somewhat more than usual (2) 
o Much more than usual (3) 
• Been managing to keep yourself busy and occupied? 
o More so than usual (0) 
o Same as usual (1) 
o Somewhat less than usual (2) 
o Much less than usual (3) 
• Been taking longer over the things you do? 
o Quicker than usual (0) 
o Same as usual 91) 
o Longer than usual (2) 
o Much longer than usual (3) 
• Felt on the whole you were doing things well? 
o Better than usual (0) 
o About the same (1) 
o Less well than usual (2) 
o Much less well (3) 
• Been satisfied with the way you’ve carried out your task? 
o More satisfied (0) 
o About the same as usual (1) 
o Less satisfied than usual (2) 
o Much less satisfied (3) 
• Felt that you are playing a useful part in things? 
o More so than usual (0) 
o Same as usual (1) 
o Somewhat less than usual (2) 
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o Much less than usual (3) 
• Felt capable of making decisions about things? 
o More so than usual (0) 
o Same as usual (1) 
o Somewhat less than usual (2) 
o Much less than usual (3) 
• Been able to enjoy your normal day-to-day activities? 
o More so than usual (0) 
o Same as usual (1) 
o Somewhat less than usual (2) 
o Much less than usual (3) 
• Been thinking of yourself as a worthless person? 
o Not at all (0) 
o No more than usual (1) 
o Somewhat more than usual (2) 
o Much more than usual (3) 
• Felt that life is entirely hopeless? 
o Not at all (0) 
o No more than usual (1) 
o Somewhat more than usual (2) 
o Much more than usual (3) 
• Felt that life isn’t worth living? 
o Not at all (0) 
o No more than usual (1) 
o Somewhat more than usual (2) 
o Much more than usual (3) 
• Thought of the possibility that you might do away with yourself? 
o Definitely not (0) 
o I don’t think so (1) 
o Has crossed my mind (2) 
o Definitely have (3) 
• Found at times you couldn’t do anything because your nerves were too bad? 
o Not at all (0) 
o No more than usual (1) 
o Somewhat more than usual (2) 
o Much more than usual (3) 
• Found yourself wishing you were dead and away from it all? 
o Not at all (0) 
o No more than usual (1) 
o Somewhat more than usual (2) 
o Much more than usual (3) 
• Found that the idea of taking your own life kept coming into your mind? 
o Not at all (0) 
o No more than usual (1) 
o Somewhat more than usual (2) 
o Much more than usual (3) 
 
 GHQ Total Score = sum 
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7. Mexico 2001 
 
Screening (Stage 1) 
1. Age: 
 
2. Age of you children younger than 18 years (from youngest to oldest) 
1. 
2. 
3. 
4. 
5. 
6. 
 
3. Marital status:____________ 
 
4. Factory: 
 
5. Type of activity in factory: 
1. Sewing 
2. Inspection 
3. labels 
4. sleeves 
5. making pockets 
6. ironing 
7. packaging 
8. Sales department 
9. quality control 
10. embroidering 
11. cutting the clothes 
12. cleaning the facility 
13. other (_________________________) 
 
6. How long do you do this kind of activity? _________ 
 
7. Do you have another employment?  
Yes:  No: Type:________________________ 
 
8. Do you use oral contraceptives? 
Yes No 
 
9. Date of last menstruation:_____________ 
 
10. Cycle is regular?  
Yes No 
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11. Are you currently:  
Pregnant 
Breast feeding 
None of the above 
 
12. Weight (kg):_______________ 
 
13. Height (m):________________ 
 
2nd Stage:  
 
Ms. ………………….(name of participant), thank you for participating in our study. 
My name is …………………..(name of interviewer). During this interview we will 
talk about how you have been feeling recently. In addition, I will ask you a few 
questions about your home. This information will help us to understand how your 
nutrition affects you. Before we start, I would like to remind you that we can stop this 
interview at any time, if you wish so. Please feel free to interrupt and ask me, if my 
questions are not clear. It is important to us that we understand your life as best as we 
can. 
 
First I would like to ask you a few general questions in the beginning: 
 
1. How old are you?_____________ 
 
2. What is your birth date?______________ 
 
I would like to learn a bit more about your family. I am going to read you a few 
answer choices to my questions. Please indicate which option describes your situation 
best: 
 
3. Do you have children? 
Yes___________ No____________ 
(if answer is no please skip to question 7) 
 
4. Are you  
Married 
Married but separated 
Divorced 
Not married, but father of child/children lives with you 
Not married, father does not live in house 
 
5. Does the father help you with the child care? 
 
6. Do you live 
By yourself 
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With a friend 
With your parents 
With your parents-in-law 
With siblings 
Other person (_____________________) 
 
(only ask if children were indicated) Now I would like to ask a few questions about 
your children and other persons who live in the house:  
 
7. How many children under 18 live in the household?_______ 
 
8. How many rooms do you have?__________ 
 
9. How many persons sleep in your household?_________ 
 
Now I would like to ask you a few questions about your time use. This includes the 
time at work and at home. I will give you the answer choices, please indicate which 
one describes best your situation. 
 
10. How many hours did you work in the factory during a typical day? 
1–4 hours____ 
5–6 hours____ 
7–8 hours______ 
More than 8 hours______ 
 
11. Did you have a second job in the previous month? 
Yes No (if no, skip to q.14) 
 
If yes: 12. For you second job, do you work  
Outside of home 
At home 
At home and outside of your home 
 
13. How many days a week do you work in your second job? 
1–3 days______ 
4–5 days______ 
6 days_______ 
7 days_______ 
 
Before continuing, I would like to remind you that all the information you are giving 
us is completely confidential. 
 
14. Out of which material is the floor of your household? 
Soil 
Concrete 
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Tiles, wood, or other 
Don’t know 
 
15. Out of which materiel are most of the walls of your household? 
Carton 
Bamboo or palm tree 
Mud or plaster 
Wood 
Sheets of asbestos or metal 
Brick (clay) 
Brick (e.g. concrete) 
Other_____________________ 
Don’t know 
 
16. Out of which material is the roof of your home? 
Carton 
Bamboo or palm tree 
Sheet of asbestos or metal 
Tile 
Concrete, wood 
Other 
Don’t know 
 
17. Do you have a separate room for cooking in your home? 
Si No 
 
18. Do you use that room for cooking and for sleeping? 
Si No 
 
19. How many rooms do you have in total in your house, without counting walkways, 
the bath and the kitchen? 
 
 
20. What type of water do you have in your house? 
Tap in the kitchen or bath 
Tap outside of home, right next to it  
             Water form a public bath or hydrant 
Water from a well or pump 
Water from a spring, river or lake 
Water from a pipe 
Other……………… 
 
 
21. The people in your home use 
A toilet 
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A latrine 
An outhouse 
A hole in the ground 
Do not use a special place 
 
22. What do you do with the waste? Do they go in the 
Ground 
River or lake 
Septic tank 
Public system 
There is no system for it 
 
23. Does your home have a (number) 
Radio or recorder……… 
TV………… 
VCR……….. 
Telephone or cell………… 
Refrigerator…………. 
Washing machine………… 
Car, truck or motor cycle…………. 
 
24. You monthly income is  
<437724 pesos 
4377–8754 
>8754 
 
25. The household income is  
<4377 pesos 
4377–8754 
>8754 
 
Health Check list 
 
26. Smoking 
Yes No 
 
If yes: 27. Number of cigarettes per day:________ 
 
28. Drinks alcohol 
Yes No  
 
If yes: 29. daily weekly  monthly Number of glasses:________ 
 
                                                 
24 Equivalent of $147 in summer 2001 
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30. Takes medication: 
Yes No 
 
If yes:31. Specify___________ 
 
32. Diarrhea (this or last week):  
Yes No 
 
33. Chronic diseases (over the last 3 months) 
 
Hypertension 
Yes No 
 
Diabetes 
Yes No 
 
Rheumatisms 
Yes No 
 
Cardiovascular 
Yes No 
 
Cancer 
Yes No 
 
34. Respiratory disease: 
 
Upper respiratory 
Yes No 
 
Bronchitis 
Yes No 
 
Pulmonary 
Yes No 
 
Asthma 
Yes No 
 
35. Other illness, accidents or surgery:____________________________________ 
 
36. Amenorrhea: 
Yes no 
 
37. Date of last menstruation: 
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Yes no 
 
38. Regular cycle: 
Yes No 
 
3rd stage (stress): 
 
Initial information 
 
Before we begin, I would like to ask you some questions, in order to whether there 
might be factors that affect the concentrations of hormones in you saliva. 
1. Are you pregnant? 
Yes No 
 
2. During the last month, did you take oral contraceptives? 
Yes No  
 
Form for participant for record keeping of 1st saliva sample at home 
 
3. Time of wake-up 
Hour s Minutes 
 
4. Time of saliva sample at home (30 minutes after wake-up) 
Hour Minute 
 
Reminder form for participant of sampling time 
 
5. Time of 2nd sample 
Hour Minute 
 
6. Time of 3rd sample 
Hour Minute 
 
7. Time of 4th sample 
Hour  Minute 
 
Form for interviewer for record keeping of sampling 
 
8. Time of wake up 
Hour Minute  
 
9. Time of sampling of first sample 
Hour Minute 
 
10. Programmed time of 2nd sample (+3 hours after wake up) 
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Hour Minute 
 
11. Actual time 2nd sample 
Hour Minute 
 
12. Programmed time of 3rd sample (+7 hours after wake up) 
Hour Minute 
 
13. Actual time of 3rd sample 
Hour  Minute 
 
14. Programmed time of 4th sample (+10 hours after wake up) 
Hour  Minute 
 
15. Actual time of 4th sample 
Hour  Minute 
 
Quality Control 
 
16. Did anything unusual happen today? 
……………………………………….. 
 
17. Did you think that you experienced something particularly stressful or difficult 
today? 
Yes No 
 
If yes: Could you please explain? 
………………………………………………… 
 
When did this event occur? 
 Hour Minute 
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